drugName,cIds,drugNameOfficial,molecularWeight,smilesString,SMILES,Target
Lenalidomide,CIDs00216326,lenalidomide,259.26062,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,CRL4(CRBN) E3 ubiquitin ligase
Cladribine,CIDs00020279,cladribine,285.68698,C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O,C1C(C(OC1N2C=NC3=C(N=C(N=C32)Cl)N)CO)O,DNA
Pentostatin,CIDs00439693,pentostatin,268.26914,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,Adenosine deaminase
Everolimus,CIDs06442177,everolimus,958.22442,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OCCO)C)C)O)OC)C)C)C)OC,FK506-binding protein 1A
Aminoglutethimide,CIDs00002145,aminoglutethimide,232.27834,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,"Cytochrome P450 19A1, Cytochrome P450 11A1"
Letrozole,CIDs00003902,letrozole,285.30274,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,Cytochrome P450 19A1
Pemetrexed disodium,CIDs135413520,,0,,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+],"Dihydrofolate reductase, GAR transformylase, Thymidylate synthase"
Plinabulin,CIDs09949641,plinabulin,336.3877,CC(C)(C)C1=C(N=CN1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2,CC(C)(C)C1=C(N=CN1)C=C2C(=O)NC(=CC3=CC=CC=C3)C(=O)N2,Tubulin
Topotecan hydrochloride,CIDs00060699,topotecan,457.90676,CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O.Cl,CCC1(C2=C(COC1=O)C(=O)N3CC4=CC5=C(C=CC(=C5CN(C)C)O)N=C4C3=C2)O.Cl,"DNA topoisomerase I, mitochondrial"
5-Azacitidine,CIDs00009444,5-azacytidine,244.20468,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,"DNA (cytosine-5)-methyltransferase 3A, DNA (cytosine-5)-methyltransferase 1, DNA, RNA"
Actinomycin D,CIDs00457193,Lyovac Cosmegen,1255.41704,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,DNA
Itraconazole,CIDs00003793,itraconazole oral solution,705.63342,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,Cytochrome P450 51
Hydroxychloroquine sulfate,CIDs00012947,,0,,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O,"Toll-like receptor 7, Toll-like receptor 9, Ferriprotoporphyrin IX"
Acadesine,CIDs00017513,acadesine,258.23126,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)N)C(=O)N,"AMP-activated protein kinase, AMPK"
DCC-2036,CIDs25066467,rebastinib,553.586823,CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5,CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=CC(=NC=C3)C(=O)NC)F)C4=CC5=C(C=C4)N=CC=C5,Tyrosine-protein kinase ABL
Dasatinib,CIDs03062316,dasatinib,488.00554,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO,"SRC, Stem cell growth factor receptor, Platelet-derived growth factor receptor beta, Bcr/Abl fusion protein, Tyrosine-protein kinase ABL, Ephrin type-A receptor 2"
Bosutinib,CIDs05328940,bosutinib,530.44616,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,"Tyrosine-protein kinase Lyn, Tyrosine-protein kinase SRC, Tyrosine-protein kinase ABL, Tyrosine-protein kinase HCK"
Saracatinib,CIDs10302451,saracatinib,542.02648,CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6,CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl,"Tyrosine-protein kinase SRC, Tyrosine-protein kinase ABL"
Vandetanib,CIDs03081361,vandetanib,475.353963,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,"Epidermal growth factor receptor, Tyrosine-protein kinase TIE-2, Tyrosine-protein kinase SRC, Tyrosine-protein kinase BRK, Vascular endothelial growth factor receptor, Ephrin receptor, Tyrosine-protein kinase receptor RET"
Gefitinib,CIDs00123631,gefitinib,446.902363,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,Epidermal growth factor receptor erbB1
Neratinib,CIDs09915743,neratinib,557.04266,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2, Receptor protein-tyrosine kinase erbB-4"
Dacomitinib,CIDs11511120,dacomitinib,469.939003,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2, Receptor protein-tyrosine kinase erbB-4"
AEE-788,CIDs10297043,NVP-AEE788,440.58318,CCN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N3)N=CN=C4NC(C)C5=CC=CC=C5,CCN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N3)N=CN=C4NC(C)C5=CC=CC=C5,"Epidermal growth factor receptor erbB1, Vascular endothelial growth factor receptor 2, Receptor protein-tyrosine kinase erbB-2, Vascular endothelial growth factor receptor 1"
CUDC-101,CIDs24756910,CUDC-101,434.48764,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,"Histone deacetylase, Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2"
Pelitinib,CIDs06445562,pelitinib,467.923123,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C,CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C,Epidermal growth factor receptor erbB1
Linifanib,CIDs11485656,linifanib,375.398923,CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N,CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N,"Macrophage colony stimulating factor receptor, Vascular endothelial growth factor receptor, Tyrosine-protein kinase receptor FLT3, Platelet-derived growth factor receptor"
Axitinib,CIDs06450551,axitinib,386.46952,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,Vascular endothelial growth factor receptor
Vatalanib,CIDs00151194,,0,,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4,"Macrophage colony stimulating factor receptor, Vascular endothelial growth factor receptor, Stem cell growth factor receptor, Platelet-derived growth factor receptor"
Motesanib,CIDs11667893,motesanib,373.45092,CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C,CC1(CNC2=C1C=CC(=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4)C,"Platelet-derived growth factor receptor, Stem cell growth factor receptor, Tyrosine-protein kinase receptor RET, Vascular endothelial growth factor receptor"
Tivozanib,CIDs09911830,tivozanib,454.86306,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,Vascular endothelial growth factor receptor
Brivanib,CIDs11234052,brivanib,370.377563,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NN4C3=C(C(=C4)OCC(C)O)C,"Fibroblast growth factor receptor, Vascular endothelial growth factor receptor"
Telatinib,CIDs09808844,telatinib,409.82574,CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl,CNC(=O)C1=NC=CC(=C1)COC2=NN=C(C3=C2OC=C3)NC4=CC=C(C=C4)Cl,"Vascular endothelial growth factor receptor 3, Vascular endothelial growth factor receptor 2, Stem cell growth factor receptor, Platelet-derived growth factor receptor beta"
Cediranib,CIDs09933475,cediranib,450.505283,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,"Vascular endothelial growth factor receptor, Stem cell growth factor receptor, Platelet-derived growth factor receptor"
BMS-794833,CIDs44155856,BMS 794833,468.840006,C1=CC(=CC=C1C2=CNC=C(C2=O)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F)F,C1=CC(=CC=C1C2=CNC=C(C2=O)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F)F,"Vascular endothelial growth factor receptor 2, Hepatocyte growth factor receptor"
OSI-632,CIDs09811611,CP-547632,532.402066,C1CCN(C1)CCCCNC(=O)NC2=C(C(=NS2)OCC3=C(C=C(C=C3F)Br)F)C(=O)N,C1CCN(C1)CCCCNC(=O)NC2=C(C(=NS2)OCC3=C(C=C(C=C3F)Br)F)C(=O)N,Vascular endothelial growth factor receptor 2
Foretinib,CIDs42642645,Foretinib,632.653766,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,"Tyrosine-protein kinase TIE-2, Tyrosine-protein kinase receptor FLT3, Platelet-derived growth factor receptor, Stem cell growth factor receptor, Vascular endothelial growth factor receptor, Hepatocyte growth factor receptor"
Regorafenib,CIDs11167602,regorafenib,482.815413,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,"Vascular endothelial growth factor receptor, Tyrosine-protein kinase TIE-2, Discoidin domain-containing receptor 2, Nerve growth factor receptor Trk-A, Serine/threonine-protein kinase RAF, Serine/threonine-protein kinase B-raf, Platelet-derived growth factor receptor, Stem cell growth factor receptor, Tyrosine-protein kinase ABL, MAP kinase p38 beta, Tyrosine-protein kinase FRK, Ephrin type-A receptor 2, Fibroblast growth factor receptor 2, Tyrosine-protein kinase receptor RET, Fibroblast growth factor receptor 1"
Dovitinib,CIDs135398510,,0,,CN1CCN(CC1)C2=CC3=C(C=C2)N=C(N3)C4=C(C5=C(C=CC=C5F)NC4=O)N,"Tyrosine-protein kinase receptor FLT3, Platelet-derived growth factor receptor, Stem cell growth factor receptor, Fibroblast growth factor receptor 3, Vascular endothelial growth factor receptor"
Masitinib,CIDs10074640,masitinib,498.6424,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,"Stem cell growth factor receptor, Fibroblast growth factor receptor 3, Platelet-derived growth factor receptor"
SG-00529,CIDs11998575,Palomid 529,406.42788,CC(C1=CC2=C(C=C1)C3=CC(=C(C=C3OC2=O)OCC4=CC=C(C=C4)OC)OC)O,CC(C1=CC2=C(C=C1)C3=CC(=C(C=C3OC2=O)OCC4=CC=C(C=C4)OC)OC)O,Serine/threonine-protein kinase mTOR
Amuvatinib,CIDs11282283,amuvatinib,447.50954,C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6,C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6,"Tyrosine-protein kinase receptor FLT3, Platelet-derived growth factor receptor alpha, Stem cell growth factor receptor, Hepatocyte growth factor receptor"
OSI-930,CIDs09868037,OSI-930,443.44155,C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F,C1=CC=C2C(=C1)C(=CC=N2)CNC3=C(SC=C3)C(=O)NC4=CC=C(C=C4)OC(F)(F)F,"Stem cell growth factor receptor, Vascular endothelial growth factor receptor"
Crizotinib,CIDs11626560,crizotinib,450.336683,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,"ALK tyrosine kinase receptor, NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor), Hepatocyte growth factor receptor, EML4-ALK"
BMS-777607,CIDs24794418,BMS-777607,512.892566,CCOC1=C(C(=O)N(C=C1)C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F,CCOC1=C(C(=O)N(C=C1)C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C(=NC=C4)N)Cl)F,Hepatocyte growth factor receptor
PF-04217903,CIDs17754438,PF-04217903,372.38334,C1=CC2=C(C=CC(=C2)CN3C4=NC(=CN=C4N=N3)C5=CN(N=C5)CCO)N=C1,C1=CC2=C(C=CC(=C2)CN3C4=NC(=CN=C4N=N3)C5=CN(N=C5)CCO)N=C1,Hepatocyte growth factor receptor
JNJ-38877605,CIDs46911863,JNJ-38877605,377.350226,CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2,CN1C=C(C=N1)C2=NN3C(=NN=C3C(C4=CC5=C(C=C4)N=CC=C5)(F)F)C=C2,Hepatocyte growth factor receptor
SGX-523,CIDs24779724,SGX-523,359.40772,CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=C(C=C4)N=CC=C5)C=C2,CN1C=C(C=N1)C2=NN3C(=NN=C3SC4=CC5=C(C=C4)N=CC=C5)C=C2,Hepatocyte growth factor receptor
Linsitinib,CIDs11640390,linsitinib,421.49372,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,"Insulin receptor, Insulin-like growth factor I receptor"
LY2157299,CIDs10090485,galunisertib,369.41916,CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,TGF-beta receptor type I
Tandutinib,CIDs03038522,tandutinib,562.70298,CC(C)OC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCCC5,CC(C)OC1=CC=C(C=C1)NC(=O)N2CCN(CC2)C3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCCC5,"Tyrosine-protein kinase receptor FLT3, Stem cell growth factor receptor, Platelet-derived growth factor receptor beta"
Quizartinib,CIDs24889392,quizartinib,560.66718,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,"Tyrosine-protein kinase receptor FLT3, Platelet-derived growth factor receptor, Stem cell growth factor receptor, Macrophage colony stimulating factor receptor, Tyrosine-protein kinase receptor RET"
R-406,CIDs11213558,R406 free base,470.453623,CC1(C(=O)NC2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)C,CC1(C(=O)NC2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)C,Tyrosine-protein kinase SYK
Pictilisib,CIDs17755052,pictilisib,513.63558,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,PI3-kinase class I
GSK-2126458,CIDs25167777,GSK2126458,505.495986,COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F,COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F,"PI3-kinase class I, Serine/threonine-protein kinase mTOR"
BKM-120,CIDs16654980,NVP-BKM120,410.39355,C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4,C1COCCN1C2=NC(=NC(=C2)C3=CN=C(C=C3C(F)(F)F)N)N4CCOCC4,PI3-kinase class I
Idelalisib,CIDs11625818,idelalisib,415.423023,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PI3-kinase p110-delta subunit
AZD-6482,CIDs44137675,AZD-6482,408.45036,CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3C(=O)O)N4CCOCC4,CC1=CN2C(=O)C=C(N=C2C(=C1)C(C)NC3=CC=CC=C3C(=O)O)N4CCOCC4,PI3-kinase class I
MK-2206,CIDs24964624,MK-2206 dihydrochloride,407.46714,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,C1CC(C1)(C2=CC=C(C=C2)C3=C(C=C4C(=N3)C=CN5C4=NNC5=O)C6=CC=CC=C6)N,Serine/threonine-protein kinase AKT
GSK-690693,CIDs16725726,GSK690693,425.48418,CCN1C2=C(C(=NC=C2OCC3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N,CCN1C2=C(C(=NC=C2OCC3CCCNC3)C#CC(C)(C)O)N=C1C4=NON=C4N,"Serine/threonine-protein kinase AKT, Protein kinase C (PKC), cAMP-dependent protein kinase (PKA)"
BEZ-235,CIDs11977753,NVP-BEZ235,469.53652,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,CC(C)(C#N)C1=CC=C(C=C1)N2C3=C4C=C(C=CC4=NC=C3N(C2=O)C)C5=CC6=CC=CC=C6N=C5,"PI3-kinase class I, Serine/threonine-protein kinase mTOR"
PF-05212384,CIDs44516953,PKI-587,615.72584,CN(C)C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6,CN(C)C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6,"PI3-kinase class I, Serine/threonine-protein kinase mTOR"
GDC-0980,CIDs25254071,Apitolisib,498.6011,CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)C(C)O,CC1=C(SC2=C1N=C(N=C2N3CCOCC3)C4=CN=C(N=C4)N)CN5CCN(CC5)C(=O)C(C)O,"PI3-kinase class I, Serine/threonine-protein kinase mTOR"
AZD-8055,CIDs25262965,AZD8055,465.54474,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOCC5C,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=C(C=C4)OC)CO)N5CCOCC5C,Serine/threonine-protein kinase mTOR
Salirasib,CIDs05469318,salirasib,358.5374,CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C,CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C,RAS
VX-702,CIDs10341154,vx-702,404.317793,C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F,C1=CC(=C(C(=C1)F)N(C2=NC(=C(C=C2)C(=O)N)C3=C(C=C(C=C3)F)F)C(=O)N)F,MAP kinase p38 alpha
VX-745,CIDs03038525,Vx-745,436.262066,C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl,C1=CC(=C(C(=C1)Cl)C2=C3C=CC(=NN3C=NC2=O)SC4=C(C=C(C=C4)F)F)Cl,MAP kinase p38 alpha
Doramapimod,CIDs00156422,BIRB796,527.65718,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,MAP kinase p38 alpha
PH-797804,CIDs22049997,PH-797804,477.298666,CC1=C(C=C(C=C1)C(=O)NC)N2C(=CC(=C(C2=O)Br)OCC3=C(C=C(C=C3)F)F)C,CC1=C(C=C(C=C1)C(=O)NC)N2C(=CC(=C(C2=O)Br)OCC3=C(C=C(C=C3)F)F)C,MAP kinase p38 alpha
RWJ-67657,CIDs03008319,Rwj 67657,425.497363,C1=CC=C(C=C1)CCCN2C(=NC(=C2C3=CC=NC=C3)C4=CC=C(C=C4)F)C#CCCO,C1=CC=C(C=C1)CCCN2C(=NC(=C2C3=CC=NC=C3)C4=CC=C(C=C4)F)C#CCCO,"MAP kinase p38 beta, MAP kinase p38 alpha"
Talmapimod,CIDs09871074,talmapimod,513.003503,CC1CN(C(CN1C(=O)C2=C(C=C3C(=C2)C(=CN3C)C(=O)C(=O)N(C)C)Cl)C)CC4=CC=C(C=C4)F,CC1CN(C(CN1C(=O)C2=C(C=C3C(=C2)C(=CN3C)C(=O)C(=O)N(C)C)Cl)C)CC4=CC=C(C=C4)F,MAP kinase p38 alpha
Bardoxolone methyl,CIDs00400769,CDDO-Me,505.68812,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C,"Peroxisome proliferator-activated receptor gamma, Inhibitor of nuclear factor kappa B kinase beta subunit, Keap1/Nrf2"
IMD-0354,CIDs05081913,IKK-2 inhibitor V,383.672939,C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O,C1=CC(=C(C=C1Cl)C(=O)NC2=CC(=CC(=C2)C(F)(F)F)C(F)(F)F)O,Inhibitor of nuclear factor kappa B kinase beta subunit
cycloheximide,CIDs00006197,cycloheximide,281.34742,CC1CC(C(=O)C(C1)C(CC2CC(=O)NC(=O)C2)O)C,CC1CC(C(=O)C(C1)C(CC2CC(=O)NC(=O)C2)O)C,80S Ribosome
SPC-839,CIDs09820526,A4715,366.39376,CC1=CC(=O)N(C1=O)NC2=NC(=NC3=C2C(=CC=C3)OC)C4=CC=CS4,CC1=CC(=O)N(C1=O)NC2=NC(=NC3=C2C(=CC=C3)OC)C4=CC=CS4,"Inhibitor of nuclear factor kappa B kinase beta subunit, Tyrosine-protein kinase receptor FLT3"
Sulfasalazine,CIDs00005339,,0,,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,"Cyclooxygenase, Arachidonate 5-lipoxygenase"
Navitoclax (ABT-263),CIDs24978538,navitoclax,974.61271,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,CC1(CCC(=C(C1)CN2CCN(CC2)C3=CC=C(C=C3)C(=O)NS(=O)(=O)C4=CC(=C(C=C4)NC(CCN5CCOCC5)CSC6=CC=CC=C6)S(=O)(=O)C(F)(F)F)C7=CC=C(C=C7)Cl)C,"Apoptosis regulator Bcl-X, Apoptosis regulator Bcl-2, Apoptosis regulator Bcl-W"
AZD-7762,CIDs11152667,AZD7762,362.421763,C1CC(CNC1)NC(=O)C2=C(C=C(S2)C3=CC(=CC=C3)F)NC(=O)N,C1CC(CNC1)NC(=O)C2=C(C=C(S2)C3=CC(=CC=C3)F)NC(=O)N,Serine/threonine-protein kinase Chk1
Flavopiridol,CIDs05287969,flavopiridol,401.8402,CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,CN1CCC(C(C1)O)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=CC=C4Cl)O)O,"Cyclin-dependent kinase 2, Cyclin-dependent kinase 9, Cyclin-dependent kinase 1, Cyclin-dependent kinase 7, Cyclin-dependent kinase 6, Cyclin-dependent kinase 4"
Seliciclib,CIDs00160355,roscovitine,354.44934,CCC(CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C,CCC(CO)NC1=NC(=C2C(=N1)N(C=N2)C(C)C)NCC3=CC=CC=C3,"Cyclin-dependent kinase 2, Cyclin-dependent kinase 9, Cyclin-dependent kinase 1, Cyclin-dependent kinase 7, Cyclin-dependent kinase 5"
AT-7519,CIDs11338033,AT7519,382.24448,C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl,C1CNCCC1NC(=O)C2=C(C=NN2)NC(=O)C3=C(C=CC=C3Cl)Cl,Cyclin-dependent kinase
SNS-032,CIDs03025986,Sns-032,380.52806,CC(C)(C)C1=CN=C(O1)CSC2=CN=C(S2)NC(=O)C3CCNCC3,CC(C)(C)C1=CN=C(O1)CSC2=CN=C(S2)NC(=O)C3CCNCC3,"Cyclin-dependent kinase 2, Cyclin-dependent kinase 9, Cyclin-dependent kinase 7"
PHA-793887,CIDs46191454,PHA-793887,361.48174,CC(C)CC(=O)NC1=NNC2=C1CN(C2(C)C)C(=O)C3CCN(CC3)C,CC(C)CC(=O)NC1=NNC2=C1CN(C2(C)C)C(=O)C3CCN(CC3)C,Cyclin-dependent kinase
Palbociclib,CIDs05330286,palbociclib,447.53276,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C,"CDK6/cyclin D1, Cyclin-dependent kinase 4/cyclin D1"
Tozasertib,CIDs05494449,tozasertib,464.58642,CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5,CC1=CC(=NN1)NC2=CC(=NC(=N2)SC3=CC=C(C=C3)NC(=O)C4CC4)N5CCN(CC5)C,Serine/threonine-protein kinase Aurora
Alisertib,CIDs24771867,alisertib,518.923503,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,Serine/threonine-protein kinase Aurora-A
Danusertib,CIDs11442891,danusertib,474.5548,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC,Serine/threonine-protein kinase Aurora
CYC-116,CIDs06420138,CYC116,368.456,CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4,CC1=C(SC(=N1)N)C2=NC(=NC=C2)NC3=CC=C(C=C3)N4CCOCC4,"Vascular endothelial growth factor receptor 2, Serine/threonine-protein kinase Aurora"
Barasertib,CIDs11497983,AZD1152,587.539805,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O,Serine/threonine-protein kinase Aurora-B
AMG-900,CIDs24856041,AMG 900,503.57764,CC1=CSC(=C1)C2=NN=C(C3=CC=CC=C32)NC4=CC=C(C=C4)OC5=C(C=CC=N5)C6=NC(=NC=C6)N,CC1=CSC(=C1)C2=NN=C(C3=CC=CC=C32)NC4=CC=C(C=C4)OC5=C(C=CC=N5)C6=NC(=NC=C6)N,Serine/threonine-protein kinase Aurora
ENMD-981693,CIDs16041424,ENMD-2076,375.4701,CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)C=CC4=CC=CC=C4,CC1=CC(=NN1)NC2=CC(=NC(=N2)C=CC3=CC=CC=C3)N4CCN(CC4)C,"Vascular endothelial growth factor receptor 2, Serine/threonine-protein kinase Aurora-A, Serine/threonine-protein kinase Aurora-B, Stem cell growth factor receptor, Fibroblast growth factor receptor 3, Macrophage colony stimulating factor receptor, Tyrosine-protein kinase receptor FLT3"
CHIR-265,CIDs11656518,CHIR-265,518.413859,CN1C2=C(C=C(C=C2)OC3=CC(=NC=C3)C4=NC=C(N4)C(F)(F)F)N=C1NC5=CC=C(C=C5)C(F)(F)F,CN1C2=C(C=C(C=C2)OC3=CC(=NC=C3)C4=NC=C(N4)C(F)(F)F)N=C1NC5=CC=C(C=C5)C(F)(F)F,"Vascular endothelial growth factor receptor 2, Serine/threonine-protein kinase B-raf"
Vemurafenib,CIDs42611257,vemurafenib,489.922126,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=C2C=C(C=N3)C4=CC=C(C=C4)Cl)F,Serine/threonine-protein kinase B-raf
Refametinib,CIDs44182295,RDEA119,572.33718,COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F,COC1=CC(=C(C(=C1NS(=O)(=O)C2(CC2)CC(CO)O)NC3=C(C=C(C=C3)I)F)F)F,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2"
Selumetinib,CIDs10127622,selumetinib,457.681403,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2"
PD-0325901,CIDs09826528,PD 0325901,482.19304,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2"
Trametinib,CIDs11707110,trametinib,615.394793,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC=CC(=C4)NC(=O)C)C5CC5,Dual specificity mitogen-activated protein kinase kinase; MEK1/2
TAK-733,CIDs24963252,TAK-733,504.226676,CN1C2=C(C(=C(C1=O)F)NC3=C(C=C(C=C3)I)F)C(=O)N(C=N2)CC(CO)O,CN1C2=C(C(=C(C1=O)F)NC3=C(C=C(C=C3)I)F)C(=O)N(C=N2)CC(CO)O,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2"
Ibrutinib (PCI-32765),CIDs24821094,ibrutinib,440.49706,C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,Tyrosine-protein kinase BTK
Midostaurin,CIDs09829523,midostaurin,570.6371,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,"Tyrosine-protein kinase receptor FLT3, Stem cell growth factor receptor, Platelet-derived growth factor receptor, Protein kinase C (PKC), Vascular endothelial growth factor receptor 2"
Enzastaurin,CIDs00176167,,0,,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,Protein kinase C beta
Sotrastaurin,CIDs10296883,sotrastaurin,438.48118,CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,Protein kinase C (PKC)
BI-2536,CIDs11364421,BI 2536,521.65436,CCC1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C,CCC1C(=O)N(C2=CN=C(N=C2N1C3CCCC3)NC4=C(C=C(C=C4)C(=O)NC5CCN(CC5)C)OC)C,Serine/threonine-protein kinase PLK1
GSK-461364A,CIDs15983966,GSK461364A,543.60373,CC(C1=CC=CC=C1C(F)(F)F)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)CN5CCN(CC5)C)C(=O)N,CC(C1=CC=CC=C1C(F)(F)F)OC2=C(SC(=C2)N3C=NC4=C3C=C(C=C4)CN5CCN(CC5)C)C(=O)N,Serine/threonine-protein kinase PLK1
AZD-1480,CIDs16659841,AZD1480,348.765963,CC1=CC(=NN1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=N3)F,CC1=CC(=NN1)NC2=NC(=NC=C2Cl)NC(C)C3=NC=C(C=N3)F,Tyrosine-protein kinase JAK2
Momelotinib,CIDs25062766,momelotinib,414.45978,C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N,C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)NCC#N,"Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK2"
Lestaurtinib,CIDs00126565,lestaurtinib,439.46264,CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O,CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O,"Nerve growth factor receptor Trk-A, Tyrosine-protein kinase receptor FLT3, NT-3 growth factor receptor, Tyrosine-protein kinase JAK2, Tyrosine-protein kinase receptor RET, Neurotrophic tyrosine kinase receptor type 2"
Leflunomide,CIDs00003899,leflunomide,270.20727,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,Dihydroorotate dehydrogenase
Silmitasertib,CIDs24748573,CX-4945 (Silmitasertib,349.77048,C1=CC(=CC(=C1)Cl)NC2=C3C=CN=CC3=C4C=CC(=CC4=N2)C(=O)O,C1=CC(=CC(=C1)Cl)NC2=NC3=C(C=CC(=C3)C(=O)O)C4=C2C=CN=C4,Casein kinase II alpha
Taladegib,CIDs49848070,LY2940680,512.501973,CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F,CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F,Smoothened homolog
Vismodegib,CIDs24776445,vismodegib,421.29706,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,Smoothened homolog
RO-4929097,CIDs49867930,RO4929097,469.404516,CC(C)(C(=O)NCC(C(F)(F)F)(F)F)C(=O)NC1C2=CC=CC=C2C3=CC=CC=C3NC1=O,CC(C)(C(=O)NCC(C(F)(F)F)(F)F)C(=O)NC1C2=CC=CC=C2C3=CC=CC=C3NC1=O,Gamma-secretase
Apilimod,CIDs10173277,apilimod,418.49154,CC1=CC=CC(=C1)C=NNC2=NC(=NC(=C2)N3CCOCC3)OCCC4=CC=CC=N4,CC1=CC(=CC=C1)C=NNC2=CC(=NC(=N2)OCCC3=CC=CC=N3)N4CCOCC4,1-phosphatidylinositol 3-phosphate 5-kinase
SGI-1776,CIDs24795070,SGI-1776,405.41679,CN1CCC(CC1)CNC2=NN3C(=NC=C3C4=CC(=CC=C4)OC(F)(F)F)C=C2,CN1CCC(CC1)CNC2=NN3C(=NC=C3C4=CC(=CC=C4)OC(F)(F)F)C=C2,Serine/threonine-protein kinase PIM
MK-1775,CIDs24856436,MK-1775,500.59538,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,Serine/threonine-protein kinase WEE1
TG-101348,CIDs16722836,fedratinib,524.67814,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,"Tyrosine-protein kinase receptor FLT3, Tyrosine-protein kinase JAK2"
CNF-2024,CIDs16736529,BIIB021,318.7615,CC1=CN=C(C(=C1OC)C)CN2C=NC3=C2N=C(N=C3Cl)N,CC1=CN=C(C(=C1OC)C)CN2C=NC3=C2N=C(N=C3Cl)N,Heat shock protein HSP90
Vorinostat (SAHA),CIDs00005311,vorinostat,264.3202,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Histone deacetylase 3, Histone deacetylase 2, Histone deacetylase 1, Histone deacetylase 6"
Belinostat,CIDs06918638,belinostat,318.34766,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,Histone deacetylase
Mocetinostat,CIDs09865515,MGCD0103,396.4445,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4,"Histone deacetylase 2, Histone deacetylase 11, Histone deacetylase 1, Histone deacetylase 3, Histone deacetylase 8"
Romidepsin,CIDs05352062,depsipeptide,540.69584,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,Histone deacetylase
Entinostat,CIDs00004261,entinostat,376.4085,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,Histone deacetylase
Veliparib,CIDs11960529,veliparib,244.29234,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,"PARP 1, 2 and 3"
Olaparib,CIDs23725625,olaparib,434.462823,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,"PARP 1, 2 and 3"
Rucaparib,CIDs09931954,,0,,CNCC1=CC=C(C=C1)C2=C3CCNC(=O)C4=C3C(=CC(=C4)F)N2,"PARP 1, 2 and 3"
Ixazomib,CIDs25183872,ixazomib,361.02866,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,26S proteasome
Carfilzomib,CIDs11556711,carfilzomib,719.90988,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,26S proteasome
Bortezomib,CIDs00387447,bortezomib,384.2372,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O,26S proteasome
Tosedostat,CIDs15547703,tosedostat,406.4727,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C1=CC=CC=C1)C(=O)OC2CCCC2,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C1=CC=CC=C1)C(=O)OC2CCCC2,Aminopeptidase
Hydrocortisone,CIDs00005754,cortisol,362.4599,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,Glucocorticoid receptor
Dexamethasone,CIDs00005743,dexamethasone,392.461063,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Glucocorticoid receptor
Cortivazol,CIDs00066249,corticoid,530.65452,CC1CC2C3C=C(C4=CC5=C(CC4(C3C(CC2(C1(C(=O)COC(=O)C)O)C)O)C)C=NN5C6=CC=CC=C6)C,CC1CC2C3C=C(C4=CC5=C(CC4(C3C(CC2(C1(C(=O)COC(=O)C)O)C)O)C)C=NN5C6=CC=CC=C6)C,Glucocorticoid receptor
Abiraterone,CIDs00132971,abiraterone,349.50904,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,"Cytochrome P450 17A1, Steroid 5-alpha-reductase, Androgen Receptor"
Doxercalciferol,CIDs05281107,doxercalciferol,412.64776,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Vitamin D receptor
Seocalcitol,CIDs05288149,seocalcitol,454.68444,CCC(CC)(C=CC=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)O,CCC(CC)(C=CC=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C)O,Vitamin D receptor
Bicalutamide,CIDs00002375,bicalutamide,430.373373,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,Androgen Receptor
Enzalutamide,CIDs15951529,enzalutamide,464.435953,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,Androgen Receptor
Pioglitazone hydrochloride,CIDs00060560,,0,,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl,Peroxisome proliferator-activated receptor gamma
GW-501516,CIDs09803963,GW 501516,453.49773,CC1=C(C=CC(=C1)SCC2=C(N=C(S2)C3=CC=C(C=C3)C(F)(F)F)C)OCC(=O)O,CC1=C(C=CC(=C1)SCC2=C(N=C(S2)C3=CC=C(C=C3)C(F)(F)F)C)OCC(=O)O,Peroxisome proliferator-activated receptor delta
Telmisartan,CIDs00065999,telmisartan,514.6169,CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C,CCCC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C=C(C=C2C)C5=NC6=CC=CC=C6N5C,Type-1 angiotensin II receptor
Apratastat,CIDs11452716,apratastat,414.49638,CC1(C(N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OCC#CCO)C(=O)NO)C,CC1(C(N(CCS1)S(=O)(=O)C2=CC=C(C=C2)OCC#CCO)C(=O)NO)C,"Matrix metalloproteinase 13, ADAM17"
Omeprazole,CIDs00004594,omeprazole,345.41606,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,Potassium-transporting ATPase
Sildenafil citrate,CIDs135413523,,0,,CCCC1=NN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Phosphodiesterase 5A
Riluzole,CIDs00005070,riluzole,234.19831,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,Sodium channel alpha subunit
Ivacaftor,CIDs16220172,ivacaftor,392.49072,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,Cystic fibrosis transmembrane conductance regulator
Ivabradine hydrochloride,CIDs03045381,,0,,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC.Cl,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4
Meclinertant,CIDs00119192,Meclinertant,587.06534,COC1=C(C(=CC=C1)OC)C2=CC(=NN2C3=C4C=CC(=CC4=NC=C3)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(=O)O,COC1=C(C(=CC=C1)OC)C2=CC(=NN2C3=C4C=CC(=CC4=NC=C3)Cl)C(=O)NC5(C6CC7CC(C6)CC5C7)C(=O)O,Neurotensin receptor 1
Zibotentan,CIDs09910224,zibotentan,424.43314,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,Endothelin receptor ET-A
Turofexorate isopropyl,CIDs10026128,WAY-362450,438.466466,CC(C)OC(=O)C1=CN(CC(C2=C1NC3=CC=CC=C32)(C)C)C(=O)C4=CC(=C(C=C4)F)F,CC(C)OC(=O)C1=CN(CC(C2=C1NC3=CC=CC=C32)(C)C)C(=O)C4=CC(=C(C=C4)F)F,Bile acid receptor FXR
Aprepitant,CIDs135413536,,0,,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NNC(=O)N3)C4=CC=C(C=C4)F,Neurokinin 1 receptor
Rolofylline,CIDs00064627,rolofylline,356.46192,CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CC5CC(C3)CC4C5,CCCN1C2=C(C(=O)N(C1=O)CCC)NC(=N2)C34CC5CC(C3)CC4C5,Adenosine A1 receptor
Veliflapon,CIDs00123723,BAYx 1005,361.43362,C1CCC(C1)C(C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C(=O)O,C1CCC(C1)C(C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C(=O)O,5-lipoxygenase activating protein
Zileuton,CIDs00060490,zileuton,236.29018,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,Arachidonate 5-lipoxygenase
Celecoxib,CIDs00002662,celecoxib,381.37217,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,Cyclooxygenase-2
Simvastatin,CIDs00054454,simvastatin,418.56622,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,HMG-CoA reductase
Dalcetrapib,CIDs06918540,dalcetrapib,389.5945,CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,CCC(CC)CC1(CCCCC1)C(=O)NC2=CC=CC=C2SC(=O)C(C)C,Cholesteryl ester transfer protein
Ezetimibe,CIDs00150311,ezetimibe,409.425246,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,Niemann-Pick C1-like protein 1
Ibutamoren mesilate,CIDs06450830,,0,,CC(C)(C(=O)NC(COCC1=CC=CC=C1)C(=O)N2CCC3(CC2)CN(C4=CC=CC=C34)S(=O)(=O)C)N.CS(=O)(=O)O,Ghrelin receptor
Dapagliflozin,CIDs09887712,dapagliflozin,408.8726,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,Sodium/glucose cotransporter 2
Efavirenz,CIDs00064139,efavirenz,315.67497,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,Human immunodeficiency virus type 1 reverse transcriptase
Etoposide,CIDs00036462,etoposide,588.55658,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,DNA topoisomerase II
Paclitaxel,CIDs00036314,paclitaxel,853.90614,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C,Tubulin
Cytarabine,CIDs00006253,,0,,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,"DNA, DNA polymerase (alpha/delta/epsilon), RNA"
Mitomycin C,CIDs00005746,mitomycin C,334.32722,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,DNA
Raltitrexed,CIDs135400182,,0,,CC1=NC2=C(C=C(C=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O)C(=O)N1,Thymidylate synthase
Methotrexate,CIDs00126941,methotrexate,454.43928,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Dihydrofolate reductase
Pralatrexate,CIDs00148121,pralatrexate,477.47262,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,Dihydrofolate reductase
Pyrimethamine,CIDs00004993,pyrimethamine,248.71142,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,Dihydrofolate reductase
Cytisine,CIDs00010235,cytisine,190.24166,C1C2CNCC1C3=CC=CC(=O)N3C2,C1C2CNCC1C3=CC=CC(=O)N3C2,Neuronal acetylcholine receptor; alpha4/beta2
Prazosin hydrochloride,CIDs00068546,,0,,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.Cl,Adrenergic receptor alpha-1
Ciclopirox,CIDs00002749,ciclopirox,207.26888,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,"Iron, Aluminium"
Chloroxine,CIDs00002722,halquinol,214.0481,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,DNA
Prochlorperazine,CIDs00004917,prochlorperazine,373.94266,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Dopamine D2 receptor
Marizomib,CIDs11347535,salinosporamide A,313.7766,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,20S proteasome
Mebendazole,CIDs00004030,mebendazole,295.29272,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3,Tubulin
Fingolimod hydrochloride,CIDs00107969,fingolimod,343.93176,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl,Sphingosine 1-phosphate receptor
BMS-754807,CIDs24785538,BMS-754807,461.494763,CC1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F,CC1(CCCN1C2=NN3C=CC=C3C(=N2)NC4=NNC(=C4)C5CC5)C(=O)NC6=CN=C(C=C6)F,"Insulin receptor, Insulin-like growth factor I receptor"
Dinaciclib (SCH727965),CIDs46926350,dinaciclib,396.48602,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,"Cyclin-dependent kinase 2, Cyclin-dependent kinase 9, Cyclin-dependent kinase 1, Cyclin-dependent kinase 5"
PF-04691502,CIDs25033539,PF-04691502,425.48088,CC1=C2C=C(C(=O)N(C2=NC(=N1)N)C3CCC(CC3)OCCO)C4=CN=C(C=C4)OC,CC1=C2C=C(C(=O)N(C2=NC(=N1)N)C3CCC(CC3)OCCO)C4=CN=C(C=C4)OC,"PI3-kinase class I, Serine/threonine-protein kinase mTOR"
Fostamatinib,CIDs11671467,fostamatinib,580.459505,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,Tyrosine-protein kinase SYK
Birinapant,CIDs49836020,birinapant,806.940846,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,cIAP1/cIAP2
Raloxifene hydrochloride,CIDs00054900,,0,,C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl,Estrogen receptor beta
Niclosamide,CIDs00004477,niclosamide,327.11962,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,DNA
Emricasan,CIDs12000240,Emricasan,569.502093,CC(C(=O)NC(CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C,CC(C(=O)NC(CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C,Caspase
VX-765,CIDs11398092,belnacasan,508.99502,CCOC1C(CC(=O)O1)NC(=O)C2CCCN2C(=O)C(C(C)(C)C)NC(=O)C3=CC(=C(C=C3)N)Cl,CCOC1C(CC(=O)O1)NC(=O)C2CCCN2C(=O)C(C(C)(C)C)NC(=O)C3=CC(=C(C=C3)N)Cl,Caspase-1
Odanacatib,CIDs10152654,odanacatib,525.558793,CC(C)(CC(C(=O)NC1(CC1)C#N)NC(C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F,CC(C)(CC(C(=O)NC1(CC1)C#N)NC(C2=CC=C(C=C2)C3=CC=C(C=C3)S(=O)(=O)C)C(F)(F)F)F,Cathepsin K
Olmesartan,CIDs00158781,olmesartan,446.50164,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,Type-1 angiotensin II receptor
Enalapril maleate,CIDs05388961,enalapril,492.51888,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O,Angiotensin-converting enzyme
Ramipril,CIDs05362129,ramipril,416.51058,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,Angiotensin-converting enzyme
Venetoclax (ABT-199),CIDs49846579,venetoclax,868.4392,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,Apoptosis regulator Bcl-2
AMG-232,CIDs58573469,AMG-232,568.5522,CC(C)C(CS(=O)(=O)C(C)C)N1C(C(CC(C1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC=C(C=C3)Cl,CC(C)C(CS(=O)(=O)C(C)C)N1C(C(CC(C1=O)(C)CC(=O)O)C2=CC(=CC=C2)Cl)C3=CC=C(C=C3)Cl,Tumour suppressor p53/oncoprotein Mdm2
Idasanutlin,CIDs53358942,RG7388,616.482466,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,Tumour suppressor p53/oncoprotein Mdm2
R-Etodolac,CIDs00667528,R-etodolac,287.35354,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Retinoid X receptor alpha
M2698,CIDs89808643,SCHEMBL15262358,449.85667,C1CN(C1)CC(C2=CC(=C(C=C2)Cl)C(F)(F)F)NC3=NC=NC4=C3C=CC=C4C(=O)N,C1CN(C1)CC(C2=CC(=C(C=C2)Cl)C(F)(F)F)NC3=NC=NC4=C3C=CC=C4C(=O)N,"Ribosomal protein S6 kinase (P70S6K), Serine/threonine-protein kinase AKT, Serine/threonine-protein kinase AKT3"
Ipatasertib,CIDs24788740,GDC-0068,457.99618,CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O,CC1CC(C2=C1C(=NC=N2)N3CCN(CC3)C(=O)C(CNC(C)C)C4=CC=C(C=C4)Cl)O,Serine/threonine-protein kinase AKT
GSK2141795,CIDs51042438,uprosertib,429.248046,CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)NC(CC3=CC(=C(C=C3)F)F)CN)Cl,CN1C(=C(C=N1)Cl)C2=C(OC(=C2)C(=O)NC(CC3=CC(=C(C=C3)F)F)CN)Cl,Serine/threonine-protein kinase AKT
BAY-1125976,CIDs70817911,AGN-PC-0J36CX,383.44574,C1CC(C1)(C2=CC=C(C=C2)C3=C(N4C(=N3)C=CC(=N4)C(=O)N)C5=CC=CC=C5)N,C1CC(C1)(C2=CC=C(C=C2)C3=C(N4C(=N3)C=CC(=N4)C(=O)N)C5=CC=CC=C5)N,"Serine/threonine-protein kinase AKT2, Serine/threonine-protein kinase AKT"
Miransertib,CIDs53262401,AGN-PC-0HD3LN,432.51966,C1CC(C1)(C2=CC=C(C=C2)N3C4=C(C=CC(=N4)C5=CC=CC=C5)N=C3C6=C(N=CC=C6)N)N,C1CC(C1)(C2=CC=C(C=C2)N3C4=C(C=CC(=N4)C5=CC=CC=C5)N=C3C6=C(N=CC=C6)N)N,Serine/threonine-protein kinase AKT
AZD-5363,CIDs25227436,AZD5363,428.9152,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,C1CN(CCC1(C(=O)NC(CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4,Serine/threonine-protein kinase AKT
Triciribine phosphate,CIDs00043860,TCN-P,400.283842,CN1C2=NC=NC3=C2C(=CN3C4C(C(C(O4)COP(=O)(O)O)O)O)C(=N1)N,CN1C2=NC=NC3=C2C(=CN3C4C(C(C(O4)COP(=O)(O)O)O)O)C(=N1)N,Serine/threonine-protein kinase AKT
Afuresertib (GSK2110183),CIDs46843057,,0,,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl,Serine/threonine-protein kinase AKT
AT-13148,CIDs24905401,AT-13148,313.78144,C1=CC(=CC=C1C2=CNN=C2)C(CN)(C3=CC=C(C=C3)Cl)O,C1=CC(=CC=C1C2=CNN=C2)C(CN)(C3=CC=C(C=C3)Cl)O,"Rho-associated protein kinase, MAP kinase-activated protein kinase 2"
MKC-1,CIDs05327686,MKC-1,400.38684,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=C4C=CC(=C5)[N+](=O)[O-])C,CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=C4C=CC(=C5)[N+](=O)[O-])C,"Vascular endothelial growth factor receptor 2, Platelet-derived growth factor receptor, Fibroblast growth factor receptor, Tyrosine-protein kinase receptor FLT3, SRC, Serine/threonine-protein kinase Aurora-A"
ASP-3026,CIDs25134326,ASP3026,580.7447,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC=NC(=N2)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,CC(C)S(=O)(=O)C1=CC=CC=C1NC2=NC(=NC=N2)NC3=C(C=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC,ALK tyrosine kinase receptor
Vactosertib,CIDs54766013,EW-7197,399.423623,CC1=CC=CC(=N1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4,CC1=NC(=CC=C1)C2=C(N=C(N2)CNC3=CC=CC=C3F)C4=CN5C(=NC=N5)C=C4,TGF-beta receptor type I
TPX-0005,CIDs135565923,,0,,CC1CNC(=O)C2=C3N=C(C=CN3N=C2)NC(C4=C(O1)C=CC(=C4)F)C,"Nerve growth factor receptor Trk-A, CD74-ROS1, Proto-oncogene tyrosine-protein kinase ROS, Neurotrophic tyrosine kinase receptor type 2, ROS1-SDC4, NT-3 growth factor receptor"
AP-26113,CIDs68165256,AGN-PC-0HUR20,584.092422,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,"ALK tyrosine kinase receptor, Epidermal growth factor receptor erbB1"
Ceritinib,CIDs57379345,ceritinib,558.13514,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,"NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor), ALK tyrosine kinase receptor, EML4-ALK"
Lorlatinib,CIDs71731823,MolPort-035-789-724,406.412963,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,CC1C2=C(C=CC(=C2)F)C(=O)N(CC3=NN(C(=C3C4=CC(=C(N=C4)N)O1)C#N)C)C,"ALK tyrosine kinase receptor, EML4-ALK"
Ensartinib,CIDs56960363,SCHEMBL15131489,561.435383,CC1CN(CC(N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)OC(C)C4=C(C=CC(=C4Cl)F)Cl)N,CC1CN(CC(N1)C)C(=O)C2=CC=C(C=C2)NC(=O)C3=NN=C(C(=C3)OC(C)C4=C(C=CC(=C4Cl)F)Cl)N,ALK tyrosine kinase receptor
BAY-1895344,CIDs118869362,,0,,CC1COCCN1C2=NC3=C(C=CN=C3C4=CC=NN4)C(=C2)C5=CC=NN5C,Serine-protein kinase ATR
Berzosertib,CIDs59472121,VE-822,463.552,CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N,CC(C)S(=O)(=O)C1=CC=C(C=C1)C2=CN=C(C(=N2)C3=CC(=NO3)C4=CC=C(C=C4)CNC)N,Serine-protein kinase ATR
AZD-6738,CIDs54761306,SCHEMBL9979340,412.50856,CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=N)(=O)C)C4=C5C=CNC5=NC=C4,CC1COCCN1C2=NC(=NC(=C2)C3(CC3)S(=N)(=O)C)C4=C5C=CNC5=NC=C4,Serine-protein kinase ATR
Selonsertib,CIDs71245288,AGN-PC-0JIBUS,445.492063,CC1=C(C=C(C(=C1)F)C(=O)NC2=CC=CC(=N2)C3=NN=CN3C(C)C)N4C=C(N=C4)C5CC5,CC1=CC(=C(C=C1N2C=C(N=C2)C3CC3)C(=O)NC4=CC=CC(=N4)C5=NN=CN5C(C)C)F,Mitogen-activated protein kinase kinase kinase 5
PF-03814735,CIDs51346455,W-5656,474.47881,CC(=O)NCC(=O)N1C2CCC1C3=C2C=CC(=C3)NC4=NC=C(C(=N4)NC5CCC5)C(F)(F)F,CC(=O)NCC(=O)N1C2CCC1C3=C2C=CC(=C3)NC4=NC=C(C(=N4)NC5CCC5)C(F)(F)F,"Serine/threonine-protein kinase Aurora-A, Serine/threonine-protein kinase Aurora-B"
MLN-8054,CIDs11712649,MLN8054,476.862006,C1C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)C(=N1)C4=C(C=CC=C4F)F)NC5=CC=C(C=C5)C(=O)O,C1C2=CN=C(N=C2C3=C(C=C(C=C3)Cl)C(=N1)C4=C(C=CC=C4F)F)NC5=CC=C(C=C5)C(=O)O,Serine/threonine-protein kinase Aurora-A
TAK-901,CIDs16124208,TAK-901,504.64368,CCS(=O)(=O)C1=CC=CC(=C1)C2=CC(=C(C3=C2C4=CC(=CN=C4N3)C)C)C(=O)NC5CCN(CC5)C,CCS(=O)(=O)C1=CC=CC(=C1)C2=CC(=C(C3=C2C4=C(N3)N=CC(=C4)C)C)C(=O)NC5CCN(CC5)C,Serine/threonine-protein kinase Aurora-B
GSK-1070916A,CIDs46885626,GSK1070916A,507.62932,CCN1C=C(C(=N1)C2=CC=C(C=C2)NC(=O)N(C)C)C3=C4C=C(NC4=NC=C3)C5=CC(=CC=C5)CN(C)C,CCN1C=C(C(=N1)C2=CC=C(C=C2)NC(=O)N(C)C)C3=C4C=C(NC4=NC=C3)C5=CC=CC(=C5)CN(C)C,"Serine/threonine-protein kinase Aurora-C, Serine/threonine-protein kinase Aurora-B"
AZD1152,CIDs11497983,AZD1152,587.539805,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O,CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O,Serine/threonine-protein kinase Aurora-B
Gilteritinib,CIDs49803313,Gilteritinib,552.71146,CCC1=NC(=C(N=C1NC2CCOCC2)NC3=CC(=C(C=C3)N4CCC(CC4)N5CCN(CC5)C)OC)C(=O)N,CCC1=C(N=C(C(=N1)C(=O)N)NC2=CC(=C(C=C2)N3CCC(CC3)N4CCN(CC4)C)OC)NC5CCOCC5,"Tyrosine-protein kinase receptor FLT3, Tyrosine-protein kinase receptor UFO"
Bemcentinib,CIDs46215462,R-428,506.64456,C1CCN(C1)C2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76,C1CCN(C1)C2CCC3=C(CC2)C=C(C=C3)NC4=NN(C(=N4)N)C5=NN=C6C(=C5)CCCC7=CC=CC=C76,Tyrosine-protein kinase receptor UFO
KW-2449,CIDs11427553,KW-2449,332.399,C1CN(CCN1)C(=O)C2=CC=C(C=C2)C=CC3=NNC4=CC=CC=C43,C1CN(CCN1)C(=O)C2=CC=C(C=C2)C=CC3=NNC4=CC=CC=C43,"Tyrosine-protein kinase receptor FLT3, Serine/threonine-protein kinase Aurora-A, Tyrosine-protein kinase ABL, Serine/threonine-protein kinase Aurora-B"
Bafetinib,CIDs11387605,bafetinib,576.61535,CC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CCC(C3)N(C)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CN=C5,CC1=C(C=C(C=C1)NC(=O)C2=CC(=C(C=C2)CN3CCC(C3)N(C)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CN=C5,"Tyrosine-protein kinase ABL, Tyrosine-protein kinase Lyn"
Asciminib,CIDs72165228,SCHEMBL15388306,449.838426,C1CN(CC1O)C2=NC=C(C=C2C3=CC=NN3)C(=O)NC4=CC=C(C=C4)OC(F)(F)Cl,C1CN(CC1O)C2=C(C=C(C=N2)C(=O)NC3=CC=C(C=C3)OC(F)(F)Cl)C4=CC=NN4,Tyrosine-protein kinase ABL
GZD-824,CIDs51038269,GZD824,532.55949,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CC5=C(NN=C5)N=C4,CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CC5=C(NN=C5)N=C4,Bcr/Abl fusion protein
Acalabrutinib,CIDs71226662,SCHEMBL14637368,465.50652,CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,CC#CC(=O)N1CCCC1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5,Tyrosine-protein kinase BTK
Evobrutinib,CIDs71479709,AGN-PC-0J7FYQ,429.51418,C=CC(=O)N1CCC(CC1)CNC2=NC=NC(=C2C3=CC=C(C=C3)OC4=CC=CC=C4)N,C=CC(=O)N1CCC(CC1)CNC2=NC=NC(=C2C3=CC=C(C=C3)OC4=CC=CC=C4)N,Tyrosine-protein kinase BTK
RG-7845 (GDC-0853),CIDs86567195,SCHEMBL14912882,664.79646,CC1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8,CC1CN(CCN1C2=CN=C(C=C2)NC3=CC(=CN(C3=O)C)C4=C(C(=NC=C4)N5CCN6C7=C(CC(C7)(C)C)C=C6C5=O)CO)C8COC8,Tyrosine-protein kinase BTK
SB-1317,CIDs16739650,SB1317/TG02,372.46286,CN1CC=CCCOC2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C1,CN1CC=CCCOC2=CC=CC(=C2)C3=NC(=NC=C3)NC4=CC=CC(=C4)C1,"Cyclin-dependent kinase 1, Cyclin-dependent kinase 7, Tyrosine-protein kinase JAK2, Cyclin-dependent kinase 2, Cyclin-dependent kinase 9, Tyrosine-protein kinase receptor FLT3"
R-547,CIDs06918852,R-547,441.452246,COC1=C(C(=C(C=C1)F)F)C(=O)C2=CN=C(N=C2N)NC3CCN(CC3)S(=O)(=O)C,COC1=C(C(=C(C=C1)F)F)C(=O)C2=CN=C(N=C2N)NC3CCN(CC3)S(=O)(=O)C,"Cyclin-dependent kinase 1, Cyclin-dependent kinase 2, Cyclin-dependent kinase 4"
Milciclib,CIDs16718576,milciclib,460.57458,CC1(CC2=CN=C(N=C2C3=C1C(=NN3C)C(=O)NC)NC4=CC=C(C=C4)N5CCN(CC5)C)C,CC1(CC2=CN=C(N=C2C3=C1C(=NN3C)C(=O)NC)NC4=CC=C(C=C4)N5CCN(CC5)C)C,"Cyclin-dependent kinase 1, Nerve growth factor receptor Trk-A, Cyclin-dependent kinase 2, Cyclin-dependent kinase 4"
AZD-5438,CIDs16747683,AZD5438,371.45664,CC1=NC=C(N1C(C)C)C2=NC(=NC=C2)NC3=CC=C(C=C3)S(=O)(=O)C,CC1=NC=C(N1C(C)C)C2=NC(=NC=C2)NC3=CC=C(C=C3)S(=O)(=O)C,Cyclin-dependent kinase
Ribociclib (LEE011),CIDs44631912,ribociclib,434.5373,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,"Cyclin-dependent kinase 4, Cyclin-dependent kinase 6"
Abemaciclib,CIDs46220502,abemaciclib,506.593386,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F,"Cyclin-dependent kinase 4, Cyclin-dependent kinase 6"
TAK-931,CIDs135564531,,0,,CC1=C(C=NN1)C2=CC3=C(S2)C(=O)NC(=N3)C4CC5CCN4CC5,Cell division cycle 7-related protein kinase
Rabusertib,CIDs11955855,LY2603618,436.30298,CC1=CC(=C(C=C1Br)NC(=O)NC2=NC=C(N=C2)C)OCC3CNCCO3,CC1=CC(=C(C=C1Br)NC(=O)NC2=NC=C(N=C2)C)OCC3CNCCO3,Serine/threonine-protein kinase Chk1
MK-8776,CIDs46239015,Y0217,376.25432,CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4,CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4,Serine/threonine-protein kinase Chk1
SCH 900776,CIDs46239015,Y0217,376.25432,CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4,CN1C=C(C=N1)C2=C3N=C(C(=C(N3N=C2)N)Br)C4CCCNC4,Serine/threonine-protein kinase Chk1
Prexasertib,CIDs46700756,,0,,COC1=C(C(=CC=C1)OCCCN)C2=CC(=NN2)NC3=NC=C(N=C3)C#N,"Serine/threonine-protein kinase Chk1, Serine/threonine-protein kinase Chk2"
Pexidartinib,CIDs25151352,Pexidartinib,417.81481,C1=CC(=NC=C1CC2=CNC3=NC=C(C=C23)Cl)NCC4=CN=C(C=C4)C(F)(F)F,C1=CC(=NC=C1CC2=CNC3=C2C=C(C=N3)Cl)NCC4=CN=C(C=C4)C(F)(F)F,"Macrophage colony stimulating factor receptor, Stem cell growth factor receptor, Tyrosine-protein kinase receptor FLT3"
CC-115,CIDs58298318,AGN-PC-0H9OGU,336.35124,CCN1C(=O)CNC2=NC=C(N=C21)C3=C(N=C(C=C3)C4=NC=NN4)C,CCN1C(=O)CNC2=NC=C(N=C21)C3=C(N=C(C=C3)C4=NC=NN4)C,"Serine/threonine-protein kinase mTOR, DNA-dependent protein kinase"
BAY-1161909,CIDs71599640,SCHEMBL15036597,559.611243,CC(C1=CC=C(C=C1)F)C(=O)NC2=CC=C(C=C2)C3=CN4C(=NC(=N4)NC5=C(C=C(C=C5)S(=O)(=O)C)OC)C=C3,CC(C1=CC=C(C=C1)F)C(=O)NC2=CC=C(C=C2)C3=CN4C(=NC(=N4)NC5=C(C=C(C=C5)S(=O)(=O)C)OC)C=C3,Dual specificity protein kinase TTK
BAY-1217389,CIDs78320750,SCHEMBL15555839,561.503176,CC1=C(C=CC(=C1)C2=CN=C3N2N=C(C=C3NCCC(F)(F)F)OC4=C(C(=C(C=C4)OC)F)F)C(=O)NC5CC5,CC1=C(C=CC(=C1)C2=CN=C3N2N=C(C=C3NCCC(F)(F)F)OC4=C(C(=C(C=C4)OC)F)F)C(=O)NC5CC5,Dual specificity protein kinase TTK
AC-480,CIDs10437018,BMS-599626,530.553483,CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F,CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2, Receptor protein-tyrosine kinase erbB-4"
TAK-285,CIDs11620908,TAK-285,547.95661,CC(C)(CC(=O)NCCN1C=CC2=C1C(=NC=N2)NC3=CC(=C(C=C3)OC4=CC=CC(=C4)C(F)(F)F)Cl)O,CC(C)(CC(=O)NCCN1C=CC2=C1C(=NC=N2)NC3=CC(=C(C=C3)OC4=CC=CC(=C4)C(F)(F)F)Cl)O,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2"
Avitinib,CIDs72734520,SCHEMBL15455613,487.528743,CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F,CN1CCN(CC1)C2=C(C=C(C=C2)NC3=NC4=C(C=CN4)C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)F,"Epidermal growth factor receptor erbB1, Tyrosine-protein kinase BTK"
XL647,CIDs10458325,EXEL-7647,491.385303,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,"Epidermal growth factor receptor erbB1, Ephrin type-B receptor 4, Receptor protein-tyrosine kinase erbB-2"
Tesevatinib,CIDs10458325,EXEL-7647,491.385303,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,"Epidermal growth factor receptor erbB1, Ephrin type-B receptor 4, Receptor protein-tyrosine kinase erbB-2"
CEP-32496,CIDs56846693,CEP-32496,517.45719,CC(C)(C1=CC(=NO1)NC(=O)NC2=CC(=CC=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(F)(F)F,CC(C)(C1=CC(=NO1)NC(=O)NC2=CC(=CC=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(F)(F)F,"Epidermal growth factor receptor erbB1, Tyrosine-protein kinase receptor RET, Serine/threonine-protein kinase B-raf"
Poziotinib,CIDs25127713,poziotinib,491.342243,COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C,COC1=C(C=C2C(=C1)N=CN=C2NC3=C(C(=C(C=C3)Cl)Cl)F)OC4CCN(CC4)C(=O)C=C,Epidermal growth factor receptor
BMS-599626,CIDs10437018,BMS-599626,530.553483,CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F,CC1=C2C(=NC=NN2C=C1NC(=O)OCC3COCCN3)NC4=CC5=C(C=C4)N(N=C5)CC6=CC(=CC=C6)F,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2, Receptor protein-tyrosine kinase erbB-4"
AZD-3759,CIDs78209992,SCHEMBL16010006,459.901123,CC1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C,CC1CN(CCN1C(=O)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC)C,Epidermal growth factor receptor erbB1
Osimertinib mesylate,CIDs78357807,,0,,CN1C=C(C2=CC=CC=C21)C3=NC(=NC=C3)NC4=C(C=C(C(=C4)NC(=O)C=C)N(C)CCN(C)C)OC.CS(=O)(=O)O,Epidermal growth factor receptor erbB1
Rociletinib,CIDs57335384,rociletinib,555.55153,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,Epidermal growth factor receptor erbB1
PF-06747775,CIDs91668194,"N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methyl-pyrazol-4-yl)amino]-9-methyl-purin-2-yl]pyrrolidin-3-yl]acrylamide",415.424783,CN1C=C(C(=N1)OC)NC2=NC(=NC3=C2N=CN3C)N4CC(C(C4)F)NC(=O)C=C,CN1C=C(C(=N1)OC)NC2=C3C(=NC(=N2)N4CC(C(C4)F)NC(=O)C=C)N(C=N3)C,Epidermal growth factor receptor erbB1
Mubritinib,CIDs06444692,mubritinib,468.47093,C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F,C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F,Receptor protein-tyrosine kinase erbB-2
Tucatinib,CIDs51039094,Irbinitinib,480.52116,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,CC1=C(C=CC(=C1)NC2=NC=NC3=C2C=C(C=C3)NC4=NC(CO4)(C)C)OC5=CC6=NC=NN6C=C5,Receptor protein-tyrosine kinase erbB-2
Sapitinib,CIDs11488320,Sapitinib,473.927703,CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC,CNC(=O)CN1CCC(CC1)OC2=C(C=C3C(=C2)C(=NC=N3)NC4=C(C(=CC=C4)Cl)F)OC,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2, Receptor tyrosine-protein kinase erbB-3"
AST-1306,CIDs24739943,AST-1306,448.876723,C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl,C=CC(=O)NC1=CC2=C(C=C1)N=CN=C2NC3=CC(=C(C=C3)OCC4=CC(=CC=C4)F)Cl,"Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2"
CH-5183284,CIDs66555680,AGN-PC-0H0OY8,356.38064,CC1=NC2=C(N1)C=C(C=C2)N3C(=C(C=N3)C(=O)C4=CC5=CC=CC=C5N4)N,CC1=NC2=C(N1)C=C(C=C2)N3C(=C(C=N3)C(=O)C4=CC5=CC=CC=C5N4)N,"Fibroblast growth factor receptor 3, Fibroblast growth factor receptor 2, Fibroblast growth factor receptor 1"
Erdafitinib,CIDs67462786,AGN-PC-0HG6YB,446.5447,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,CC(C)NCCN(C1=CC2=NC(=CN=C2C=C1)C3=CN(N=C3)C)C4=CC(=CC(=C4)OC)OC,Fibroblast growth factor receptor
Derazantinib,CIDs46834118,SCHEMBL2805038,468.565163,COCCNCCC1=CC(=CC=C1)NC2=NC=C3CC(C4=CC=CC=C4C3=N2)C5=CC=CC=C5F,COCCNCCC1=CC(=CC=C1)NC2=NC=C3CC(C4=CC=CC=C4C3=N2)C5=CC=CC=C5F,Fibroblast growth factor receptor
Infigratinib,CIDs53235510,NVP-BGJ398,560.47544,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,CCN1CCN(CC1)C2=CC=C(C=C2)NC3=CC(=NC=N3)N(C)C(=O)NC4=C(C(=CC(=C4Cl)OC)OC)Cl,Fibroblast growth factor receptor
NVP-FGF-401,CIDs118036971,,0,,CN1CCN(C(=O)C1)CC2=C(N=C3C(=C2)CCCN3C(=O)NC4=NC=C(C(=C4)NCCOC)C#N)C=O,Fibroblast growth factor receptor 4
Suramin sodium,CIDs00008514,,0,,CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],Acidic fibroblast growth factor
Semaxanib,CIDs05329098,romiplostim,238.28446,CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C,CC1=CC(=C(N1)C=C2C3=CC=CC=C3NC2=O)C,"Vascular endothelial growth factor receptor, Stem cell growth factor receptor"
AST-487,CIDs11409972,NVP-AST487,529.55731,CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)NC3=CC=C(C=C3)OC4=NC=NC(=C4)NC)C(F)(F)F,CCN1CCN(CC1)CC2=C(C=C(C=C2)NC(=O)NC3=CC=C(C=C3)OC4=NC=NC(=C4)NC)C(F)(F)F,"Tyrosine-protein kinase receptor RET, Tyrosine-protein kinase receptor FLT3"
GSK-2256098,CIDs46214930,AGN-PC-0A9VW2,414.88862,CC1=NN(C(=C1)NC2=NC=C(C(=C2)NC3=CC=CC=C3C(=O)NOC)Cl)C(C)C,CC1=NN(C(=C1)NC2=NC=C(C(=C2)NC3=CC=CC=C3C(=O)NOC)Cl)C(C)C,Focal adhesion kinase 1
Defactinib,CIDs25117126,Defactinib,510.49275,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,"Focal adhesion kinase 1, Protein tyrosine kinase 2 beta"
LY-2090314,CIDs10029385,LY2090314,512.534903,C1CCN(CC1)C(=O)N2CCN3C=C(C4=CC(=CC(=C43)C2)F)C5=C(C(=O)NC5=O)C6=CN=C7N6C=CC=C7,C1CCN(CC1)C(=O)N2CCN3C=C(C4=CC(=CC(=C43)C2)F)C5=C(C(=O)NC5=O)C6=CN=C7N6C=CC=C7,"Glycogen synthase kinase-3 beta, Glycogen synthase kinase-3 alpha"
Valproic acid sodium salt,CIDs16760703,,0,,CCCC(CCC)C(=O)[O-].[Na+],Succinate semialdehyde dehydrogenase
Tideglusib,CIDs11313622,tideglusib,334.39166,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,Glycogen synthase kinase-3 beta
AMG-337,CIDs44181686,SCHEMBL4304600,463.464283,CC(C1=NN=C2N1C=C(C=C2F)C3=CN(N=C3)C)N4C=CC5=NC=C(C=C5C4=O)OCCOC,CC(C1=NN=C2N1C=C(C=C2F)C3=CN(N=C3)C)N4C=CC5=C(C4=O)C=C(C=N5)OCCOC,Hepatocyte growth factor receptor
Savolitinib,CIDs68289010,Savolitinib,345.3613,CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C,CC(C1=CN2C=CN=C2C=C1)N3C4=NC(=CN=C4N=N3)C5=CN(N=C5)C,Hepatocyte growth factor receptor
AMG-208,CIDs24864821,AMG-208,383.40268,COC1=CC2=NC=CC(=C2C=C1)OCC3=NN=C4N3N=C(C=C4)C5=CC=CC=C5,COC1=CC2=NC=CC(=C2C=C1)OCC3=NN=C4N3N=C(C=C4)C5=CC=CC=C5,Hepatocyte growth factor receptor
Tivantinib,CIDs11494412,tivantinib,369.41586,C1CC2=CC=CC3=C2N(C1)C=C3C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,C1CC2=C3C(=CC=C2)C(=CN3C1)C4C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,Hepatocyte growth factor receptor
Capmatinib,CIDs25145656,INCB28060,412.419083,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,CNC(=O)C1=C(C=C(C=C1)C2=NN3C(=CN=C3N=C2)CC4=CC5=C(C=C4)N=CC=C5)F,Hepatocyte growth factor receptor
MK-8033,CIDs45142457,MK-8033,471.53094,CN1C=C(C=N1)C2=CN=C3C=CC4=C(C=C(C=C4)CS(=O)(=O)NCC5=CC=CC=N5)C(=O)C3=C2,CN1C=C(C=N1)C2=CC3=C(C=CC4=C(C3=O)C=C(C=C4)CS(=O)(=O)NCC5=CC=CC=N5)N=C2,"Hepatocyte growth factor receptor, Macrophage-stimulating protein receptor"
Altiratinib,CIDs54576299,Altiratinib,510.46455,C1CC1C(=O)NC2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F)F,C1CC1C(=O)NC2=NC=CC(=C2)OC3=C(C=C(C(=C3)F)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F)F,"Hepatocyte growth factor receptor, Tyrosine-protein kinase TIE-2, Neurotrophic tyrosine kinase receptor, Vascular endothelial growth factor receptor 2"
Brigatinib,CIDs68165256,AGN-PC-0HUR20,584.092422,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,CN1CCN(CC1)C2CCN(CC2)C3=CC(=C(C=C3)NC4=NC=C(C(=N4)NC5=CC=CC=C5P(=O)(C)C)Cl)OC,"Epidermal growth factor receptor erbB1, ALK tyrosine kinase receptor"
XL-228,CIDs59757974,XL228,437.54124,CC(C)C1=NOC(=C1)CNC2=NC(=CC(=N2)NC3=NNC(=C3)C4CC4)N5CCN(CC5)C,CC(C)C1=NOC(=C1)CNC2=NC(=CC(=N2)N3CCN(CC3)C)NC4=NNC(=C4)C5CC5,"Insulin-like growth factor I receptor, SRC, Tyrosine-protein kinase ABL"
Entrectinib,CIDs25141092,RXDX-101,560.637466,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,CN1CCN(CC1)C2=CC(=C(C=C2)C(=O)NC3=NNC4=C3C=C(C=C4)CC5=CC(=CC(=C5)F)F)NC6CCOCC6,"Proto-oncogene tyrosine-protein kinase ROS, Neurotrophic tyrosine kinase receptor, ALK tyrosine kinase receptor"
Picropodophyllin,CIDs00072435,picropodophyllin,414.40528,COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O,COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)O,Insulin-like growth factor I receptor
Cerdulatinib,CIDs44595079,Cerdulatinib,445.53848,CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N,CCS(=O)(=O)N1CCN(CC1)C2=CC=C(C=C2)NC3=NC=C(C(=N3)NC4CC4)C(=O)N,"Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK3, Tyrosine-protein kinase TYK2, Tyrosine-protein kinase SYK"
Solcitinib,CIDs44603362,solcitinib,389.45032,CC1(CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(=NN43)NC(=O)C5CC5)C,CC1(CN(C1)C(=O)C2=CC=C(C=C2)C3=CC=CC4=NC(=NN43)NC(=O)C5CC5)C,Tyrosine-protein kinase JAK1
Itacitinib,CIDs53380437,AGN-PC-09S7E5,553.514133,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,C1CN(CCC1N2CC(C2)(CC#N)N3C=C(C=N3)C4=C5C=CNC5=NC=N4)C(=O)C6=C(C(=NC=C6)C(F)(F)F)F,Tyrosine-protein kinase JAK1
Filgotinib,CIDs49831257,GLPG0634,425.50402,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,"Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK3, Tyrosine-protein kinase JAK2, Tyrosine-protein kinase TYK2"
Gandotinib,CIDs46213929,gandotinib,469.942303,CC1=CC(=NN1)NC2=NN3C(=C(N=C3C(=C2)CN4CCOCC4)C)CC5=C(C=C(C=C5)Cl)F,CC1=CC(=NN1)NC2=NN3C(=C(N=C3C(=C2)CN4CCOCC4)C)CC5=C(C=C(C=C5)Cl)F,Tyrosine-protein kinase JAK2
BMS-911543,CIDs50922691,BMS-911543,432.52142,CCN1C(=CC2=C3C(=C(N=C21)NC4=NN(C(=C4)C)C)N=CN3C)C(=O)N(C5CC5)C6CC6,CCN1C(=CC2=C3C(=C(N=C21)NC4=NN(C(=C4)C)C)N=CN3C)C(=O)N(C5CC5)C6CC6,Tyrosine-protein kinase JAK2
Baricitinib,CIDs44205240,baricitinib,371.41688,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,"Tyrosine-protein kinase JAK1, Tyrosine-protein kinase JAK2"
Decernotinib,CIDs59422203,decernotinib,392.37827,CCC(C)(C(=O)NCC(F)(F)F)NC1=NC(=NC=C1)C2=CNC3=C2C=CC=N3,CCC(C)(C(=O)NCC(F)(F)F)NC1=NC(=NC=C1)C2=CNC3=C2C=CC=N3,Tyrosine-protein kinase JAK3
PF-06651600,CIDs118115473,,0,,CC1CCC(CN1C(=O)C=C)NC2=NC=NC3=C2C=CN3,"Tyrosine-protein kinase JAK3, TEC family kinase"
Olmutinib,CIDs54758501,AGN-PC-0AC0Q9,486.58864,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4,CN1CCN(CC1)C2=CC=C(C=C2)NC3=NC4=C(C(=N3)OC5=CC=CC(=C5)NC(=O)C=C)SC=C4,Epidermal growth factor receptor erbB1
CC-401,CIDs10430360,cc-401,388.46556,C1CCN(CC1)CCOC2=CC=CC(=C2)C3=NNC4=C3C=C(C=C4)C5=NC=NN5,C1CCN(CC1)CCOC2=CC=CC(=C2)C3=NNC4=C3C=C(C=C4)C5=NC=NN5,"c-Jun N-terminal kinase 2, c-Jun N-terminal kinase 1, c-Jun N-terminal kinase 3"
AS-602801,CIDs10195250,bentamapimod,457.54742,C1COCCN1CC2=CC=C(C=C2)COC3=NC=CC(=N3)C(C#N)C4=NC5=CC=CC=C5S4,C1COCCN1CC2=CC=C(C=C2)COC3=NC=CC(=N3)C(C#N)C4=NC5=CC=CC=C5S4,"c-Jun N-terminal kinase, JNK"
Tolimidone,CIDs00039065,Tolimidone,202.2093,CC1=CC(=CC=C1)OC2=CNC(=O)N=C2,CC1=CC(=CC=C1)OC2=CNC(=O)N=C2,Tyrosine-protein kinase Lyn
Merestinib,CIDs44603533,LY2801653,552.530886,CC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F,CC1=CC=C(C(=O)N1C2=CC=C(C=C2)F)C(=O)NC3=CC(=C(C=C3)OC4=C(C=C5C(=C4)C=NN5C)C6=CNN=C6)F,Hepatocyte growth factor receptor
ARRY-162,CIDs10288191,binimetinib,441.226806,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2"
Pimasertib,CIDs44187362,pimasertib,431.200773,C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O,C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2"
PD-184352,CIDs06918454,Ci-1040,478.659536,C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl,C1CC1CONC(=O)C2=C(C(=C(C=C2)F)F)NC3=C(C=C(C=C3)I)Cl,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2"
Cobimetinib,CIDs16222096,cobimetinib,531.31002,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2"
RO-4987655,CIDs11548630,RO4987655,565.28164,C1CC(=O)N(OC1)CC2=C(C(=C(C(=C2)C(=O)NOCCO)NC3=C(C=C(C=C3)I)F)F)F,C1CC(=O)N(OC1)CC2=CC(=C(C(=C2F)F)NC3=C(C=C(C=C3)I)F)C(=O)NOCCO,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2"
AZD-8330,CIDs16666708,ARRY 704,461.226753,CC1=CC(=C(N(C1=O)C)NC2=C(C=C(C=C2)I)F)C(=O)NOCCO,CC1=CC(=C(N(C1=O)C)NC2=C(C=C(C=C2)I)F)C(=O)NOCCO,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2"
Ravoxertinib,CIDs71727581,GDC-0994,440.858023,CN1C(=CC=N1)NC2=NC=CC(=N2)C3=CC(=O)N(C=C3)C(CO)C4=CC(=C(C=C4)Cl)F,CN1C(=CC=N1)NC2=NC=CC(=N2)C3=CC(=O)N(C=C3)C(CO)C4=CC(=C(C=C4)Cl)F,"MAP kinase ERK1, MAP kinase ERK2"
Ulixertinib,CIDs11719003,VRT752271,433.33098,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,"MAP kinase ERK1, MAP kinase ERK2"
LY-3214996,CIDs121408882,,0,,CC1(C2=C(C=C(S2)C3=NC(=NC=C3)NC4=CC=NN4C)C(=O)N1CCN5CCOCC5)C,Mitogen-activated protein kinase; ERK1/ERK2
CC-223,CIDs58298316,AGN-PC-0CBJ2I,397.47078,CC(C)(C1=NC=C(C=C1)C2=CN=C3C(=N2)N(C(=O)CN3)C4CCC(CC4)OC)O,CC(C)(C1=NC=C(C=C1)C2=CN=C3C(=N2)N(C(=O)CN3)C4CCC(CC4)OC)O,Serine/threonine-protein kinase mTOR
Temsirolimus,CIDs06918289,temsirolimus,1030.28708,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OC(=O)C(C)(CO)CO)C)C)O)OC)C)C)C)OC,FK506-binding protein 1A
Ridaforolimus,CIDs11520894,ridaforolimus,990.206122,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OP(=O)(C)C)C)C)O)OC)C)C)C)OC,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OP(=O)(C)C)C)C)O)OC)C)C)C)OC,Serine/threonine-protein kinase mTOR
INK-128,CIDs45375953,INK-128,309.3259,CC(C)N1C2=C(C(=N1)C3=CC4=C(C=C3)OC(=N4)N)C(=NC=N2)N,CC(C)N1C2=NC=NC(=C2C(=N1)C3=CC4=C(C=C3)OC(=N4)N)N,Serine/threonine-protein kinase mTOR
Vistusertib,CIDs25262792,AZD2014,462.5441,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOCC5C,CC1COCCN1C2=NC(=NC3=C2C=CC(=N3)C4=CC(=CC=C4)C(=O)NC)N5CCOCC5C,Serine/threonine-protein kinase mTOR
Voxtalisib,CIDs16123056,SAR245409,270.28986,CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N,CCN1C2=NC(=NC(=C2C=C(C1=O)C3=CC=NN3)C)N,"Serine/threonine-protein kinase mTOR, PI3-kinase class I"
eFT508,CIDs118598754,,0,,CC1=C2C(=O)NC3(N2C(=O)C(=C1)NC4=NC=NC(=C4)N)CCCCC3,MAP kinase-interacting serine/threonine-protein kinase 1/2
Iguratimod,CIDs00124246,iguratimod,374.36786,CS(=O)(=O)NC1=C(C=C2C(=C1)OC=C(C2=O)NC=O)OC3=CC=CC=C3,CS(=O)(=O)NC1=C(C=C2C(=C1)OC=C(C2=O)NC=O)OC3=CC=CC=C3,"E3 ubiquitin ligase TRAF3IP2, Macrophage migration inhibitory factor, Cyclooxygenase-2"
Capsaicin,CIDs01548943,capsaicin,305.41188,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,Vanilloid receptor
Erythromycin,CIDs00012560,erythromycin,733.92678,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,Bacterial 70S ribosome
Dimethyl fumarate,CIDs00637568,dimethyl fumarate,144.12532,COC(=O)C=CC(=O)OC,COC(=O)C=CC(=O)OC,Kelch-like ECH-associated protein 1
PF-3758309,CIDs25227462,PF-3758309,490.6237,CC1=NC2=C(C(=N1)NC3=NNC4=C3CN(C4(C)C)C(=O)NC(CN(C)C)C5=CC=CC=C5)SC=C2,CC1=NC2=C(C(=N1)NC3=NNC4=C3CN(C4(C)C)C(=O)NC(CN(C)C)C5=CC=CC=C5)SC=C2,Serine/threonine-protein kinase PAK 4
SD-06,CIDs09865587,SD-06,397.8581,C1CN(CCC1C2=C(C(=NN2)C3=CC=C(C=C3)Cl)C4=NC=NC=C4)C(=O)CO,C1CN(CCC1C2=C(C(=NN2)C3=CC=C(C=C3)Cl)C4=NC=NC=C4)C(=O)CO,MAP kinase p38 alpha
TAK-715,CIDs09952773,Tak-715,399.50804,CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC(=CC=C4)C,CCC1=NC(=C(S1)C2=CC(=NC=C2)NC(=O)C3=CC=CC=C3)C4=CC=CC(=C4)C,MAP kinase p38 alpha
AMG-548,CIDs11167112,AMG-548,461.55758,CN1C(=O)C(=C(N=C1NCC(CC2=CC=CC=C2)N)C3=CC=NC=C3)C4=CC5=CC=CC=C5C=C4,CN1C(=O)C(=C(N=C1NCC(CC2=CC=CC=C2)N)C3=CC=NC=C3)C4=CC5=CC=CC=C5C=C4,MAP kinase p38 alpha
Losmapimod,CIDs11552706,losmapimod,383.459143,CC1=C(C=C(C=C1C2=NC=C(C=C2)C(=O)NCC(C)(C)C)C(=O)NC3CC3)F,CC1=C(C=C(C=C1F)C(=O)NC2CC2)C3=NC=C(C=C3)C(=O)NCC(C)(C)C,"MAP kinase p38 beta, MAP kinase p38 alpha"
Pexmetinib,CIDs24765037,ARRY-614,556.630523,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NCC3=C(C=CC(=C3)F)OC4=CC5=C(C=C4)N(N=C5)CCO,CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NCC3=C(C=CC(=C3)F)OC4=CC5=C(C=C4)N(N=C5)CCO,"Tyrosine-protein kinase TIE-2, MAP kinase p38 alpha"
BMS-582949,CIDs10409068,3Z6GAP3R9Q,406.48084,CCCNC(=O)C1=CN2C(=C1C)C(=NC=N2)NC3=C(C=CC(=C3)C(=O)NC4CC4)C,CCCNC(=O)C1=CN2C(=C1C)C(=NC=N2)NC3=C(C=CC(=C3)C(=O)NC4CC4)C,MAP kinase p38 alpha
Crenolanib,CIDs10366136,crenolanib,443.54076,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,"Platelet-derived growth factor receptor, Tyrosine-protein kinase receptor FLT3"
TAK-593,CIDs24767976,TAK-593,445.47382,CC1=C(C=C(C=C1)OC2=NN3C=C(N=C3C=C2)NC(=O)C4CC4)NC(=O)C5=CC(=NN5C)C,CC1=C(C=C(C=C1)OC2=NN3C=C(N=C3C=C2)NC(=O)C4CC4)NC(=O)C5=CC(=NN5C)C,"Platelet-derived growth factor receptor, Vascular endothelial growth factor receptor"
DCC-2618,CIDs71584930,AGN-PC-0JHIDR,510.358243,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,CCN1C2=CC(=NC=C2C=C(C1=O)C3=CC(=C(C=C3Br)F)NC(=O)NC4=CC=CC=C4)NC,"Stem cell growth factor receptor, Platelet-derived growth factor receptor alpha"
OSU-03012,CIDs10027278,OSU-03012,460.45047,C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F,C1=CC=C2C(=C1)C=CC3=C2C=CC(=C3)C4=CC(=NN4C5=CC=C(C=C5)NC(=O)CN)C(F)(F)F,3-phosphoinositide dependent protein kinase-1
Serabelisib,CIDs70798655,AGN-PC-0JHA5V,363.36998,C1COCCN1C(=O)C2=CN=C3N2C=C(C=C3)C4=CC5=C(C=C4)OC(=N5)N,C1COCCN1C(=O)C2=CN=C3N2C=C(C=C3)C4=CC5=C(C=C4)OC(=N5)N,PI3-kinase p110-alpha subunit
Gedatolisib,CIDs44516953,PKI-587,615.72584,CN(C)C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6,CN(C)C1CCN(CC1)C(=O)C2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)C4=NC(=NC(=N4)N5CCOCC5)N6CCOCC6,"Serine/threonine-protein kinase mTOR, PI3-kinase class I"
Seletalisib,CIDs56928390,64CW205BDD,482.84507,C1=CC2=CC(=C(N=C2C(=C1)Cl)C3=C[N+](=CC=C3)[O-])C(C(F)(F)F)NC4=NC=NC5=C4N=CC=C5,C1=CC2=CC(=C(N=C2C(=C1)Cl)C3=C[N+](=CC=C3)[O-])C(C(F)(F)F)NC4=NC=NC5=C4N=CC=C5,PI3-kinase p110-delta subunit
Alpelisib,CIDs56649450,NVP-BYL719,441.47049,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,PI3-kinase p110-alpha subunit
Copanlisib,CIDs135565596,,0,,COC1=C(C=CC2=C3NCCN3C(=NC(=O)C4=CN=C(N=C4)N)N=C21)OCCCN5CCOCC5,"PI3-kinase p110-delta subunit, PI3-kinase p110-alpha subunit"
Tenalisib,CIDs86291103,3-(3-fluorophenyl)-2-[(1S)-1-(7H-purin-6-ylamino)propyl]chromone,415.419723,CCC(C1=C(C(=O)C2=CC=CC=C2O1)C3=CC(=CC=C3)F)NC4=NC=NC5=C4NC=N5,CCC(C1=C(C(=O)C2=CC=CC=C2O1)C3=CC(=CC=C3)F)NC4=NC=NC5=C4NC=N5,"PI3-kinase p110-delta subunit, PI3-kinase p110-gamma subunit"
IPI-549,CIDs91933883,,0,,CC(C1=CC2=C(C(=CC=C2)C#CC3=CN(N=C3)C)C(=O)N1C4=CC=CC=C4)NC(=O)C5=C6N=CC=CN6N=C5N,PI3-kinase p110-gamma subunit
LY-3023414,CIDs57519748,SCHEMBL10322619,406.47754,CC(CN1C2=C3C=C(C=CC3=NC=C2N(C1=O)C)C4=CC(=CN=C4)C(C)(C)O)OC,CC(CN1C2=C3C=C(C=CC3=NC=C2N(C1=O)C)C4=CC(=CN=C4)C(C)(C)O)OC,"Serine/threonine-protein kinase mTOR, PI3-kinase class I"
ZSTK-474,CIDs11647372,ZSTK474,417.412546,C1COCCN1C2=NC(=NC(=N2)N3C4=CC=CC=C4N=C3C(F)F)N5CCOCC5,C1COCCN1C2=NC(=NC(=N2)N3C4=CC=CC=C4N=C3C(F)F)N5CCOCC5,PI3-kinase class I
XL-147,CIDs56599306,pilaralisib,541.0218,CC(C)(C(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=C(C=CC(=C4)OC)Cl)N,CC(C)(C(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=C(C=CC(=C4)OC)Cl)N,PI3-kinase class I
TG-100115,CIDs10427712,TG100-115,346.34276,C1=CC(=CC(=C1)O)C2=NC3=C(N=C2C4=CC(=CC=C4)O)N=C(N=C3N)N,C1=CC(=CC(=C1)O)C2=NC3=C(N=C(N=C3N=C2C4=CC(=CC=C4)O)N)N,"PI3-kinase p110-delta subunit, PI3-kinase p110-gamma subunit"
GDC-0084,CIDs57384863,AGN-PC-0BTCQD,382.41968,CC1(C2=NC3=C(N2CCO1)N=C(N=C3N4CCOCC4)C5=CN=C(N=C5)N)C,CC1(C2=NC3=C(N2CCO1)N=C(N=C3N4CCOCC4)C5=CN=C(N=C5)N)C,PI3-kinase class I
CUDC-907,CIDs54575456,CUDC-907,508.55286,CN(CC1=CC2=C(S1)C(=NC(=N2)C3=CN=C(C=C3)OC)N4CCOCC4)C5=NC=C(C=N5)C(=O)NO,CN(CC1=CC2=C(S1)C(=NC(=N2)C3=CN=C(C=C3)OC)N4CCOCC4)C5=NC=C(C=N5)C(=O)NO,"PI3-kinase p110-delta subunit, PI3-kinase p110-beta subunit, Histone deacetylase, PI3-kinase p110-alpha subunit"
PX-866,CIDs09849735,Px-866,525.5901,CC(=O)OC1CC2(C(CCC2=O)C3=C1C4(C(OC(=O)C(=CN(CC=C)CC=C)C4=C(C3=O)O)COC)C)C,CC(=O)OC1CC2(C(CCC2=O)C3=C1C4(C(OC(=O)C(=CN(CC=C)CC=C)C4=C(C3=O)O)COC)C)C,PI3-kinase class I
AZD-8186,CIDs52913813,SCHEMBL1636956,457.469806,CC(C1=C2C(=CC(=C1)C(=O)N(C)C)C(=O)C=C(O2)N3CCOCC3)NC4=CC(=CC(=C4)F)F,CC(C1=CC(=CC2=C1OC(=CC2=O)N3CCOCC3)C(=O)N(C)C)NC4=CC(=CC(=C4)F)F,"PI3-kinase p110-delta subunit, PI3-kinase p110-beta subunit"
GDC-0077,CIDs124173720,,0,,CC(C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4C(COC4=O)C(F)F,PI3-kinase p110-alpha subunit
GSK-615,CIDs23582824,GSK1059615,333.36384,C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4,C1=CC2=NC=CC(=C2C=C1C=C3C(=O)NC(=O)S3)C4=CC=NC=C4,PI3-kinase class I
Pilaralisib,CIDs56599306,pilaralisib,541.0218,CC(C)(C(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=C(C=CC(=C4)OC)Cl)N,CC(C)(C(=O)NC1=CC(=CC=C1)S(=O)(=O)NC2=NC3=CC=CC=C3N=C2NC4=C(C=CC(=C4)OC)Cl)N,PI3-kinase class I
CH-5132799,CIDs49784945,CH5132799,377.42146,CS(=O)(=O)N1CCC2=C(N=C(N=C21)N3CCOCC3)C4=CN=C(N=C4)N,CS(=O)(=O)N1CCC2=C(N=C(N=C21)N3CCOCC3)C4=CN=C(N=C4)N,PI3-kinase class I
GSK-2636771,CIDs56949517,GSK2636771,433.42359,CC1=C(C=CC=C1C(F)(F)F)CN2C(=NC3=C2C=C(C=C3C(=O)O)N4CCOCC4)C,CC1=C(C=CC=C1C(F)(F)F)CN2C(=NC3=C(C=C(C=C32)N4CCOCC4)C(=O)O)C,PI3-kinase p110-beta subunit
Duvelisib,CIDs50905713,IPI-145,416.86298,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,"PI3-kinase p110-delta subunit, PI3-kinase p110-gamma subunit"
Acalisib,CIDs11618268,Acalisib,401.396443,CC(C1=NC2=C(C=C(C=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,CC(C1=NC2=C(C=C(C=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,PI3-kinase p110-delta subunit
AMG-319,CIDs68947304,3VC,385.397043,CC(C1=C(N=C2C=C(C=CC2=C1)F)C3=CC=CC=N3)NC4=NC=NC5=C4NC=N5,CC(C1=C(N=C2C=C(C=CC2=C1)F)C3=CC=CC=N3)NC4=NC=NC5=C4NC=N5,PI3-kinase p110-delta subunit
LGH-447,CIDs44814409,SCHEMBL3215332,440.46083,CC1CC(CC(C1)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F,CC1CC(CC(C1)N)C2=C(C=NC=C2)NC(=O)C3=NC(=C(C=C3)F)C4=C(C=CC=C4F)F,Serine/threonine-protein kinase PIM
GDC-0349,CIDs59239165,GDC-0349,452.54928,CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CCN(C3)C4COC4)C(=N2)N5CCOCC5C,CCNC(=O)NC1=CC=C(C=C1)C2=NC3=C(CCN(C3)C4COC4)C(=N2)N5CCOCC5C,Serine/threonine-protein kinase mTOR
TAK-960,CIDs53357478,yl)benzamide,561.59917,CN1CCC(CC1)NC(=O)C2=CC(=C(C=C2F)NC3=NC=C4C(=N3)N(CC(C(=O)N4C)(F)F)C5CCCC5)OC,CN1CCC(CC1)NC(=O)C2=CC(=C(C=C2F)NC3=NC=C4C(=N3)N(CC(C(=O)N4C)(F)F)C5CCCC5)OC,Serine/threonine-protein kinase PLK1
Briciclib,CIDs11248490,Briciclib,474.418682,COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)OP(=O)(O)O,COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)OP(=O)(O)O,G1/S-specific cyclin D1
IVX-214,CIDs09888590,HMN-214,424.4696,CC(=O)N(C1=CC=CC=C1C=CC2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC,CC(=O)N(C1=CC=CC=C1C=CC2=CC=[N+](C=C2)[O-])S(=O)(=O)C3=CC=C(C=C3)OC,Serine/threonine-protein kinase PLK1
NMS-P937,CIDs49792852,NMS-P937,532.51819,CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO,CN1CCN(CC1)C2=CC(=C(C=C2)OC(F)(F)F)NC3=NC=C4CCC5=C(C4=N3)N(N=C5C(=O)N)CCO,Serine/threonine-protein kinase PLK1
PLX-8394,CIDs90116675,SCHEMBL15666953,542.53285,C1CC1C2=NC=C(C=N2)C3=CN=C4C(=C3)C(=CN4)C(=O)C5=C(C=CC(=C5F)NS(=O)(=O)N6CCC(C6)F)F,C1CC1C2=NC=C(C=N2)C3=CC4=C(NC=C4C(=O)C5=C(C=CC(=C5F)NS(=O)(=O)N6CCC(C6)F)F)N=C3,Serine/threonine-protein kinase B-raf
RO-5126766,CIDs16719221,CHEBI:78825,471.461523,CC1=C(C(=O)OC2=C1C=CC(=C2)OC3=NC=CC=N3)CC4=C(C(=NC=C4)NS(=O)(=O)NC)F,CC1=C(C(=O)OC2=C1C=CC(=C2)OC3=NC=CC=N3)CC4=C(C(=NC=C4)NS(=O)(=O)NC)F,"Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2"
RAF-265 derivative,CIDs11656518,CHIR-265,518.413859,CN1C2=C(C=C(C=C2)OC3=CC(=NC=C3)C4=NC=C(N4)C(F)(F)F)N=C1NC5=CC=C(C=C5)C(F)(F)F,CN1C2=C(C=C(C=C2)OC3=CC(=NC=C3)C4=NC=C(N4)C(F)(F)F)N=C1NC5=CC=C(C=C5)C(F)(F)F,"Vascular endothelial growth factor receptor 2, Serine/threonine-protein kinase B-raf"
MLN-2480,CIDs25161177,MLN 2480,506.28909,CC(C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl,CC(C1=NC=C(S1)C(=O)NC2=NC=C(C(=C2)C(F)(F)F)Cl)NC(=O)C3=C(C(=NC=N3)N)Cl,RAF serine/threonine protein kinase
LY-3009120,CIDs71721540,DP-4978,424.514363,CC1=CC(=C(C=C1C2=C(N=C3C(=C2)C=NC(=N3)NC)C)NC(=O)NCCC(C)(C)C)F,CC1=CC(=C(C=C1C2=C(N=C3C(=C2)C=NC(=N3)NC)C)NC(=O)NCCC(C)(C)C)F,"Serine/threonine-protein kinase RAF, Serine/threonine-protein kinase A-Raf, Serine/threonine-protein kinase B-raf"
Encorafenib,CIDs50922675,encorafenib,540.010683,CC(C)N1C=C(C(=N1)C2=CC(=CC(=C2F)NS(=O)(=O)C)Cl)C3=NC(=NC=C3)NCC(C)NC(=O)OC,CC(C)N1C=C(C(=N1)C2=C(C(=CC(=C2)Cl)NS(=O)(=O)C)F)C3=NC(=NC=C3)NCC(C)NC(=O)OC,Serine/threonine-protein kinase B-raf
LY-2584702,CIDs25118925,LY2584702 tosylate,445.416073,CN1C=C(N=C1C2CCN(CC2)C3=NC=NC4=C3C=NN4)C5=CC(=C(C=C5)F)C(F)(F)F,CN1C=C(N=C1C2CCN(CC2)C3=NC=NC4=C3C=NN4)C5=CC(=C(C=C5)F)C(F)(F)F,Ribosomal protein S6 kinase 1
GSK-2982772,CIDs77108121,SCHEMBL15956219,377.39656,CN1C2=CC=CC=C2OCC(C1=O)NC(=O)C3=NNC(=N3)CC4=CC=CC=C4,CN1C2=CC=CC=C2OCC(C1=O)NC(=O)C3=NNC(=N3)CC4=CC=CC=C4,Receptor-interacting serine/threonine-protein kinase 1
KD-025,CIDs11950170,KD-025,452.50776,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,CC(C)NC(=O)COC1=CC=CC(=C1)C2=NC3=CC=CC=C3C(=N2)NC4=CC5=C(C=C4)NN=C5,Rho-associated protein kinase 2
Y-39983,CIDs09810884,Y-39983,280.32444,CC(C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N,CC(C1=CC=C(C=C1)C(=O)NC2=C3C=CNC3=NC=C2)N,Rho-associated protein kinase
Ripasudil,CIDs09863672,,0,,CC1CNCCCN1S(=O)(=O)C2=CC=CC3=CN=CC(=C32)F,Rho-associated protein kinase
ABC-294640,CIDs15604015,ABC294640,380.9104,C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl,C1C2CC3(CC1CC(C2)(C3)C(=O)NCC4=CC=NC=C4)C5=CC=C(C=C5)Cl,Sphingosine kinase 2
M-475271,CIDs05330175,Methoxy Aniline 7,442.93848,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=CC(=C4)OC)Cl)OC,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=CC(=C4)OC)Cl)OC,"Tyrosine-protein kinase ABL, Tyrosine-protein kinase SRC"
TG-100801,CIDs11973736,TG 100801,580.076,CC1=C2C(=CC(=C1)C3=C(C=CC(=C3)OC(=O)C4=CC=CC=C4)Cl)N=NC(=N2)NC5=CC=C(C=C5)OCCN6CCCC6,CC1=CC(=CC2=C1N=C(N=N2)NC3=CC=C(C=C3)OCCN4CCCC4)C5=C(C=CC(=C5)OC(=O)C6=CC=CC=C6)Cl,"Platelet-derived growth factor receptor beta, SRC, Fibroblast growth factor receptor 1, Vascular endothelial growth factor receptor 2, Vascular endothelial growth factor receptor 1, Ephrin type-B receptor 4, Fibroblast growth factor receptor 2"
KX-01,CIDs23635314,KX2-391,431.52676,C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4,C1COCCN1CCOC2=CC=C(C=C2)C3=CN=C(C=C3)CC(=O)NCC4=CC=CC=C4,Tyrosine-protein kinase SRC
Entospletinib,CIDs59473233,entospletinib,411.45914,C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6,C1COCCN1C2=CC=C(C=C2)NC3=NC(=CN4C3=NC=C4)C5=CC6=C(C=C5)C=NN6,Tyrosine-protein kinase SYK
Galunisertib,CIDs10090485,galunisertib,369.41916,CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,TGF-beta receptor type I
Larotrectinib,CIDs46188928,"US8865698, 14",428.435186,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,C1CC(N(C1)C2=NC3=C(C=NN3C=C2)NC(=O)N4CCC(C4)O)C5=C(C=CC(=C5)F)F,Neurotrophic tyrosine kinase receptor
Sunitinib malate,CIDs06456015,sunitinib malate,532.561223,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O,"Stem cell growth factor receptor, Tyrosine-protein kinase receptor RET, Platelet-derived growth factor receptor, Macrophage colony stimulating factor receptor, Tyrosine-protein kinase receptor FLT3, Vascular endothelial growth factor receptor"
Fruquintinib,CIDs44480399,AGN-PC-076MKL,393.39266,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC,Vascular endothelial growth factor receptor
Glesatinib,CIDs25181472,AGN-PC-04XEQ8,619.704586,COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=S)NC(=O)CC5=CC=C(C=C5)F)F,COCCNCC1=CN=C(C=C1)C2=CC3=NC=CC(=C3S2)OC4=C(C=C(C=C4)NC(=S)NC(=O)CC5=CC=C(C=C5)F)F,"Macrophage-stimulating protein receptor, Tyrosine-protein kinase TIE-2, Vascular endothelial growth factor receptor, Hepatocyte growth factor receptor"
BFH-772,CIDs24756034,AGN-PC-0H2ZNQ,439.38665,C1=CC(=CC(=C1)NC(=O)C2=CC=CC3=C2C=CC(=C3)OC4=NC=NC(=C4)CO)C(F)(F)F,C1=CC(=CC(=C1)NC(=O)C2=CC=CC3=C2C=CC(=C3)OC4=NC=NC(=C4)CO)C(F)(F)F,Vascular endothelial growth factor receptor 2
Sulfatinib,CIDs52920501,AGN-PC-09LPDY,480.58252,CC1=CC2=C(N1)C=CC(=C2)OC3=NC(=NC=C3)NC4=CC=CC(=C4)CS(=O)(=O)NCCN(C)C,CC1=CC2=C(N1)C=CC(=C2)OC3=NC(=NC=C3)NC4=CC=CC(=C4)CS(=O)(=O)NCCN(C)C,"Fibroblast growth factor receptor 1, Vascular endothelial growth factor receptor"
Golvatinib,CIDs16118392,golvatinib,633.688186,CN1CCN(CC1)C2CCN(CC2)C(=O)NC3=NC=CC(=C3)OC4=CC(=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,CN1CCN(CC1)C2CCN(CC2)C(=O)NC3=NC=CC(=C3)OC4=CC(=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,"Vascular endothelial growth factor receptor 2, Hepatocyte growth factor receptor"
SU-014813,CIDs10138259,SU14813,442.483283,CC1=C(NC(=C1C(=O)NCC(CN2CCOCC2)O)C)C=C3C4=C(C=CC(=C4)F)NC3=O,CC1=C(NC(=C1C(=O)NCC(CN2CCOCC2)O)C)C=C3C4=C(C=CC(=C4)F)NC3=O,"Tyrosine-protein kinase receptor FLT3, Stem cell growth factor receptor, Platelet-derived growth factor receptor, Vascular endothelial growth factor receptor"
AG-13958,CIDs09934283,RS0092,467.497583,CC1=NN(C(=C1)C(=O)NC2=C(C=CC(=C2)NC3=CC4=C(C=C3)C(=NN4)C=CC5=CC=CC=N5)F)C,CC1=NN(C(=C1)C(=O)NC2=C(C=CC(=C2)NC3=CC4=C(C=C3)C(=NN4)C=CC5=CC=CC=N5)F)C,Vascular endothelial growth factor receptor
Orantinib,CIDs05329099,orantinib,310.34712,CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O,CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O,"Vascular endothelial growth factor receptor 2, Platelet-derived growth factor receptor, Fibroblast growth factor receptor"
KRN-633,CIDs09549295,KRN-633,416.85814,CCCNC(=O)NC1=C(C=C(C=C1)OC2=NC=NC3=CC(=C(C=C32)OC)OC)Cl,CCCNC(=O)NC1=C(C=C(C=C1)OC2=NC=NC3=CC(=C(C=C32)OC)OC)Cl,Vascular endothelial growth factor receptor
Anlotinib,CIDs25017411,AGN-PC-0BT9LA,407.437483,CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,CC1=CC2=C(N1)C=CC(=C2F)OC3=C4C=C(C(=CC4=NC=C3)OCC5(CC5)N)OC,"Vascular endothelial growth factor receptor 2, Stem cell growth factor receptor, Platelet-derived growth factor receptor beta, Vascular endothelial growth factor receptor 3"
BMS-690514,CIDs11349170,BMS-690514,368.43286,COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CCC(C(C4)O)N,COC1=CC=CC(=C1)NC2=NC=NN3C2=C(C=C3)CN4CCC(C(C4)O)N,"Receptor protein-tyrosine kinase erbB-4, Vascular endothelial growth factor receptor, Epidermal growth factor receptor erbB1, Receptor protein-tyrosine kinase erbB-2"
Abexinostat,CIDs11749858,Abexinostat,397.42442,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,Histone deacetylase
Quisinostat,CIDs11538455,quisinostat,394.47014,CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO,CN1C=C(C2=CC=CC=C21)CNCC3CCN(CC3)C4=NC=C(C=N4)C(=O)NO,Histone deacetylase
Tacedinaline,CIDs00002746,acetyldinaline,269.2985,CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2N,CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC=C2N,Histone deacetylase
ACY-1215,CIDs53340666,ricolinostat,433.50288,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,Histone deacetylase 6
SRT-2104,CIDs25108829,sirtuin modulator,516.63776,CC1=C(SC(=N1)C2=CN=CC=C2)C(=O)NC3=CC=CC=C3C4=CN5C(=CSC5=N4)CN6CCOCC6,CC1=C(SC(=N1)C2=CN=CC=C2)C(=O)NC3=CC=CC=C3C4=CN5C(=CSC5=N4)CN6CCOCC6,NAD-dependent deacetylase sirtuin 1
GSK-126,CIDs68210102,EZH2 inhibitor,526.67242,CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(C=C(NC5=O)C)C)C,CCC(C)N1C=C(C2=C(C=C(C=C21)C3=CN=C(C=C3)N4CCNCC4)C(=O)NCC5=C(C=C(NC5=O)C)C)C,Histone-lysine N-methyltransferase EZH2
GSK-3326595,CIDs90241742,SCHEMBL15826074,452.54928,CC(=O)N1CCC(CC1)NC2=NC=NC(=C2)C(=O)NCC(CN3CCC4=CC=CC=C4C3)O,CC(=O)N1CCC(CC1)NC2=NC=NC(=C2)C(=O)NCC(CN3CCC4=CC=CC=C4C3)O,Protein arginine N-methyltransferase 5
Birabresib,CIDs09936746,,0,,CC1=C(SC2=C1C(=NC(C3=NN=C(N32)C)CC(=O)NC4=CC=C(C=C4)O)C5=CC=C(C=C5)Cl)C,Bromodomain and extra-terminal motif (BET)
I-BET762,CIDs46943432,I-BET762,423.89538,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,Bromodomain and extra-terminal motif (BET)
BMS-986158,CIDs118196485,,0,,CC1=C(N(N=N1)C)C2=CC3=C(C4=C(N3C(C5CCOCC5)C6=CC=CC=C6)C=C(C=C4)C(C)(C)O)N=C2,Bromodomain and extra-terminal motif (BET)
CPI-0610,CIDs57389999,SCHEMBL15926539,365.81294,CC1=NOC2=C1C3=CC=CC=C3C(=NC2CC(=O)N)C4=CC=C(C=C4)Cl,CC1=NOC2=C1C3=CC=CC=C3C(=NC2CC(=O)N)C4=CC=C(C=C4)Cl,Bromodomain and extra-terminal motif (BET)
BMN-673,CIDs135565082,,0,,CN1C(=NC=N1)C2C(NC3=CC(=CC4=C3C2=NNC4=O)F)C5=CC=C(C=C5)F,"Poly [ADP-ribose] polymerase-1, Poly [ADP-ribose] polymerase 2"
E-7449,CIDs135565981,,0,,C1C2=CC=CC=C2CN1CC3=NC4=NNC(=O)C5=C4C(=CC=C5)N3,"Tankyrase 1/2, Poly [ADP-ribose] polymerase-1, Poly [ADP-ribose] polymerase 2"
Niraparib,CIDs24958200,niraparib,320.3883,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,"Poly [ADP-ribose] polymerase-1, Poly [ADP-ribose] polymerase 2"
Methacycline hydrochloride,CIDs54685047,,0,,CN(C)C1C2C(C3C(=C)C4=C(C(=CC=C4)O)C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O.Cl,Bacterial 70S ribosome
Oxytetracycline,CIDs54675779,oxytetracycline,460.43396,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O,Bacterial 70S ribosome
Triapine,CIDs09571836,Triapine,195.24486,C1=CC(=C(N=C1)C=NNC(=S)N)N,C1=CC(=C(N=C1)C=NNC(=S)N)N,Ribonucleotide reductase
Hydroxyurea,CIDs00003657,hydroxyurea,76.05466,C(=O)(N)NO,C(=O)(N)NO,Ribonucleoside-diphosphate reductase RR1
Tioguanine,CIDs02723601,6-thioguanine,167.1917,C1=NC2=C(N1)C(=S)N=C(N2)N,C1=NC2=C(N1)C(=S)N=C(N2)N,"DNA, Inosine-5'-monophosphate dehydrogenase (IMPDH)"
Fludarabine phosphate,CIDs00030751,FAMP,365.211685,C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)COP(=O)(O)O)O)O)F)N,"Ribonucleoside-diphosphate reductase RR1, DNA polymerase (alpha/delta/epsilon)"
Nelarabine,CIDs03011155,nelarabine,297.2673,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,DNA
Azathioprine,CIDs00002265,azathioprine,277.26258,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],"DNA, Amidophosphoribosyltransferase"
Fluorouracil,CIDs00003385,5-fluorouracil,130.077223,C1=C(C(=O)NC(=O)N1)F,C1=C(C(=O)NC(=O)N1)F,"DNA, RNA, Thymidylate synthase"
Flucytosine,CIDs00003366,flucytosine,129.092463,C1=NC(=O)NC(=C1F)N,C1=NC(=O)NC(=C1F)N,Thymidylate synthase
Floxuridine,CIDs00005790,FUdR,246.192443,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,Thymidylate synthase
Tegafur,CIDs00005386,tegafur,200.167063,C1CC(OC1)N2C=C(C(=O)NC2=O)F,C1CC(OC1)N2C=C(C(=O)NC2=O)F,"DNA, RNA, Thymidylate synthase"
Capecitabine,CIDs00060953,capecitabine,359.350083,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,"DNA, RNA, Thymidylate synthase"
Decitabine,CIDs00451668,decitabine,228.20528,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,"DNA (cytosine-5)-methyltransferase 3A, DNA (cytosine-5)-methyltransferase 1, DNA"
Aciclovir,CIDs135398513,,0,,C1=NC2=C(N1COCCO)N=C(NC2=O)N,Human herpesvirus 1 DNA polymerase
Ganciclovir,CIDs135398740,,0,,C1=NC2=C(N1COC(CO)CO)N=C(NC2=O)N,Human herpesvirus 1 DNA polymerase
Brincidofovir,CIDs00483477,HDP-CDV,561.691442,CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O,CCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O,DNA polymerase
Clofarabine,CIDs00119182,clofarabine,303.677443,C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(N=C2N)Cl,C1=NC2=C(N=C(N=C2N1C3C(C(C(O3)CO)O)F)Cl)N,"Ribonucleoside-diphosphate reductase RR1, DNA polymerase (alpha/delta/epsilon), DNA"
Adefovir dipivoxil,CIDs00060871,adefovir dipivoxil,501.470542,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)C(C)(C)C,DNA polymerase/reverse transcriptase
Troxacitabine,CIDs00454194,Q-4344,213.19064,C1C(OC(O1)CO)N2C=CC(=NC2=O)N,C1C(OC(O1)CO)N2C=CC(=NC2=O)N,DNA polymerase (alpha/delta/epsilon)
Telbivudine,CIDs00159269,telbivudine,242.22856,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,DNA polymerase/reverse transcriptase
Doxifluridine,CIDs00018343,5'-DFUR,246.192443,CC1C(C(C(O1)N2C=C(C(=O)NC2=O)F)O)O,CC1C(C(C(O1)N2C=C(C(=O)NC2=O)F)O)O,"DNA, RNA, Thymidylate synthase"
Trifluridine,CIDs00006256,trifluridine,296.19995,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,DNA
Pemetrexed,CIDs135410875,,0,,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O,"Thymidylate synthase, GAR transformylase, Dihydrofolate reductase"
Chlorambucil,CIDs00002708,chlorambucil,304.21216,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,C1=CC(=CC=C1CCCC(=O)O)N(CCCl)CCCl,DNA
Carmustine,CIDs00002578,BCNU,214.04986,C(CCl)NC(=O)N(CCCl)N=O,C(CCl)NC(=O)N(CCCl)N=O,"DNA, RNA, Glutathione reductase"
Melphalan,CIDs00460612,melphalan,305.20022,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,DNA
Busulfan,CIDs00002478,busulfan,246.30176,CS(=O)(=O)OCCCCOS(=O)(=O)C,CS(=O)(=O)OCCCCOS(=O)(=O)C,DNA
Chlormethine,CIDs00004033,nitrogen mustard,156.05354,CN(CCCl)CCCl,CN(CCCl)CCCl,DNA
Dacarbazine,CIDs135398738,,0,,CN(C)N=NC1=C(NC=N1)C(=O)N,DNA
Lomustine,CIDs00003950,lomustine,233.69524,C1CCC(CC1)NC(=O)N(CCCl)N=O,C1CCC(CC1)NC(=O)N(CCCl)N=O,DNA
Fotemustine,CIDs00104799,fotemustine,315.691022,CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC,CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC,DNA
Altretamine,CIDs00002123,hexamethylmelamine,210.27942,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,DNA
Procarbazine hydrochloride,CIDs00009703,,0,,CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl,DNA
Apaziquone,CIDs05813717,apaziquone,288.29854,CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO,CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO,DNA
Evofosfamide,CIDs11984561,TH-302,449.036202,CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr,CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr,DNA
Trabectedin,CIDs00108150,trabectedin,761.83722,CC1=C(C(=C2C3C4C5C6=C(C(N4C(C(N3C)CC2=C1)O)COC(=O)C7(CS5)C8=CC(=C(C=C8CCN7)O)OC)C9=C(C(=C6OC(=O)C)C)OCO9)O)OC,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,DNA
Tirapazamine,CIDs135413511,,0,,C1=CC=C2C(=C1)[N+](=C(N=[N+]2[O-])N)[O-],DNA
SJG-136,CIDs00393111,NSC-694501,556.60898,COC1=C(C=C2C(=C1)C(=O)N3CC(=C)CC3C=N2)OCCCOC4=C(C=C5C(=C4)N=CC6CC(=C)CN6C5=O)OC,COC1=C(C=C2C(=C1)C(=O)N3CC(=C)CC3C=N2)OCCCOC4=C(C=C5C(=C4)N=CC6CC(=C)CN6C5=O)OC,DNA
Exatecan,CIDs00151115,,0,,CCC1(C2=C(COC1=O)C(=O)N3CC4=C5C(CCC6=C5C(=CC(=C6C)F)N=C4C3=C2)N)O,DNA topoisomerase I
Amrubicin,CIDs00114897,amrubicin,519.92824,CC(=O)C1(CC(C2=C(C3=C(C(=C2C1)O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(CO5)O)O)N.Cl,CC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=CC=CC=C4C3=O)O)OC5CC(C(CO5)O)O)N.Cl,DNA topoisomerase II alpha
Belotecan,CIDs06456014,belotecan,433.49958,CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CCNC(C)C)O,CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C5=CC=CC=C5N=C4C3=C2)CCNC(C)C)O,DNA topoisomerase I
Amsacrine,CIDs00002179,amsacrine,393.45886,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,DNA topoisomerase II
Vosaroxin,CIDs09952884,vosaroxin,401.43956,CNC1CN(CC1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O,CNC1CN(CC1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O,"DNA, DNA topoisomerase II"
Valrubicin,CIDs00454216,valrubicin,723.64375,CCCCC(=O)OCC(=O)C1(CC(C2=C(C3=C(C(=C2C1)O)C(=O)C4=C(C3=O)C(=CC=C4)OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,CCCCC(=O)OCC(=O)C1(CC(C2=C(C1)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4OC)O)OC5CC(C(C(O5)C)O)NC(=O)C(F)(F)F)O,"DNA topoisomerase II alpha, DNA"
Daunorubicin,CIDs00030323,daunorubicin,527.51986,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)C)O)N)O,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)N)O,"DNA topoisomerase II alpha, DNA"
Temozolomide,CIDs00005394,temozolomide,194.15084,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,DNA
Dexrazoxane hydrochloride,CIDs06918223,,0,,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2.Cl,"Iron, DNA topoisomerase II"
Teniposide,CIDs00452548,teniposide,656.65368,COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O,COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O,DNA topoisomerase II
Norfloxacin,CIDs00004539,norfloxacin,319.330823,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCNCC3)F)C(=O)O,"Topoisomerase IV, Bacterial DNA gyrase"
Ciprofloxacin,CIDs00002764,ciprofloxacin,331.341523,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O,"Topoisomerase IV, Bacterial DNA gyrase"
Gatifloxacin,CIDs00005379,gatifloxacin,375.394083,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,"Topoisomerase IV, DNA gyrase"
Sparfloxacin,CIDs00060464,sparfloxacin,392.399786,CC1CN(CC(N1)C)C2=C(C3=C(C(=C2F)N)C(=O)C(=CN3C4CC4)C(=O)O)F,CC1CN(CC(N1)C)C2=C(C(=C3C(=C2F)N(C=C(C3=O)C(=O)O)C4CC4)N)F,"Topoisomerase IV, Bacterial DNA gyrase"
Sitafloxacin hydrate,CIDs06918203,,0,,C1CC12CN(CC2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)C5CC5F)F.O,"Topoisomerase IV, Bacterial DNA gyrase"
Moxifloxacin hydrochloride,CIDs00101526,moxifloxacin,437.892303,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl,"Topoisomerase IV, Bacterial DNA gyrase"
Epothilone B,CIDs00448013,patupilone,507.68254,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,Tubulin
Epothilone D,CIDs00447865,epothilone D,491.68314,CC1CCCC(=CCC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC2=CSC(=N2)C)C)C,CC1CCCC(=CCC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC2=CSC(=N2)C)C)C,Tubulin
Lexibulin hydrochloride,CIDs11351021,CYT997,434.534,CCCC(C1=CN=CC=C1)NC2=NC(=NC=C2C)C3=CC(=C(C=C3)NC(=O)NCC)OC,CCCC(C1=CN=CC=C1)NC2=NC(=NC=C2C)C3=CC(=C(C=C3)NC(=O)NCC)OC,Tubulin
Cabazitaxel,CIDs09854073,cabazitaxel,835.93238,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)OC(C)(C)C)O)O)OC(=O)C6=CC=CC=C6)(CO4)OC(=O)C)OC)C)OC,Tubulin
Colchicine,CIDs00006167,colchicine,399.437,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,Tubulin
Dolastatin 10,CIDs09810929,dolastatin 10,785.09092,CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C,CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C,Tubulin
Indibulin,CIDs00002929,indibulin,389.83434,C1=CC=C2C(=C1)C(=CN2CC3=CC=C(C=C3)Cl)C(=O)C(=O)NC4=CC=NC=C4,C1=CC=C2C(=C1)C(=CN2CC3=CC=C(C=C3)Cl)C(=O)C(=O)NC4=CC=NC=C4,Tubulin
E-7010,CIDs03035714,ABT-751,371.41028,COC1=CC=C(C=C1)S(=O)(=O)NC2=C(N=CC=C2)NC3=CC=C(C=C3)O,COC1=CC=C(C=C1)S(=O)(=O)NC2=C(N=CC=C2)NC3=CC=C(C=C3)O,Tubulin beta
Ombrabulin,CIDs06918405,,0,,COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)NC(=O)C(CO)N,Tubulin
Ixabepilone,CIDs06445540,ixabepilone,506.69778,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,CC1CCCC2(C(O2)CC(NC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,Tubulin
Filanesib,CIDs44224257,ARRY-520,420.476086,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,Kinesin-like protein 1
Litronesib,CIDs25167017,litronesib,511.70098,CCNCCS(=O)(=O)NCC1(N(N=C(S1)NC(=O)C(C)(C)C)C(=O)C(C)(C)C)C2=CC=CC=C2,CCNCCS(=O)(=O)NCC1(N(N=C(S1)NC(=O)C(C)(C)C)C(=O)C(C)(C)C)C2=CC=CC=C2,Kinesin-like protein 1
Onalespib,CIDs11955716,AT13387,409.52124,CC(C)C1=C(C=C(C(=C1)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C)O)O,CC(C)C1=CC(=C(C=C1O)O)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C,Heat shock protein HSP90
Ganetespib (STA-9090),CIDs135564985,,0,,CC(C)C1=C(C=C(C(=C1)C2=NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)O)O,Heat shock protein HSP90
Retaspimycin Hydrochloride,CIDs11685945,,0,,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=C(C(=C2O)C1)NCC=C)O)C)OC)OC(=O)N)C)C)O)OC.Cl,Heat shock protein HSP90
Ixazomib citrate,CIDs56844015,D10131,517.12162,B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,B1(OC(=O)C(O1)(CC(=O)O)CC(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,26S proteasome
Oprozomib,CIDs25067547,oprozomib,532.60918,CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C,CC1=NC=C(S1)C(=O)NC(COC)C(=O)NC(COC)C(=O)NC(CC2=CC=CC=C2)C(=O)C3(CO3)C,26S proteasome
MLN-4924,CIDs16720766,pevonedistat,443.5193,C1CC2=CC=CC=C2C1NC3=NC=NC4=C3C=CN4C5CC(C(C5)O)COS(=O)(=O)N,C1CC2=CC=CC=C2C1NC3=C4C=CN(C4=NC=N3)C5CC(C(C5)O)COS(=O)(=O)N,NEDD8 activating enzyme
Probucol,CIDs00004912,probucol,516.84162,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,ATP-binding cassette sub-family A member 1
Marimastat,CIDs00119031,marimastat,331.40786,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,"Matrix metalloproteinase-1, Matrix metalloproteinase 12, Matrix metalloproteinase 3, Matrix metalloproteinase 7, Matrix metalloproteinase 9, Matrix metalloproteinase-2"
CTS-1027,CIDs03342298,CTS-1027,425.8832,C1COCCC1(CS(=O)(=O)C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C(=O)NO,C1COCCC1(CS(=O)(=O)C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)C(=O)NO,"Matrix metalloproteinase 12, Matrix metalloproteinase 3, Matrix metalloproteinase 14, Matrix metalloproteinase 9, Matrix metalloproteinase 13, Matrix metalloproteinase-2, Matrix metalloproteinase 8"
Abametapir,CIDs00015664,"5,5'-dimethyl-2,2'-bipyridine",184.23708,CC1=CN=C(C=C1)C2=NC=C(C=C2)C,CC1=CN=C(C=C1)C2=NC=C(C=C2)C,"Iron, Zinc, Metalloproteinase, Copper"
Thiabendazole,CIDs00005430,thiabendazole,201.24768,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,Tubulin
Tariquidar,CIDs00148201,tariquidar,646.73152,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)NC(=O)C4=CC(=C(C=C4NC(=O)C5=CC6=CC=CC=C6N=C5)OC)OC)OC,P-glycoprotein 1
Valspodar,CIDs05281884,valspodar,1214.62194,CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C,CC=CCC(C)C(=O)C1C(=O)NC(C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C)C(C)C,P-glycoprotein 1
HM-30181,CIDs11399764,HM-30181,688.72844,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)N4N=C(N=N4)C5=CC(=C(C=C5NC(=O)C6=CC(=O)C7=CC=CC=C7O6)OC)OC)OC,COC1=C(C=C2CN(CCC2=C1)CCC3=CC=C(C=C3)N4N=C(N=N4)C5=CC(=C(C=C5NC(=O)C6=CC(=O)C7=CC=CC=C7O6)OC)OC)OC,P-glycoprotein 1
Sulindac,CIDs01548887,,0,,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,Cyclooxygenase
Tigecycline,CIDs54686904,tigecycline,585.64866,CC(C)(C)NCC(=O)NC1=C(C2=C(CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O,CC(C)(C)NCC(=O)NC1=CC(=C2CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C(C2=C1O)O)O)O)C(=O)N)N(C)C)N(C)C,Bacterial 70S ribosome
Terameprocol,CIDs00476861,terameprocol,358.4712,CC(CC1=CC(=C(C=C1)OC)OC)C(C)CC2=CC(=C(C=C2)OC)OC,CC(CC1=CC(=C(C=C1)OC)OC)C(C)CC2=CC(=C(C=C2)OC)OC,DNA
Mitotane,CIDs00004211,mitotane,320.0412,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,"Cytochrome P450 11A1, Cytochrome P450 11B1"
Selinexor,CIDs71481097,selinexor,443.305959,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,Exportin-1
Miconazole nitrate,CIDs00068553,,0,,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl.[N+](=O)(O)[O-],Cytochrome P450 51
Anastrozole,CIDs00002187,anastrozole,293.36626,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,Cytochrome P450 19A1
Exemestane,CIDs00060198,exemestane,296.40336,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,Cytochrome P450 19A1
Reparixin,CIDs09838712,reparixin,283.38644,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C,CC(C)CC1=CC=C(C=C1)C(C)C(=O)NS(=O)(=O)C,"Interleukin-8 receptor A, Interleukin-8 receptor B"
Danirixin,CIDs24780598,danirixin,441.904143,CC1=C(C=CC=C1F)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)C3CCCNC3)O,CC1=C(C=CC=C1F)NC(=O)NC2=C(C(=C(C=C2)Cl)S(=O)(=O)C3CCCNC3)O,Interleukin-8 receptor B
Seviteronel,CIDs78357816,VT-464,399.339493,CC(C)C(C1=CC2=CC(=C(C=C2C=C1)OC(F)F)OC(F)F)(C3=NNN=C3)O,CC(C)C(C1=CC2=CC(=C(C=C2C=C1)OC(F)F)OC(F)F)(C3=NNN=C3)O,"Cytochrome P450 17A1, Androgen Receptor"
Olanzapine (LY-170053),CIDs135398745,,0,,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,"D2-like dopamine receptor, Serotonin 2c (5-HT2c) receptor, Serotonin 2a (5-HT2a) receptor"
Isoniazid,CIDs00003767,isoniazid,137.13928,C1=CN=CC=C1C(=O)NN,C1=CN=CC=C1C(=O)NN,Enoyl-[acyl-carrier-protein] reductase
Methoxsalen,CIDs00004114,8-methoxypsoralen,216.18952,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,DNA
Taselisib (GDC-0032),CIDs51001932,taselisib,460.53152,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,CC1=NN(C(=N1)C2=CN3CCOC4=C(C3=N2)C=CC(=C4)C5=CN(N=C5)C(C)(C)C(=O)N)C(C)C,PI3-kinase class I
Ranolazine,CIDs00056959,ranolazine,427.53652,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,"Sodium channel protein type V alpha subunit, Sodium channel protein type IV alpha subunit"
Acetaminophen,CIDs00001983,paracetamol,151.16256,CC(=O)NC1=CC=C(C=C1)O,CC(=O)NC1=CC=C(C=C1)O,"Vanilloid receptor, Anandamide amidohydrolase, Cyclooxygenase"
Valdecoxib,CIDs00119607,valdecoxib,314.35896,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,Cyclooxygenase-2
Parecoxib sodium,CIDs15895902,,0,,CCC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C.[Na+],Cyclooxygenase-2
ThioTEPA,CIDs00005453,thiotepa,189.218342,C1CN1P(=S)(N2CC2)N3CC3,C1CN1P(=S)(N2CC2)N3CC3,DNA
LGK-974,CIDs46926973,LGK-974,396.4445,CC1=C(N=CC(=C1)CC(=O)NC2=NC=C(C=C2)C3=NC=CN=C3)C4=CC(=NC=C4)C,CC1=CC(=CN=C1C2=CC(=NC=C2)C)CC(=O)NC3=NC=C(C=C3)C4=NC=CN=C4,Probable protein-cysteine N-palmitoyltransferase porcupine
BMS-833923,CIDs57662985,XL139,473.56828,CC1=C(C=C(C=C1)CNC)NC(=O)C2=CC=C(C=C2)NC3=NC4=CC=CC=C4C(=N3)C5=CC=CC=C5,CC1=C(C=C(C=C1)CNC)NC(=O)C2=CC=C(C=C2)NC3=NC4=CC=CC=C4C(=N3)C5=CC=CC=C5,Smoothened homolog
Glasdegib,CIDs25166913,glasdegib,374.43898,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,CN1CCC(CC1C2=NC3=CC=CC=C3N2)NC(=O)NC4=CC=C(C=C4)C#N,Smoothened homolog
Patidegib,CIDs25027363,saridegib,504.76802,CC1CC2C(C(C3(O2)CCC4C5CCC6CC(CCC6(C5CC4=C(C3)C)C)NS(=O)(=O)C)C)NC1,CC1CC2C(C(C3(O2)CCC4C5CCC6CC(CCC6(C5CC4=C(C3)C)C)NS(=O)(=O)C)C)NC1,Smoothened homolog
TAK-441,CIDs44187367,TAK-441,576.56415,CCC1=CC2=C(C(=C(N2C)C(=O)NC3CCN(CC3)C(=O)CO)OCC(F)(F)F)C(=O)N1CC(=O)C4=CC=CC=C4,CCC1=CC2=C(C(=C(N2C)C(=O)NC3CCN(CC3)C(=O)CO)OCC(F)(F)F)C(=O)N1CC(=O)C4=CC=CC=C4,Smoothened homolog
Pomalidomide,CIDs00134780,pomalidomide,273.24414,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,CRL4(CRBN) E3 ubiquitin ligase
Thalidomide,CIDs00005426,thalidomide,258.2295,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,CRL4(CRBN) E3 ubiquitin ligase
Methylrosaniline chloride,CIDs00011057,,0,,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-],DNA
Nirogacestat,CIDs46224413,PF-3084014,489.644146,CCCC(C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)NC2CCC3=CC(=CC(=C3C2)F)F,CCCC(C(=O)NC1=CN(C=N1)C(C)(C)CNCC(C)(C)C)NC2CCC3=C(C2)C(=CC(=C3)F)F,Gamma-secretase
Avagacestat,CIDs46883536,avagacestat,520.884993,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,Gamma-secretase
Semagacestat,CIDs09843750,,0,,CC(C)C(C(=O)NC(C)C(=O)NC1C2=CC=CC=C2CCN(C1=O)C)O,Gamma-secretase
MK-8931,CIDs51352361,Verubecestat,409.410386,CC1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F,CC1(CS(=O)(=O)N(C(=N1)N)C)C2=C(C=CC(=C2)NC(=O)C3=NC=C(C=C3)F)F,Beta-secretase 1
PF-05175157,CIDs52934180,AGN-PC-09LZEN,405.49278,CC1=NC2=C(N1)C=C(C=C2)C(=O)N3CCC4(CC3)CC5=C(C(=O)C4)N(N=C5)C(C)C,CC1=NC2=C(N1)C=C(C=C2)C(=O)N3CCC4(CC3)CC5=C(C(=O)C4)N(N=C5)C(C)C,Acetyl-CoA carboxylase
Tolrestat,CIDs00053359,tolrestat,357.34747,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC,CN(CC(=O)O)C(=S)C1=CC=CC2=C1C=CC(=C2C(F)(F)F)OC,Aldose reductase
Epalrestat,CIDs01549120,,0,,CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O,Aldose reductase
PF-04457845,CIDs24771824,PF-04457845,455.43241,C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4,C1CN(CCC1=CC2=CC(=CC=C2)OC3=NC=C(C=C3)C(F)(F)F)C(=O)NC4=NN=CC=C4,Anandamide amidohydrolase
JNJ-42165279,CIDs54576693,AGN-PC-0HG8J8,410.802386,C1CN(CCN1CC2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4=C(C=CN=C4)Cl,C1CN(CCN1CC2=CC3=C(C=C2)OC(O3)(F)F)C(=O)NC4=C(C=CN=C4)Cl,Anandamide amidohydrolase
Pyrazinamide,CIDs00001046,pyrazinamide,123.1127,C1=CN=C(C=N1)C(=O)N,C1=CN=C(C=N1)C(=O)N,"Fatty acid synthase, 70S ribosome"
Orlistat,CIDs03034010,orlistat,495.73482,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,"Pancreatic lipase, Gastric lipase"
Riociguat,CIDs11304743,riociguat,422.415663,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,Soluble guanylate cyclase
LY-2608204,CIDs46832368,LY2608204,559.80668,C1CCC(CC1)C2CC2(C3=CC=C(C=C3)S(=O)(=O)C4CC4)C(=O)NC5=NC=C(S5)SCCN6CCCC6,C1CCC(CC1)C2CC2(C3=CC=C(C=C3)S(=O)(=O)C4CC4)C(=O)NC5=NC=C(S5)SCCN6CCCC6,Hexokinase type IV
PF-04937319,CIDs46916694,AGN-PC-080XDF,432.432,CC1=CC2=C(O1)C=C(C=C2OC3=CN=C(N=C3)C(=O)N(C)C)C(=O)NC4=NC=C(N=C4)C,CC1=CC2=C(O1)C=C(C=C2OC3=CN=C(N=C3)C(=O)N(C)C)C(=O)NC4=NC=C(N=C4)C,Hexokinase type IV
GSK-1292263A,CIDs24996872,GSK1292263,456.55782,CC(C)C1=NOC(=N1)N2CCC(CC2)COC3=CN=C(C=C3)C4=CC=C(C=C4)S(=O)(=O)C,CC(C)C1=NOC(=N1)N2CCC(CC2)COC3=CN=C(C=C3)C4=CC=C(C=C4)S(=O)(=O)C,Glucose-dependent insulinotropic receptor
CB-839,CIDs71577426,AGN-PC-0JHD16,571.57407,C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F,C1=CC=NC(=C1)CC(=O)NC2=NN=C(S2)CCCCC3=NN=C(C=C3)NC(=O)CC4=CC(=CC=C4)OC(F)(F)F,"Glutaminase kidney isoform, mitochondrial"
Mitapivat,CIDs59634741,AGN-PC-0D1AJ2,450.55324,C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5,C1CC1CN2CCN(CC2)C(=O)C3=CC=C(C=C3)NS(=O)(=O)C4=CC=CC5=C4N=CC=C5,Pyruvate kinase isozymes R/L
Ataciguat,CIDs00213037,ataciguat,576.49306,C1COCCN1S(=O)(=O)C2=CC=C(C=C2)NC(=O)C3=C(C=CC(=C3)Cl)NS(=O)(=O)C4=CC=C(S4)Cl,C1COCCN1S(=O)(=O)C2=CC=C(C=C2)NC(=O)C3=C(C=CC(=C3)Cl)NS(=O)(=O)C4=CC=C(S4)Cl,Soluble guanylate cyclase
Lovastatin,CIDs00053232,lovastatin,404.53964,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,HMG-CoA reductase
Atorvastatin calcium,CIDs00060822,atorvastatin,1155.341726,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2],CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2],HMG-CoA reductase
Pitavastatin calcium,CIDs05282451,pitavastatin,880.983646,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2],C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2],HMG-CoA reductase
Aspirin,CIDs00002244,aspirin,180.15742,CC(=O)OC1=CC=CC=C1C(=O)O,CC(=O)OC1=CC=CC=C1C(=O)O,Cyclooxygenase
Chlorothiazide,CIDs00002720,thiazide,295.72324,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N=CN2,Thiazide-sensitive sodium-chloride cotransporter
Hydrochlorothiazide,CIDs00003639,hydrochlorothiazide,297.73912,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,Thiazide-sensitive sodium-chloride cotransporter
Ivosidenib,CIDs71657455,SCHEMBL15122512,582.96089,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,C1CC(=O)N(C1C(=O)N(C2=CC(=CN=C2)F)C(C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N,Isocitrate dehydrogenase [NADP] cytoplasmic
BAY-1436032,CIDs118310260,,0,,CC1CC(CC(C1)(C)C)N2C3=C(C=C(C=C3)CCC(=O)O)N=C2NC4=CC=C(C=C4)OC(F)(F)F,Isocitrate dehydrogenase [NADP] cytoplasmic
AG-881,CIDs117817422,,0,,CC(C(F)(F)F)NC1=NC(=NC(=N1)C2=NC(=CC=C2)Cl)NC(C)C(F)(F)F,IDH1/IDH2
Indoximod,CIDs00405012,1-methyl-D-tryptophan,218.25176,CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N,CN1C=C(C2=CC=CC=C21)CC(C(=O)O)N,mTORC1
Epacadostat,CIDs135564890,,0,,C1=CC(=C(C=C1N=C(C2=NON=C2NCCNS(=O)(=O)N)NO)Br)F,"Indoleamine 2,3-dioxygenase"
Ibiglustat,CIDs60199242,Ibiglustat,389.486863,CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)OC3CN4CCC3CC4,CC(C)(C1=CSC(=N1)C2=CC=C(C=C2)F)NC(=O)OC3CN4CCC3CC4,Ceramide glucosyltransferase
Mycophenolic acid,CIDs00446541,mycophenolic acid,320.3371,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)O)OC,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)O)O,Inosine-5'-monophosphate dehydrogenase (IMPDH)
Ribavirin,CIDs00037542,ribavirin,244.20468,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,"Hepatitis C virus NS5B RNA-dependent RNA polymerase, RNA, Inosine-5'-monophosphate dehydrogenase 1"
Mizoribine,CIDs00104762,mizoribine,259.21602,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N,"GMP synthase [glutamine-hydrolyzing], Inosine-5'-monophosphate dehydrogenase (IMPDH)"
Mycophenolate mofetil,CIDs05281078,mycophenolate mofetil,433.49474,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC,CC1=C2COC(=O)C2=C(C(=C1OC)CC=C(C)CCC(=O)OCCN3CCOCC3)O,Inosine-5'-monophosphate dehydrogenase (IMPDH)
AVN944,CIDs09918559,AVN944,477.51238,CCC(CC#N)OC(=O)NC(C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC,CCC(CC#N)OC(=O)NC(C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC,Inosine-5'-monophosphate dehydrogenase (IMPDH)
Clotrimazole,CIDs00002812,clotrimazole,344.83678,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,Cytochrome P450 51
Voriconazole,CIDs00071616,voriconazole,349.31047,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,Cytochrome P450 51
Posaconazole,CIDs00468595,posaconazole,700.777386,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,Cytochrome P450 51
Sivelestat,CIDs00107706,sivelestat,434.46288,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)O,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)O,Leukocyte elastase
Zafirlukast,CIDs00005717,zafirlukast,575.67522,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,Cysteinyl leukotriene receptor 1
Pranlukast hydrate,CIDs00004887,pranlukast,481.50262,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,Cysteinyl leukotriene receptor 1
Anacetrapib,CIDs11556427,anacetrapib,637.508432,CC1C(OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,CC1C(OC(=O)N1CC2=C(C=CC(=C2)C(F)(F)F)C3=CC(=C(C=C3OC)F)C(C)C)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F,Cholesteryl ester transfer protein
Torcetrapib,CIDs00159325,torcetrapib,600.473329,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC,Cholesteryl ester transfer protein
Evacetrapib (LY2484595),CIDs49836058,evacetrapib,638.646959,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,Cholesteryl ester transfer protein
Melatonin,CIDs00000896,melatonin,232.27834,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,Melatonin receptor
GKT-137831,CIDs58496428,GKT137831,394.85416,CN1C(=O)C=C2C(=C1C3=CC(=CC=C3)N(C)C)C(=O)N(N2)C4=CC=CC=C4Cl,CN1C(=O)C=C2C(=C1C3=CC(=CC=C3)N(C)C)C(=O)N(N2)C4=CC=CC=C4Cl,"NADPH oxidase 1, NADPH oxidase 4"
Levetiracetam,CIDs05284583,levetiracetam,170.20896,CCC(C(=O)N)N1CCCC1=O,CCC(C(=O)N)N1CCCC1=O,"Synaptic vesicle glycoprotein 2A, Voltage-gated N-type calcium channel alpha-1B subunit"
Omaveloxolone,CIDs71811910,Nrf1-activator-1,554.710866,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C,CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)NC(=O)C(C)(F)F)C,Nuclear factor erythroid 2-related factor 2
Lemborexant,CIDs56944144,Lemborexant,410.416606,CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C,CC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C,"Orexin receptor 1, Orexin receptor 2"
Gemfibrozil,CIDs00003463,gemfibrozil,250.33338,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,Peroxisome proliferator-activated receptor alpha
Ciprofibrate,CIDs00002763,ciprofibrate,289.15446,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,CC(C)(C(=O)O)OC1=CC=C(C=C1)C2CC2(Cl)Cl,Peroxisome proliferator-activated receptor alpha
Clofibrate,CIDs00002796,clofibrate,242.6987,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)Cl,Peroxisome proliferator-activated receptor alpha
Fenofibrate,CIDs00003339,fenofibrate,360.83134,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,Peroxisome proliferator-activated receptor alpha
Elafibranor,CIDs09864881,2J3H5C81A5,384.48856,CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC,CC1=CC(=CC(=C1OC(C)(C)C(=O)O)C)C=CC(=O)C2=CC=C(C=C2)SC,"Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor delta"
Pemafibrate,CIDs11526038,17VGG92R23,490.5476,CCC(C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3,CCC(C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3,Peroxisome proliferator-activated receptor alpha
Pradigastat,CIDs53387035,,0,,C1CC(CCC1CC(=O)O)C2=CC=C(C=C2)C3=NC=C(C=C3)NC4=CN=C(C=C4)C(F)(F)F,Diacylglycerol O-acyltransferase 1
Tiagabine hydrochloride,CIDs00091274,,0,,CC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C.Cl,GABA transporter 1
GSK-2256294A,CIDs59448236,L33EX3XR0T,447.45677,CC1=NC(=NC(=N1)NC)NC2CCCC(C2)C(=O)NCC3=C(C=C(C=C3)C#N)C(F)(F)F,CC1=NC(=NC(=N1)NC2CCCC(C2)C(=O)NCC3=C(C=C(C=C3)C#N)C(F)(F)F)NC,Epoxide hydratase
Cinaciguat,CIDs09808022,cinaciguat,565.69856,C1=CC=C(C=C1)CCC2=CC=C(C=C2)COC3=CC=CC=C3CCN(CCCCC(=O)O)CC4=CC=C(C=C4)C(=O)O,C1=CC=C(C=C1)CCC2=CC=C(C=C2)COC3=CC=CC=C3CCN(CCCCC(=O)O)CC4=CC=C(C=C4)C(=O)O,Soluble guanylate cyclase
Tetrabenazine,CIDs00006018,tetrabenazine,317.42258,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,CC(C)CC1CN2CCC3=CC(=C(C=C3C2CC1=O)OC)OC,Synaptic vesicular amine transporter
PX-12,CIDs00219104,1-methylpropyl 2-imidazolyl disulfide,188.31358,CCC(C)SSC1=NC=CN1,CCC(C)SSC1=NC=CN1,Thioredoxin
Deferasirox,CIDs00214348,,0,,C1=CC=C(C(=C1)C2=NN(C(=N2)C3=CC=CC=C3O)C4=CC=C(C=C4)C(=O)O)O,Iron
Penicillamine,CIDs00005852,D-penicillamine,149.21134,CC(C)(C(C(=O)O)N)S,CC(C)(C(C(=O)O)N)S,Copper
Molidustat,CIDs59603622,molidustat,314.30266,C1COCCN1C2=NC=NC(=C2)N3C(=O)C(=CN3)N4C=CN=N4,C1COCCN1C2=NC=NC(=C2)N3C(=O)C(=CN3)N4C=CN=N4,"Egl nine homolog 1, Hypoxia-inducible factor prolyl hydroxylase 1, Egl nine homolog 3"
Roxadustat,CIDs11256664,FG-4592,352.34074,CC1=NC(=C(C2=C1C=C(C=C2)OC3=CC=CC=C3)O)C(=O)NCC(=O)O,CC1=C2C=C(C=CC2=C(C(=N1)C(=O)NCC(=O)O)O)OC3=CC=CC=C3,Hypoxia-inducible factor prolyl hydroxylase
Daprodustat,CIDs91617630,Daprodustat,393.43418,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3CCCCC3)C(=O)NCC(=O)O,Hypoxia-inducible factor prolyl hydroxylase
Vadadustat,CIDs23634441,AGN-PC-0HAO1I,306.70114,C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O,C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O,"Egl nine homolog 1, Hypoxia-inducible factor prolyl hydroxylase 1, Egl nine homolog 3"
Dyphylline,CIDs00003182,diprophylline,254.24256,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,"Phosphodiesterase 4, Phosphodiesterase 3A"
Allopurinol,CIDs135401907,,0,,C1=NNC2=C1C(=O)NC=N2,Xanthine dehydrogenase
Febuxostat,CIDs00134018,febuxostat,316.37484,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,Xanthine dehydrogenase
Deferoxamine mesylate,CIDs00062881,,0,,CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O,Iron
Vidofludimus,CIDs09820008,Vidofludimus,355.359623,COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F,COC1=CC=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=C(CCC3)C(=O)O)F,Dihydroorotate dehydrogenase
Brequinar,CIDs00057030,brequinar,375.367506,CC1=C(N=C2C=CC(=CC2=C1C(=O)O)F)C3=CC=C(C=C3)C4=CC=CC=C4F,CC1=C(C2=C(C=CC(=C2)F)N=C1C3=CC=C(C=C3)C4=CC=CC=C4F)C(=O)O,Dihydroorotate dehydrogenase
Sulfadoxine,CIDs00017134,sulfadoxine,310.32896,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,Dihydropteroate synthetase
Gimeracil,CIDs54679224,,0,,C1=C(C(=CNC1=O)Cl)O,Dihydropyrimidine dehydrogenase
Linagliptin,CIDs10096344,linagliptin,472.54222,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,Dipeptidyl peptidase IV
APR-246,CIDs52918385,PRIMA-1MET,199.24688,COCC1(C(=O)C2CCN1CC2)CO,COCC1(C(=O)C2CCN1CC2)CO,Cellular tumor antigen p53
Elagolix,CIDs11250647,elagolix,631.589716,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)NCCCC(=O)O)C4=C(C(=CC=C4)OC)F,Gonadotropin-releasing hormone receptor
Relugolix,CIDs10348973,TAK-385,623.630386,CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC,CN(C)CC1=C(SC2=C1C(=O)N(C(=O)N2CC3=C(C=CC=C3F)F)C4=NN=C(C=C4)OC)C5=CC=C(C=C5)NC(=O)NOC,Gonadotropin-releasing hormone receptor
Dronedarone hydrochloride,CIDs00219025,,0,,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC.Cl,"Inward rectifier potassium channel 2, Voltage-gated L-type calcium channel, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel alpha subunit"
Epinephrine,CIDs00005816,,0,,CNCC(C1=CC(=C(C=C1)O)O)O,Adrenergic receptor
Phenylephrine hydrochloride,CIDs05284443,,0,,CNCC(C1=CC(=CC=C1)O)O.Cl,Adrenergic receptor alpha-1
Naftopidil,CIDs00004418,naftopidil,392.49072,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,Alpha-1d adrenergic receptor
Oxymetazoline hydrochloride,CIDs00066259,,0,,CC1=CC(=C(C(=C1CC2=NCCN2)C)O)C(C)(C)C.Cl,Adrenergic receptor alpha
Tizanidine hydrochloride,CIDs00114869,,0,,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl.Cl,Adrenergic receptor alpha-2
Phentolamine mesilate,CIDs00091430,,0,,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O,Adrenergic receptor alpha
Miglitol,CIDs00441314,miglitol,207.22428,C1C(C(C(C(N1CCO)CO)O)O)O,C1C(C(C(C(N1CCO)CO)O)O)O,"Maltase-glucoamylase, Lysosomal alpha-glucosidase"
Avacopan,CIDs49841217,SCHEMBL2567144,581.643513,CC1=C(C(=CC=C1)F)C(=O)N2CCCC(C2C3=CC=C(C=C3)NC4CCCC4)C(=O)NC5=CC(=C(C=C5)C)C(F)(F)F,CC1=C(C(=CC=C1)F)C(=O)N2CCCC(C2C3=CC=C(C=C3)NC4CCCC4)C(=O)NC5=CC(=C(C=C5)C)C(F)(F)F,C5a anaphylatoxin chemotactic receptor
Ampanel,CIDs00164509,talampanel,337.37246,CC1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3,CC1CC2=CC3=C(C=C2C(=NN1C(=O)C)C4=CC=C(C=C4)N)OCO3,"Glutamate receptor ionotropic, AMPA 1, Glutamate receptor ionotropic, AMPA 2"
Etrasimod,CIDs44623998,SCHEMBL1919311,457.48475,C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CCC5CC(=O)O)C(F)(F)F,C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CCC5CC(=O)O)C(F)(F)F,Sphingosine 1-phosphate receptor Edg-1
MK-0557,CIDs11491176,MK-0557,406.409663,C1CC2(CCC1C(=O)NC3=NN(C=C3)C4=CC=CC=C4F)C5=C(C=CN=C5)C(=O)O2,C1CC2(CCC1C(=O)NC3=NN(C=C3)C4=CC=CC=C4F)C5=C(C=CN=C5)C(=O)O2,Neuropeptide Y receptor type 5
Sertraline hydrochloride,CIDs00063009,sertraline,342.69052,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl,CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl,Serotonin transporter
Varespladib,CIDs00155815,varespladib,380.3939,CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N,CCC1=C(C2=C(N1CC3=CC=CC=C3)C=CC=C2OCC(=O)O)C(=O)C(=O)N,Phospholipase A2 group IIA
Darolutamide (ODM-201),CIDs67171867,SCHEMBL1814935,398.84616,CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,CC(CN1C=CC(=N1)C2=CC(=C(C=C2)C#N)Cl)NC(=O)C3=NNC(=C3)C(C)O,Androgen Receptor
Orteronel,CIDs09796590,orteronel,307.34648,CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)C3(CCN4C3=CN=C4)O,CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)C3(CCN4C3=CN=C4)O,Cytochrome P450 17A1
Testosterone cypionate,CIDs00441404,testosterone cypionate,412.6047,CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=CC(=O)CCC35C,CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=CC(=O)CCC35C,Androgen Receptor
Cyproterone acetate,CIDs00009880,cyproterone acetate,416.93766,CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)C5CC5C34C)Cl)C)OC(=O)C,CC(=O)C1(CCC2C1(CCC3C2C=C(C4=CC(=O)C5CC5C34C)Cl)C)OC(=O)C,"Glucocorticoid receptor, Androgen Receptor, Progesterone receptor"
Finasteride,CIDs00057363,finasteride,372.54414,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,Steroid 5-alpha-reductase 2
17 alpha-propionate,CIDs11750009,cortexolone 17alpha-propionate,402.52376,CCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)CO,CCC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C)C(=O)CO,Androgen Receptor
Flutamide,CIDs00003397,flutamide,276.21185,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,Androgen Receptor
Nilutamide,CIDs00004493,nilutamide,317.22071,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,CC1(C(=O)N(C(=O)N1)C2=CC(=C(C=C2)[N+](=O)[O-])C(F)(F)F)C,Androgen Receptor
Apalutamide,CIDs24872560,ARN-509,477.434713,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CN=C(C(=C4)C(F)(F)F)C#N)F,CNC(=O)C1=C(C=C(C=C1)N2C(=S)N(C(=O)C23CCC3)C4=CC(=C(N=C4)C#N)C(F)(F)F)F,Androgen Receptor
AZD-3514,CIDs46893585,AZD3514,519.56249,CC(=O)N1CCN(CC1)CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5C(F)(F)F)CC4,CC(=O)N1CCN(CC1)CCOC2=CC=C(C=C2)C3CCN(CC3)C4=NN5C(=NN=C5C(F)(F)F)CC4,Androgen Receptor
Prinaberel,CIDs00656954,,0,,C=CC1=C2C(=CC(=C1)O)N=C(O2)C3=CC(=C(C=C3)O)F,Estrogen receptor beta
Ostarine,CIDs11326715,enobosarm,389.32797,CC(COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,CC(COC1=CC=C(C=C1)C#N)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,Androgen Receptor
Galeterone,CIDs11188409,galeterone,388.54508,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4N5C=NC6=CC=CC=C65)C)O,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4N5C=NC6=CC=CC=C65)C)O,"Cytochrome P450 17A1, Androgen Receptor"
Brilanestrant,CIDs56941241,SCHEMBL767215,446.900603,CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl,CCC(=C(C1=CC=C(C=C1)C=CC(=O)O)C2=CC3=C(C=C2)NN=C3)C4=C(C=C(C=C4)F)Cl,Estrogen receptor alpha
Toremifene citrate,CIDs03005572,toremifene,598.08314,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Estrogen receptor
Elacestrant,CIDs23642301,SCHEMBL229431,458.63492,CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)C3CCC4=C(C3)C=CC(=C4)O,CCNCCC1=CC=C(C=C1)CN(CC)C2=C(C=CC(=C2)OC)C3CCC4=C(C3)C=CC(=C4)O,Estrogen receptor alpha
Acolbifene,CIDs00155435,acolbifene,457.56074,CC1=C(C(OC2=C1C=CC(=C2)O)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O,CC1=C(C(OC2=C1C=CC(=C2)O)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)O,Estrogen receptor
Ospemifene,CIDs03036505,ospemifene,378.89122,C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl,C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl,Estrogen receptor
Estetrol,CIDs00027125,estetrol,304.38076,CC12CCC3C(C1C(C(C2O)O)O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1C(C(C2O)O)O)CCC4=C3C=CC(=C4)O,Estrogen receptor
Dienestrol,CIDs00667476,dienestrol,266.33432,CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O,CC=C(C1=CC=C(C=C1)O)C(=CC)C2=CC=C(C=C2)O,Estrogen receptor alpha
Diethylstilbestrol,CIDs00448537,estrogen,268.3502,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,Estrogen receptor alpha
Ethinylestradiol,CIDs00005991,ethynylestradiol,296.40336,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,Estrogen receptor alpha
Estradiol,CIDs00005757,estradiol,272.38196,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,Estrogen receptor alpha
Mestranol,CIDs00006291,mestranol,310.42994,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,Estrogen receptor alpha
Estriol,CIDs00005756,estriol,288.38136,CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O,Estrogen receptor
Erteberel,CIDs10286159,SERBA-1,282.33372,C1CC2C(C1)C3=C(C=CC(=C3)O)OC2C4=CC=C(C=C4)O,C1CC2C(C1)C3=C(C=CC(=C3)O)OC2C4=CC=C(C=C4)O,Estrogen receptor beta
Trilostane,CIDs00656583,trilostane,329.43328,CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C,CC12CCC3C(C1CCC2O)CCC45C3(CC(=C(C4O5)O)C#N)C,3-beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type II
Fulvestrant,CIDs00104741,fulvestrant,606.770796,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,Estrogen receptor
Chenodeoxycholic acid,CIDs00010133,cDCs,392.572,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,Bile acid receptor FXR
Zoledronic acid monohydrate,CIDs00121586,,0,,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O.O,Farnesyl diphosphate synthase
Lonafarnib,CIDs00148195,lonafarnib,638.82164,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(C=C(C=C4CCC5=CC(=CN=C35)Br)Cl)Br)C(=O)N,C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(CCC5=C3N=CC(=C5)Br)C=C(C=C4Br)Cl)C(=O)N,Protein farnesyltransferase
Ramelteon,CIDs00208902,ramelteon,259.34344,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,Melatonin receptor
Alvimopan,CIDs05488548,,0,,CC1CN(CCC1(C)C2=CC(=CC=C2)O)CC(CC3=CC=CC=C3)C(=O)NCC(=O)O,Mu opioid receptor
Loperamide hydrochloride,CIDs00071420,,0,,CN(C)C(=O)C(CCN1CCC(CC1)(C2=CC=C(C=C2)Cl)O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl,Mu opioid receptor
Naltrexone hydrochloride,CIDs05485201,,0,,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O.Cl,Opioid receptors; mu/kappa/delta
Gallamine triethiodide,CIDs00006172,,0,,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],Muscle-type nicotinic acetylcholine receptor
Amiodarone hydrochloride,CIDs00441325,,0,,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I.Cl,HERG
Bethanechol chloride,CIDs00011548,,0,,CC(C[N+](C)(C)C)OC(=O)N.[Cl-],"Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M2"
Ticlopidine hydrochloride,CIDs00065335,,0,,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl,Purinergic receptor P2Y12
Clopidogrel bisulfate,CIDs00115366,,0,,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O,Purinergic receptor P2Y12
Rifaximin,CIDs06436173,rifaximin,785.87854,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,CC1C=CC=C(C(=O)NC2=C(C3=C(C4=C(C(=C3O)C)OC(C4=O)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C5=C2N6C=CC(=CC6=N5)C)O)C,Bacterial DNA-directed RNA polymerase
Imiquimod,CIDs00057469,imiquimod,240.30364,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,CC(C)CN1C=NC2=C1C3=CC=CC=C3N=C2N,Toll-like receptor 7
Resiquimod,CIDs00159603,resiquimod,314.38218,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,CCOCC1=NC2=C(N1CC(C)(C)O)C3=CC=CC=C3N=C2N,"Toll-like receptor 7, Toll-like receptor 8"
Vesatolimod,CIDs46241268,GS-9620,410.5126,CCCCOC1=NC2=C(C(=N1)N)NC(=O)CN2CC3=CC(=CC=C3)CN4CCCC4,CCCCOC1=NC(=C2C(=N1)N(CC(=O)N2)CC3=CC=CC(=C3)CN4CCCC4)N,Toll-like receptor 7
Motolimod,CIDs16049404,vtx-2337,458.59516,CCCN(CCC)C(=O)C1=CC2=C(C=C(C=C2)C3=CC=C(C=C3)C(=O)N4CCCC4)N=C(C1)N,CCCN(CCC)C(=O)C1=CC2=C(C=C(C=C2)C3=CC=C(C=C3)C(=O)N4CCCC4)N=C(C1)N,Toll-like receptor 8
Resatorvid,CIDs11703255,resatorvid,361.816183,CCOC(=O)C1=CCCCC1S(=O)(=O)NC2=C(C=C(C=C2)F)Cl,CCOC(=O)C1=CCCCC1S(=O)(=O)NC2=C(C=C(C=C2)F)Cl,Toll-like receptor 4
SB-705498,CIDs09910486,sb-705498,429.23435,C1CN(CC1NC(=O)NC2=CC=CC=C2Br)C3=NC=C(C=C3)C(F)(F)F,C1CN(CC1NC(=O)NC2=CC=CC=C2Br)C3=NC=C(C=C3)C(F)(F)F,Vanilloid receptor
Propofol,CIDs00004943,propofol,178.27072,CC(C)C1=C(C(=CC=C1)C(C)C)O,CC(C)C1=C(C(=CC=C1)C(C)C)O,GABA-A receptor; anion channel
Istradefylline,CIDs05311037,istradefylline,384.42896,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,Adenosine A2a receptor
CVT-6883,CIDs11270783,CVT-6883,446.42565,CCCN1C(=O)C2=C(N=C(N2)C3=CN(N=C3)CC4=CC(=CC=C4)C(F)(F)F)N(C1=O)CC,CCCN1C(=O)C2=C(N=C(N2)C3=CN(N=C3)CC4=CC(=CC=C4)C(F)(F)F)N(C1=O)CC,Adenosine A2b receptor
Preladenant,CIDs10117987,preladenant,503.55626,COCCOC1=CC=C(C=C1)N2CCN(CC2)CCN3C4=C(C=N3)C5=NC(=NN5C(=N4)N)C6=CC=CO6,COCCOC1=CC=C(C=C1)N2CCN(CC2)CCN3C4=C(C=N3)C5=NC(=NN5C(=N4)N)C6=CC=CO6,Adenosine A2a receptor
CPI-444,CIDs44537963,SCHEMBL536782,407.42584,CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)COC5CCOC5,CC1=CC=C(O1)C2=C3C(=NC(=N2)N)N(N=N3)CC4=NC(=CC=C4)COC5CCOC5,Adenosine A2a receptor
Namodenoson,CIDs03035850,Cl-IB-MECA,544.73079,CNC(=O)C1C(C(C(O1)N2C=NC3=C2N=C(N=C3NCC4=CC(=CC=C4)I)Cl)O)O,CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)Cl)NCC4=CC(=CC=C4)I)O)O,Adenosine A3 receptor
Adenosine,CIDs00060961,adenosine,267.24132,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N,Adenosine receptor
Theophyllamine,CIDs00009433,aminophylline,420.42636,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,"Phosphodiesterase 4, Adenosine receptor, Phosphodiesterase 3"
Phenoxybenzamine hydrochloride,CIDs05284441,,0,,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl,Adrenergic receptor alpha
Fluticasone furoate,CIDs09854489,fluticasone furoate,538.57577,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)SCF)OC(=O)C5=CC=CO5)C)O)F)C)F,Glucocorticoid receptor
Ciclesonide,CIDs06918155,ciclesonide,540.68756,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,CC(C)C(=O)OCC(=O)C12C(CC3C1(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)OC(O2)C6CCCCC6,Glucocorticoid receptor
Cortisone acetate,CIDs00005745,cortisone acetate,402.4807,CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O,CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O,Glucocorticoid receptor
Fluocinolone acetonide,CIDs00006215,fluocinolone acetonide,452.488206,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)F)C,Glucocorticoid receptor
Prednisolone acetate,CIDs00005834,prednisolone acetate,402.4807,CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O,CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O,Glucocorticoid receptor
Fluocinonide,CIDs00009642,fluocinonide,494.524886,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C,CC(=O)OCC(=O)C12C(CC3C1(CC(C4(C3CC(C5=CC(=O)C=CC54C)F)F)O)C)OC(O2)(C)C,Glucocorticoid receptor
Methylprednisolone,CIDs00006741,methylprednisolone,374.4706,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,Glucocorticoid receptor
Triamcinolone acetonide,CIDs00006436,triamcinolone acetonide,434.497743,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4(C(CC3(C2(O1)C(=O)CO)C)O)F)C)C,Glucocorticoid receptor
Prednisone,CIDs00005865,prednisone,358.42814,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,Glucocorticoid receptor
Betamethasone dipropionate,CIDs00021800,betamethasone dipropionate,504.587583,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC,Glucocorticoid receptor
Budesonide,CIDs05281004,budesonide,430.53386,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C,Glucocorticoid receptor
BETAMETHASONE,CIDs00009782,betamethasone,392.461063,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,Glucocorticoid receptor
Hyodeoxycholic acid,CIDs05283820,hyodeoxycholic acid,392.572,CC(CCC(=O)O)C1CCC2C1(CCC3C2CC(C4C3(CCC(C4)O)C)O)C,CC(CCC(=O)O)C1CCC2C1(CCC3C2CC(C4C3(CCC(C4)O)C)O)C,"LXR-beta, LXR-alpha"
Prednisolone,CIDs00005755,prednisolone,360.44402,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,Glucocorticoid receptor
Meprednisone,CIDs05284587,meprednisone,372.45472,CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C,CC1CC2C3CCC4=CC(=O)C=CC4(C3C(=O)CC2(C1(C(=O)CO)O)C)C,Glucocorticoid receptor
Betamethasone valerate,CIDs00016533,Betnovate,476.577483,CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO,CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO,Glucocorticoid receptor
Clobetasol propionate,CIDs00032798,clobetasol propionate,466.969983,CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl,CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl,Glucocorticoid receptor
FLUNISOLIDE,CIDs00082153,flunisolide,434.497743,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,CC1(OC2CC3C4CC(C5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)F)C,Glucocorticoid receptor
Loteprednol etabonate,CIDs00444025,loteprednol etabonate,466.95174,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,Glucocorticoid receptor
Fluticasone propionate,CIDs00444036,fluticasone propionate,500.57085,CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF,CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF,Glucocorticoid receptor
Mometasone furoate,CIDs00441336,mometasone furoate,521.4295,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C,Glucocorticoid receptor
Deflazacort,CIDs00189821,deflazacort,441.51674,CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C,CC1=NC2(C(O1)CC3C2(CC(C4C3CCC5=CC(=O)C=CC45C)O)C)C(=O)COC(=O)C,Glucocorticoid receptor
Desonide,CIDs05311066,desonide,416.50728,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,CC1(OC2CC3C4CCC5=CC(=O)C=CC5(C4C(CC3(C2(O1)C(=O)CO)C)O)C)C,Glucocorticoid receptor
Medroxyprogesterone acetate,CIDs00006279,progestins,386.52436,CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,Progesterone receptor
Megestrol acetate,CIDs00011683,megestrol acetate,384.50848,CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,Progesterone receptor
Progesterone,CIDs00005994,progesterone,314.4617,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,Progesterone receptor
Levonorgestrel,CIDs00013109,levonorgestrel,312.44582,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,Progesterone receptor
Gestodene,CIDs03033968,gestodene,310.42994,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34,Progesterone receptor
Digoxin,CIDs02724385,digoxin,780.93846,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)O)C)C)C)O)O,Sodium/potassium-transporting ATPase
Ursodiol,CIDs00031401,UDCA,392.572,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,Bile acid receptor FXR
Dutasteride,CIDs06918296,dutasteride,528.529719,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,Steroid 5-alpha-reductase
Estrone,CIDs00005870,estrone,270.36608,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,Estrogen receptor alpha
Nandrolone phenylpropionate,CIDs00229455,NTPP,406.55706,CC12CCC3C(C1CCC2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CCC35,CC12CCC3C(C1CCC2OC(=O)CCC4=CC=CC=C4)CCC5=CC(=O)CCC35,Androgen Receptor
Pancuronium bromide,CIDs00027350,pancuronium,732.6699,CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-],CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-],Muscle-type nicotinic acetylcholine receptor
Rocuronium bromide,CIDs00441351,,0,,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],Muscle-type nicotinic acetylcholine receptor
Vecuronium bromide,CIDs00039764,vecuronium,637.73138,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],Muscle-type nicotinic acetylcholine receptor
Drospirenone,CIDs00068873,drospirenone,366.4932,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C,CC12CCC(=O)C=C1C3CC3C4C2CCC5(C4C6CC6C57CCC(=O)O7)C,"Progesterone receptor, Mineralocorticoid receptor"
Oxandrolone,CIDs00005878,oxandrolone,306.4397,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C,Androgen Receptor
Stanozolol,CIDs00025249,stanozolol,328.49158,CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NN=C5)C,CC12CCC3C(C1CCC2(C)O)CCC4C3(CC5=C(C4)NN=C5)C,Androgen Receptor
Etoricoxib,CIDs00123619,etoricoxib,358.8419,CC1=NC=C(C=C1)C2=NC=C(C=C2C3=CC=C(C=C3)S(=O)(=O)C)Cl,CC1=NC=C(C=C1)C2=C(C=C(C=N2)Cl)C3=CC=C(C=C3)S(=O)(=O)C,Cyclooxygenase-2
Piroxicam,CIDs54676228,,0,,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,Cyclooxygenase
Naproxen sodium,CIDs23681059,,0,,CC(C1=CC2=C(C=C1)C=C(C=C2)OC)C(=O)[O-].[Na+],Cyclooxygenase
Meloxicam,CIDs54677470,,0,,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,Cyclooxygenase-2
Diclofenac sodium,CIDs05018304,,0,,C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+],Cyclooxygenase
Rofecoxib,CIDs00005090,rofecoxib,314.35566,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,Cyclooxygenase-2
Alprostadil,CIDs05280723,prostaglandin E1,354.48096,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,"Prostanoid EP1 receptor, Prostanoid EP2 receptor"
Prostaglandin E2,CIDs05280360,prostaglandin E2,352.46508,CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,CCCCCC(C=CC1C(CC(=O)C1CC=CCCCC(=O)O)O)O,Prostaglandin E2 receptor
Bimatoprost,CIDs05311027,bimatoprost,415.56558,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,Prostanoid FP receptor
Ramatroban,CIDs00123879,ramatroban,416.465843,C1CC2=C(CC1NS(=O)(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4N2CCC(=O)O,C1CC2=C(CC1NS(=O)(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4N2CCC(=O)O,"Thromboxane A2 receptor, G protein-coupled receptor 44"
Laropiprant,CIDs09867642,laropiprant,435.896263,CS(=O)(=O)C1=C2C(=CC(=C1)F)C3=C(N2CC4=CC=C(C=C4)Cl)C(CC3)CC(=O)O,CS(=O)(=O)C1=CC(=CC2=C1N(C3=C2CCC3CC(=O)O)CC4=CC=C(C=C4)Cl)F,Prostanoid DP receptor
Indomethacin,CIDs00003715,indomethacin,357.78764,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,Cyclooxygenase
Streptomycin (sulfate),CIDs00019648,streptomycin,1457.38356,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,Bacterial 70S ribosome
Tetracycline hydrochloride,CIDs54704426,,0,,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,Bacterial 70S ribosome
Tobramycin,CIDs00036294,tobramycin,467.51448,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,70S ribosome
Nitisinone,CIDs00115355,NTBC,329.22811,C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],C1CC(=O)C(C(=O)C1)C(=O)C2=C(C=C(C=C2)C(F)(F)F)[N+](=O)[O-],4-hydroxyphenylpyruvate dioxygenase
Azithromycin,CIDs00447043,azithromycin,748.98448,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,Bacterial 70S ribosome
Linezolid,CIDs00441401,linezolid,337.346103,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,Bacterial 70S ribosome
Masoprocol,CIDs00071398,nordihydroguaiaretic acid,302.36488,CC(CC1=CC(=C(C=C1)O)O)C(C)CC2=CC(=C(C=C2)O)O,CC(CC1=CC(=C(C=C1)O)O)C(C)CC2=CC(=C(C=C2)O)O,"Insulin-like growth factor I receptor, Receptor protein-tyrosine kinase erbB-2"
Tacrine hydrochloride,CIDs02723754,,0,,C1CCC2=NC3=CC=CC=C3C(=C2C1)N.Cl,Cholinesterases; ACHE & BCHE
Acitretin,CIDs05284513,acitretin,326.42934,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,Retinoid receptor
Isotretinoin,CIDs05282379,isotretinoin,300.43512,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,Retinoic acid receptor
Tazarotene,CIDs00005381,tazarotene,351.46194,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,Retinoic acid receptor
Tamibarotene,CIDs00108143,tamibarotene,351.4388,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,"Retinoic acid receptor alpha, Retinoic acid receptor beta"
Tretinoin,CIDs00444795,retinoic acid,300.43512,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,Retinoic acid receptor
Bexarotene,CIDs00082146,bexarotene,348.47792,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,Retinoid X receptor
AGN-194204,CIDs09863341,AGN-194204,352.50968,CC(=CC(=O)O)C=CC1CC1(C)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,CC(=CC(=O)O)C=CC1CC1(C)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,Retinoid X receptor
Adapalene,CIDs00060164,adapalene,412.52012,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,Retinoic acid receptor
Calcitriol,CIDs05280453,calcitriol,416.63646,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Vitamin D receptor
Paricalcitol-D6 (ABT-358),CIDs05281104,paricalcitol,416.63646,CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C,CC(C=CC(C)C(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3)O)O)C,Vitamin D receptor
Calcitriol (Ro-21-5535),CIDs05280453,calcitriol,416.63646,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Vitamin D receptor
Warfarin sodium,CIDs16204922,,0,,CC(=O)CC(C1=CC=CC=C1)C2=C(C3=CC=CC=C3OC2=O)[O-].[Na+],Vitamin k epoxide reductase complex subunit 1 isoform 1
Cilostazol,CIDs00002754,cilostazol,369.46068,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,Phosphodiesterase 3A
AN-2728,CIDs44591583,AN-2728,251.0451,B1(C2=C(CO1)C=C(C=C2)OC3=CC=C(C=C3)C#N)O,B1(C2=C(CO1)C=C(C=C2)OC3=CC=C(C=C3)C#N)O,Phosphodiesterase 4
Roflumilast,CIDs00449193,roflumilast,403.207466,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,Phosphodiesterase 4
GSK-256066,CIDs09827968,GSK256066,518.58414,CC1=C2C(=CC(=C1)S(=O)(=O)C3=CC=CC(=C3)C(=O)N(C)C)C(=C(C=N2)C(=O)N)NC4=CC(=CC=C4)OC,CC1=CC(=CC2=C(C(=CN=C12)C(=O)N)NC3=CC(=CC=C3)OC)S(=O)(=O)C4=CC=CC(=C4)C(=O)N(C)C,Phosphodiesterase 4
Rolipram,CIDs00005092,rolipram,275.34284,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,Phosphodiesterase 4
MP-10,CIDs11581936,MP-10,392.4525,CN1C=C(C(=N1)C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C5=CC=NC=C5,CN1C=C(C(=N1)C2=CC=C(C=C2)OCC3=NC4=CC=CC=C4C=C3)C5=CC=NC=C5,Phosphodiesterase 10A
Dipyridamole,CIDs00003108,dipyridamole,504.6256,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,"Equilibrative nucleoside transporter 1, 3',5'-cyclic phosphodiesterase"
Tadalafil,CIDs00110635,tadalafil,389.40396,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,CN1CC(=O)N2C(C1=O)CC3=C(C2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36,Phosphodiesterase 5A
Ezutromid,CIDs25109292,SMTC1100,337.3923,CCS(=O)(=O)C1=CC2=C(C=C1)OC(=N2)C3=CC4=CC=CC=C4C=C3,CCS(=O)(=O)C1=CC2=C(C=C1)OC(=N2)C3=CC4=CC=CC=C4C=C3,Utrophin
Trichlormethiazide,CIDs00005560,trichlormethiazide,380.65582,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,Thiazide-sensitive sodium-chloride cotransporter
Rifampicin,CIDs135398735,,0,,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,Bacterial DNA-directed RNA polymerase
Rifapentine,CIDs135403821,,0,,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C6CCCC6)C,Bacterial DNA-directed RNA polymerase
Mavacamten,CIDs117761397,,0,,CC(C)N1C(=O)C=C(NC1=O)NC(C)C2=CC=CC=C2,Cardiac myosin
Caffeine,CIDs00002519,caffeine,194.1906,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,CN1C=NC2=C1C(=O)N(C(=O)N2C)C,Adenosine receptor
Lumacaftor,CIDs16678941,lumacaftor,452.406926,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,Cystic fibrosis transmembrane conductance regulator
PTC-124,CIDs11219835,ataluren,284.241963,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,80S Ribosome
Ethionamide,CIDs02761171,ethionamide,166.2434,CCC1=NC=CC(=C1)C(=S)N,CCC1=NC=CC(=C1)C(=S)N,Enoyl-[acyl-carrier-protein] reductase
Cefoperazone (sodium salt),CIDs23663974,,0,,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)[O-].[Na+],Bacterial penicillin-binding protein
Tolcapone,CIDs04659569,tolcapone,273.24084,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],Catechol O-methyltransferase
Proglumide,CIDs00004922,proglumide,334.41004,CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1,CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)C1=CC=CC=C1,Cholecystokinin receptor
MK-3207,CIDs25019940,MK-3207,557.590466,C1CCC2(C1)C(=O)N(C(CN2)C3=CC(=CC(=C3)F)F)CC(=O)NC4=CC5=C(CC6(C5)C7=C(NC6=O)N=CC=C7)C=C4,C1CCC2(C1)C(=O)N(C(CN2)C3=CC(=CC(=C3)F)F)CC(=O)NC4=CC5=C(CC6(C5)C7=C(NC6=O)N=CC=C7)C=C4,Calcitonin gene-related peptide type 1 receptor
Gabapentin,CIDs00003446,gabapentin,171.23678,C1CCC(CC1)(CC(=O)O)CN,C1CCC(CC1)(CC(=O)O)CN,Voltage-gated calcium channel
Cinacalcet hydrochloride,CIDs00156418,cinacalcet,393.87293,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl,Calcium sensing receptor
Rimonabant,CIDs00104850,,0,,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,Cannabinoid CB1 receptor
Otenabant,CIDs10052040,otenabant,510.4183,CCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N,CCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N,Cannabinoid CB1 receptor
842166X,CIDs10253143,GW 842166X,449.25439,C1COCCC1CNC(=O)C2=CN=C(N=C2C(F)(F)F)NC3=C(C=C(C=C3)Cl)Cl,C1COCCC1CNC(=O)C2=CN=C(N=C2C(F)(F)F)NC3=C(C=C(C=C3)Cl)Cl,Cannabinoid CB2 receptor
Cannabidiol,CIDs00644019,cannabidiol (CBD,314.4617,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,CCCCCC1=CC(=C(C(=C1)O)C2C=C(CCC2C(=C)C)C)O,Cannabinoid CB1 receptor
Doripenem,CIDs00073303,doripenem,420.50426,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,Bacterial penicillin-binding protein
Diclofenamide,CIDs00003038,dichlorphenamide,305.15884,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,"Carbonic anhydrase XII, Carbonic anhydrase II, Carbonic anhydrase I, Carbonic anhydrase IV"
Dorzolamide hydrochloride,CIDs06918132,,0,,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl,Carbonic anhydrase II
Sulfanilamide,CIDs00005333,sulfonamide,172.20492,C1=CC(=CC=C1N)S(=O)(=O)N,C1=CC(=CC=C1N)S(=O)(=O)N,Bacterial dihydropteroate synthase
Irosustat (STX-64),CIDs05287541,irosustat,309.3376,C1CCC2=C(CC1)C(=O)OC3=C2C=CC(=C3)OS(=O)(=O)N,C1CCC2=C(CC1)C(=O)OC3=C2C=CC(=C3)OS(=O)(=O)N,Steryl-sulfatase
Indapamide,CIDs00003702,indapamide,365.83454,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,Thiazide-sensitive sodium-chloride cotransporter
Metolazone,CIDs00004170,metolazone,365.83454,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl,Thiazide-sensitive sodium-chloride cotransporter
Omecamtiv mecarbil,CIDs11689883,omecamtiv mecarbil,401.434663,CC1=NC=C(C=C1)NC(=O)NC2=CC=CC(=C2F)CN3CCN(CC3)C(=O)OC,CC1=NC=C(C=C1)NC(=O)NC2=CC=CC(=C2F)CN3CCN(CC3)C(=O)OC,Cardiac myosin
Telotristat Etiprate (LX 1606 Hippurate),CIDs25253377,telotristat etiprate,754.15461,CCOC(=O)C(CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N.C1=CC=C(C=C1)C(=O)NCC(=O)O,CCOC(=O)C(CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N.C1=CC=C(C=C1)C(=O)NCC(=O)O,Tryptophan 5-hydroxylase
Aripiprazole,CIDs00060795,aripiprazole,448.38538,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,"Serotonin 1a (5-HT1a) receptor, Dopamine D2 receptor, Serotonin 2a (5-HT2a) receptor"
Brintellix,CIDs56843850,,0,,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br,"Serotonin 3a (5-HT3a) receptor, Serotonin 1a (5-HT1a) receptor, Serotonin transporter"
Cyclobenzaprine hydrochloride,CIDs00022576,,0,,CN(C)CCC=C1C2=CC=CC=C2C=CC3=CC=CC=C31.Cl,"Serotonin 2c (5-HT2c) receptor, Serotonin 2a (5-HT2a) receptor"
Mirtazapine,CIDs00004205,mirtazapine,265.35286,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,CN1CCN2C(C1)C3=CC=CC=C3CC4=C2N=CC=C4,"Adrenergic receptor alpha-2, Serotonin 2c (5-HT2c) receptor, Serotonin 2a (5-HT2a) receptor"
Agomelatine,CIDs00082148,agomelatine,243.30098,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,"Serotonin 2c (5-HT2c) receptor, Melatonin receptor"
Prucalopride,CIDs03052762,prucalopride,367.87034,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,Serotonin 4 (5-HT4) receptor
Tegaserod maleate,CIDs135413539,,0,,CCCCCN=C(N)NN=CC1=CNC2=C1C=C(C=C2)OC.C(=CC(=O)O)C(=O)O,Serotonin 4 (5-HT4) receptor
Balsalazide disodium,CIDs135413496,,0,,C1=CC(=CC=C1C(=O)NCCC(=O)[O-])N=NC2=CC(=C(C=C2)[O-])C(=O)O.[Na+].[Na+],"Cyclooxygenase, Peroxisome proliferator-activated receptor gamma, Arachidonate 5-lipoxygenase"
Sulfamethizole,CIDs00005328,sulfamethizole,270.3313,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,Bacterial dihydropteroate synthase
Clindamycin HCl,CIDs16051951,,0,,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl.Cl,Bacterial 70S ribosome
Prulifloxacin,CIDs00065947,prulifloxacin,461.463403,CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCN(CC4)CC5=C(OC(=O)O5)C,CC1N2C3=CC(=C(C=C3C(=O)C(=C2S1)C(=O)O)F)N4CCN(CC4)CC5=C(OC(=O)O5)C,"Bacterial DNA gyrase, Topoisomerase IV"
Pefloxacin,CIDs00051081,pefloxacin,333.357403,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O,"Bacterial DNA gyrase, Topoisomerase IV"
Clindamycin palmitate,CIDs16052038,clindamycin palmitate,699.85276,CCCCCCCCCCCCCCCC(=O)OC1C(C(C(OC1SC)C(C(C)Cl)NC(=O)C2CC(CN2C)CCC)O)O.Cl,CCCCCCCCCCCCCCCC(=O)OC1C(C(C(OC1SC)C(C(C)Cl)NC(=O)C2CC(CN2C)CCC)O)O.Cl,Bacterial 70S ribosome
Ofloxacin,CIDs00004583,ofloxacin,361.367503,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,CC1COC2=C3N1C=C(C(=O)C3=CC(=C2N4CCN(CC4)C)F)C(=O)O,Bacterial DNA gyrase
Primidone,CIDs00004909,primidone,218.25176,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,"GABA-A receptor; anion channel, Sodium channel alpha subunit"
Econazole nitrate,CIDs00068589,,0,,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],Cytochrome P450 51
Fluconazole,CIDs00003365,fluconazole,306.270786,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,Cytochrome P450 51
Tioconazole,CIDs00005482,tioconazole,387.71122,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl,Cytochrome P450 51
Butoconazole nitrate,CIDs00047471,butoconazole,474.78852,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl.[N+](=O)(O)[O-],C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl.[N+](=O)(O)[O-],Cytochrome P450 51
Natamycin,CIDs05284447,Cl-12625,665.72518,CC1CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC3C(O3)C=CC(=O)O1)O)O)O)C(=O)O)OC4C(C(C(C(O4)C)O)N)O,CC1CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC3C(O3)C=CC(=O)O1)O)O)O)C(=O)O)OC4C(C(C(C(O4)C)O)N)O,Ergosterol
Vidarabine,CIDs00021704,vidarabine,267.24132,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N,Human herpesvirus 1 DNA polymerase
Docosanol,CIDs00012620,docosanol,326.60004,CCCCCCCCCCCCCCCCCCCCCCO,CCCCCCCCCCCCCCCCCCCCCCO,Envelope glycoprotein
Idoxuridine,CIDs00005905,IUdR,354.09851,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,DNA
Arbidol,CIDs00131411,,0,,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3,Hemagglutinin
Artemether,CIDs00068911,artemether,298.37464,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC)C,CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC)C,Ferriprotoporphyrin IX
Lumefantrine,CIDs06437380,lumefantrine,528.94018,CCCCN(CCCC)CC(C1=C2C3=C(C=C(C=C3)Cl)C(=CC4=CC=C(C=C4)Cl)C2=CC(=C1)Cl)O,CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O,Ferriprotoporphyrin IX
Piperaquine,CIDs00122262,piperaquine,535.51058,C1CN(CCN1CCCN2CCN(CC2)C3=C4C=CC(=CC4=NC=C3)Cl)C5=C6C=CC(=CC6=NC=C5)Cl,C1CN(CCN1CCCN2CCN(CC2)C3=C4C=CC(=CC4=NC=C3)Cl)C5=C6C=CC(=CC6=NC=C5)Cl,Ferriprotoporphyrin IX
Praziquantel,CIDs00004891,praziquantel,312.40606,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,"Voltage-activated calcium channel beta 1 subunit, Voltage-activated calcium channel beta 2 subunit"
Fenbendazole,CIDs00003334,fenbendazole,299.34762,COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3,COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3,Tubulin beta chain
Oxfendazole,CIDs00040854,oxfendazole,315.34702,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,Tubulin
Nitazoxanide,CIDs00041684,nitazoxanide,307.28196,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],Pyruvate:ferredoxin oxidoreductase
Secnidazole,CIDs00071815,secnidazole,185.18054,CC1=NC=C(N1CC(C)O)[N+](=O)[O-],CC1=NC=C(N1CC(C)O)[N+](=O)[O-],DNA
Propylthiouracil,CIDs00657298,propylthiouracil (PTU,170.2321,CCCC1=CC(=O)NC(=S)N1,CCCC1=CC(=O)NC(=S)N1,"Thyroid peroxidase, Type I iodothyronine deiodinase (Type-I 5'-deiodinase) (DIOI) (Type 1 DI) (5DI)"
Famciclovir,CIDs00003324,famciclovir,321.33176,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,Human herpesvirus 1 DNA polymerase
Benserazide,CIDs00002327,benserazide,257.2432,C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O,C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O,DOPA decarboxylase
Methyldopa,CIDs00038853,,0,,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,Adrenergic receptor alpha-2
Amisulpride,CIDs00002159,amisulpride,369.47898,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,"Dopamine receptors; D2 & D3, Serotonin (5-HT) receptor"
Clozapine,CIDs135398737,,0,,CN1CCN(CC1)C2=NC3=C(C=CC(=C3)Cl)NC4=CC=CC=C42,"Dopamine D2 receptor, Serotonin 2a (5-HT2a) receptor"
Levodopa,CIDs00006047,levodopa,197.18794,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,C1=CC(=C(C=C1CC(C(=O)O)N)O)O,Dopamine D3 receptor
Amantadine hydrochloride,CIDs00064150,,0,,C1C2CC3CC1CC(C2)(C3)N.Cl,"Matrix protein 2, Glutamate [NMDA] receptor"
Domperidone,CIDs00003151,domperidone,425.91126,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,Dopamine D2 receptor
Bupropion hydrochloride,CIDs00062884,,0,,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl,"Norepinephrine transporter, Dopamine transporter"
Salbutamol sulfate,CIDs00002083,salbutamol,239.31074,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O,Beta-2 adrenergic receptor
Isoprenaline hydrochloride,CIDs00005807,,0,,CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl,Adrenergic receptor beta
Lubiprostone,CIDs00157920,lubiprostone,390.461886,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,Chloride channel protein 2
Rivaroxaban,CIDs09875401,rivaroxaban,435.88132,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,Coagulation factor X
Apixaban,CIDs10182969,apixaban,459.4971,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,Coagulation factor X
PCI-27483,CIDs135425273,,0,,C1=CC2=C(C=C1C(=N)N)NC(=N2)C3=CC(=CC(=C3O)C4=C(C=CC(=C4)S(=O)(=O)N)O)CC(=O)NC(CC(=O)O)C(=O)O,Coagulation factor VII
Balicatib,CIDs10201696,balicatib,411.54042,CCCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3(CCCCC3)C(=O)NCC#N,CCCN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3(CCCCC3)C(=O)NCC#N,Cathepsin K
ADL-5859,CIDs11417954,ADL-5859,392.49072,CCN(CC)C(=O)C1=CC=C(C=C1)C2=CC3(CCNCC3)OC4=C2C(=CC=C4)O,CCN(CC)C(=O)C1=CC=C(C=C1)C2=CC3(CCNCC3)OC4=CC=CC(=C42)O,Delta opioid receptor
Ambrisentan,CIDs06918493,ambrisentan,378.42108,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,"Endothelin receptor, ET-A/ET-B"
Sitaxentan,CIDs00216235,sitaxsentan,454.9045,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,CC1=CC2=C(C=C1CC(=O)C3=C(C=CS3)S(=O)(=O)NC4=C(C(=NO4)C)Cl)OCO2,"Endothelin receptor, ET-A/ET-B"
Macitentan,CIDs16004692,macitentan,588.2729,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,"Endothelin receptor, ET-A/ET-B"
GLPG-0974,CIDs57520598,SCHEMBL11298599,484.995,CC1(CCN1C(=O)C2=CSC3=CC=CC=C32)C(=O)N(CCCC(=O)O)CC4=CC(=CC=C4)Cl,CC1(CCN1C(=O)C2=CSC3=CC=CC=C32)C(=O)N(CCCC(=O)O)CC4=CC(=CC=C4)Cl,Free fatty acid receptor 2
Flumazenil,CIDs00003373,flumazenil,303.288363,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,GABA-A receptor; anion channel
Felbamate,CIDs00003331,felbamate,238.23986,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,Glutamate [NMDA] receptor
TD-139,CIDs73774610,TD139,648.635006,C1=CC(=CC(=C1)F)C2=CN(N=N2)C3C(C(OC(C3O)SC4C(C(C(C(O4)CO)O)N5C=C(N=N5)C6=CC(=CC=C6)F)O)CO)O,C1=CC(=CC(=C1)F)C2=CN(N=N2)C3C(C(OC(C3O)SC4C(C(C(C(O4)CO)O)N5C=C(N=N5)C6=CC(=CC=C6)F)O)CO)O,Galectin-3
Adomeglivant,CIDs91933867,,0,,CC1=CC(=CC(=C1C2=CC=C(C=C2)C(C)(C)C)C)OC(CCC(F)(F)F)C3=CC=C(C=C3)C(=O)NCCC(=O)O,Glucagon receptor
Lansoprazole,CIDs00003883,lansoprazole,369.36147,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,Potassium-transporting ATPase
Esomeprazole Sodium,CIDs00004594,omeprazole,345.41606,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,Potassium-transporting ATPase
Telaprevir (VX-950),CIDs03010818,telaprevir,679.84932,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,"Hepatitis C virus serine protease, NS3/NS4A"
Daclatasvir dihydrochloride,CIDs25154713,daclatasvir,811.79688,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC.Cl.Cl,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC.Cl.Cl,Nonstructural protein 5A
Danoprevir,CIDs11285588,X7550,731.831243,CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,CC(C)(C)OC(=O)NC1CCCCCC=CC2CC2(NC(=O)C3CC(CN3C1=O)OC(=O)N4CC5=C(C4)C(=CC=C5)F)C(=O)NS(=O)(=O)C6CC6,"Hepatitis C virus serine protease, NS3/NS4A"
Cyproheptadine hydrochloride,CIDs00013770,,0,,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1.Cl,Histamine H1 receptor
Diphenhydramine hydrochloride,CIDs00008980,,0,,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl,Histamine H1 receptor
Nelfinavir,CIDs00064142,nelfinavir,663.88806,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,Human immunodeficiency virus type 1 protease
Elvitegravir,CIDs05277135,elvitegravir,447.883823,CC(C)C(CO)N1C=C(C(=O)C2=CC(=C(C=C21)OC)CC3=C(C(=CC=C3)Cl)F)C(=O)O,CC(C)C(CO)N1C=C(C(=O)C2=C1C=C(C(=C2)CC3=C(C(=CC=C3)Cl)F)OC)C(=O)O,Human immunodeficiency virus type 1 integrase
Rilmenidine,CIDs00068712,rilmenidine,180.24684,C1CC1C(C2CC2)NC3=NCCO3,C1CC1C(C2CC2)NC3=NCCO3,Nischarin
Cyclosporine A,CIDs05284373,ciclosporin A,1202.61124,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Cyclophilin A
Repaglinide,CIDs00065981,repaglinide,452.58574,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,"Sulfonylurea receptor 1, Kir6.2"
Nateglinide,CIDs05311309,nateglinide,317.42258,CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,"Sulfonylurea receptor 1, Kir6.2"
TAK-875,CIDs24857286,fasiglifam,524.62518,CC1=CC(=CC(=C1C2=CC(=CC=C2)COC3=CC4=C(C=C3)C(CO4)CC(=O)O)C)OCCCS(=O)(=O)C,CC1=CC(=CC(=C1C2=CC=CC(=C2)COC3=CC4=C(C=C3)C(CO4)CC(=O)O)C)OCCCS(=O)(=O)C,Free fatty acid receptor 1
RUC-4,CIDs71668132,AGN-PC-0JILBQ,386.43152,C1CN(CCN1)C2=CC(=O)N3C(=N2)SC(=N3)C4=CC(=CN=C4)NC(=O)CN,C1CN(CCN1)C2=CC(=O)N3C(=N2)SC(=N3)C4=CC(=CN=C4)NC(=O)CN,Integrin alpha-IIb/beta-3
Cilengitide,CIDs00176873,cilengitide,588.6559,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,"Integrin alpha-V/beta-3, Integrin alpha-V/beta-5"
ATN-161,CIDs09960285,ATN-161,597.6445,CC(=O)N1CCCC1C(=O)NC(CC2=CN=CN2)C(=O)NC(CO)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)N,CC(=O)N1CCCC1C(=O)NC(CC2=CN=CN2)C(=O)NC(CO)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)N,"Integrin alpha-5/beta-1, Integrin alpha-V/beta-3"
PF-06650833,CIDs118414016,,0,,CCC1C(NC(=O)C1F)COC2=NC=CC3=CC(=C(C=C32)OC)C(=O)N,Interleukin-1 receptor-associated kinase 4
Minoxidil,CIDs00004201,minoxidil,209.2483,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,"Sulfonylurea receptor 2, Kir6.2"
Levosimendan,CIDs03033825,levosimendan,280.28468,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,"Troponin, cardiac muscle, Phosphodiesterase 3"
Glipizide,CIDs00003478,glipizide,445.53518,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,"Sulfonylurea receptor 1, Kir6.2"
Glimepiride,CIDs00003476,glimepiride,490.61556,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,"Sulfonylurea receptor 1, Kir6.2"
Gliclazide,CIDs00003475,gliclazide,323.41054,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,"Sulfonylurea receptor 1, Kir6.2"
Ibutilide fumarate,CIDs05281065,,0,,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.C(=CC(=O)O)C(=O)O,HERG
Dofetilide,CIDs00071329,dofetilide,441.56478,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,HERG
Retigabine,CIDs00121892,retigabine,303.331423,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,CCOC(=O)NC1=C(C=C(C=C1)NCC2=CC=C(C=C2)F)N,KCNQ (Kv7) potassium channel
Telithromycin,CIDs03002190,telithromycin,812.0037,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,CCC1C2(C(C(C(=O)C(CC(C(C(C(=O)C(C(=O)O1)C)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)N(C(=O)O2)CCCCN4C=C(N=C4)C5=CN=CC=C5)C,Bacterial 70S ribosome
Daptomycin,CIDs16134395,daptomycin,1620.67064,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,Cell membrane
Bumetanide,CIDs00002471,bumetanide,364.4161,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,Sodium-(potassium)-chloride cotransporter 2
Pregabalin,CIDs05486971,pregabalin,159.22608,CC(C)CC(CC(=O)O)CN,CC(C)CC(CC(=O)O)CN,Voltage-gated calcium channel
Diltiazem hydrochloride,CIDs00062920,,0,,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl,Voltage-gated L-type calcium channel
BMS-986020,CIDs49792850,SCHEMBL344742,482.52714,CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5(CC5)C(=O)O,CC1=NOC(=C1NC(=O)OC(C)C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5(CC5)C(=O)O,Lysophosphatidic acid receptor Edg-2
Amiselimod hydrochloride,CIDs67418070,,0,,CCCCCCCOC1=C(C=C(C=C1)CCC(CO)(CO)N)C(F)(F)F.Cl,Sphingosine 1-phosphate receptor
BAF-312,CIDs44599207,siponimod,516.59501,CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,Sphingosine 1-phosphate receptor Edg-1
Amphotericin B,CIDs05280965,amphotericin B,924.07902,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,Ergosterol
Selegiline hydrochloride,CIDs00026758,,0,,CC(CC1=CC=CC=C1)N(C)CC#C.Cl,Monoamine oxidase B
Rasagiline mesylate,CIDs03052775,rasagiline,267.34398,CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12,CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12,Monoamine oxidase B
Amlexanox,CIDs00002161,amlexanox,298.29336,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,CC(C)C1=CC2=C(C=C1)OC3=NC(=C(C=C3C2=O)C(=O)O)N,Phosphodiesterase 4
LY-2140023,CIDs25195354,pomaglumetad methionil,366.41052,CSCCC(C(=O)NC1(CS(=O)(=O)C2C1C2C(=O)O)C(=O)O)N,CSCCC(C(=O)NC1(CS(=O)(=O)C2C1C2C(=O)O)C(=O)O)N,"Metabotropic glutamate receptor 3, Metabotropic glutamate receptor 2"
Eplerenone,CIDs00443872,eplerenone,414.4914,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,CC12CCC(=O)C=C1CC(C3C24C(O4)CC5(C3CCC56CCC(=O)O6)C)C(=O)OC,Mineralocorticoid receptor
Racecadotril,CIDs00107751,racecadotril,385.47662,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2,Neprilysin
Oseltamivir phosphate,CIDs00078000,,0,,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC.OP(=O)(O)O,Neuraminidase
Cisatracurium besylate,CIDs00062886,cisatracurium,1243.47918,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],Muscle-type nicotinic acetylcholine receptor
Dopamine hydrochloride,CIDs00065340,,0,,C1=CC(=C(C=C1CCN)O)O.Cl,Beta-1 adrenergic receptor
AZD9668,CIDs46861623,,0,,CC1=C(C=C(C(=O)N1C2=CC=CC(=C2)C(F)(F)F)C(=O)NCC3=NC=C(C=C3)S(=O)(=O)C)C4=CC=NN4C,Leukocyte elastase
Fluphenazine hydrochloride,CIDs00067356,,0,,C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO.Cl.Cl,Dopamine D2 receptor
L-tetramisol,CIDs00027944,,0,,C1CSC2=NC(CN21)C3=CC=CC=C3.Cl,Nicotinic acetylcholine receptor alpha subunit
Memantine hydrochloride,CIDs00181458,,0,,CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl,Glutamate [NMDA] receptor
Lacosamide,CIDs00219078,lacosamide,250.29362,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,CC(=O)NC(COC)C(=O)NCC1=CC=CC=C1,Sodium channel alpha subunit
D-Cycloserine,CIDs00006234,cycloserine,102.09194,C1C(C(=O)NO1)N,C1C(C(=O)NO1)N,"D-alanylalanine synthetase, Alanine racemase"
ACAMPROSATE CALCIUM,CIDs00155434,,0,,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2],"Glutamate [NMDA] receptor, GABA-A receptor; anion channel"
Cebranopadol,CIDs11848225,cebranopadol,378.482383,CN(C)C1(CCC2(CC1)C3=C(CCO2)C4=C(N3)C=CC(=C4)F)C5=CC=CC=C5,CN(C)C1(CCC2(CC1)C3=C(CCO2)C4=C(N3)C=CC(=C4)F)C5=CC=CC=C5,"Nociceptin receptor, Opioid receptors; mu/kappa/delta"
Ketoprofen,CIDs00003825,ketoprofen,254.28056,CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,CC(C1=CC(=CC=C1)C(=O)C2=CC=CC=C2)C(=O)O,Cyclooxygenase
Flurbiprofen,CIDs00003394,flurbiprofen,244.260923,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,Cyclooxygenase
Lornoxicam,CIDs54690031,lornoxicam,371.8192,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,Cyclooxygenase
Reserpine,CIDs00005770,reserpine,608.6787,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,Synaptic vesicular amine transporter
Trioxsalen,CIDs00005585,antipsoriatic,228.24328,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C,CC1=CC(=O)OC2=C1C=C3C=C(OC3=C2C)C,DNA
Fomepizole,CIDs00003406,4-methylpyrazole,82.10384,CC1=CNN=C1,CC1=CNN=C1,Alcohol dehydrogenase class I
Disulfiram,CIDs00003117,disulfiram,296.5392,CCN(CC)C(=S)SSC(=S)N(CC)CC,CCN(CC)C(=S)SSC(=S)N(CC)CC,Aldehyde dehydrogenase
Tranexamic Acid,CIDs00005526,tranexamic acid,157.2102,C1CC(CCC1CN)C(=O)O,C1CC(CCC1CN)C(=O)O,Plasminogen
Aminocaproic acid,CIDs00000564,EACA,131.17292,C(CCC(=O)O)CCN,C(CCC(=O)O)CCN,"Tissue-type plasminogen activator, Plasminogen"
Propafenone hydrochloride,CIDs00036708,,0,,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O.Cl,"Beta-1 adrenergic receptor, Sodium channel alpha subunit, Beta-2 adrenergic receptor"
Pentamidine isethionate,CIDs00008813,diamidine,592.68274,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O,C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N.C(CS(=O)(=O)O)O.C(CS(=O)(=O)O)O,"DNA, Kinetoplast DNA"
Lomefloxacin hydrochloride,CIDs00068624,,0,,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O.Cl,Bacterial DNA gyrase
Efaproxiral,CIDs00122335,efaproxiral,341.40092,CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)O)C,CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)O)C,Hemoglobin HbA
Aliskiren hemifumarate,CIDs06918427,,0,,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.C(=CC(=O)O)C(=O)O,Renin
Lamivudine,CIDs00060825,lamivudine,229.25624,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,"DNA, DNA polymerase/reverse transcriptase, Human immunodeficiency virus type 1 reverse transcriptase"
Lurbinectedin,CIDs57327016,lurbinectedin,784.87386,CC1=C(C(=C2C3C4C5C6=C(C(N4C(C(N3C)CC2=C1)O)COC(=O)C7(CS5)C8=C(CCN7)C9=C(N8)C=CC(=C9)OC)C1=C(C(=C6OC(=O)C)C)OCO1)O)OC,CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=C(CCN8)C2=C(N9)C=CC(=C2)OC)OCO7)C)OC(=O)C)C(=C1OC)O,DNA
Favipiravir,CIDs00492405,favipiravir,157.102563,C1=C(N=C(C(=O)N1)C(=O)N)F,C1=C(N=C(C(=O)N1)C(=O)N)F,RNA-directed RNA polymerase
Sofosbuvir,CIDs45375808,sofosbuvir,529.452525,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,Hepatitis C virus NS5B RNA-dependent RNA polymerase
Nesbuvir,CIDs11561383,nesbuvir,446.491823,CNC(=O)C1=C(OC2=CC(=C(C=C21)C3CC3)N(CCO)S(=O)(=O)C)C4=CC=C(C=C4)F,CNC(=O)C1=C(OC2=CC(=C(C=C21)C3CC3)N(CCO)S(=O)(=O)C)C4=CC=C(C=C4)F,Hepatitis C virus NS5B RNA-dependent RNA polymerase
Clomipramine hydrochloride,CIDs00068539,,0,,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl.Cl,Serotonin transporter
Lamotrigine,CIDs00003878,lamotrigine,256.09138,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,Sodium channel alpha subunit
Flecainide acetate,CIDs00041022,,0,,CC(=O)O.C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,Sodium channel protein type V alpha subunit
Dabigatran,CIDs00216210,dabigatran,471.5111,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,CN1C2=C(C=C(C=C2)C(=O)N(CCC(=O)O)C3=CC=CC=N3)N=C1CNC4=CC=C(C=C4)C(=N)N,Thrombin
E5555,CIDs10459564,atopaxar,527.627523,CCOC1=C(C(=C2C(=C1)CN(C2=N)CC(=O)C3=CC(=C(C(=C3)N4CCOCC4)OC)C(C)(C)C)F)OCC,CCOC1=C(C(=C2C(=C1)CN(C2=N)CC(=O)C3=CC(=C(C(=C3)N4CCOCC4)OC)C(C)(C)C)F)OCC,Proteinase-activated receptor 1
Eltrombopag olamine,CIDs135449331,,0,,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N,Thrombopoietin receptor
Taltirelin,CIDs00114750,taltirelin,405.40842,CN1C(=O)CC(NC1=O)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)N,CN1C(=O)CC(NC1=O)C(=O)NC(CC2=CN=CN2)C(=O)N3CCCC3C(=O)N,Thyrotropin-releasing hormone receptor
Monobenzone,CIDs00007638,monobenzone,200.23318,C1=CC=C(C=C1)COC2=CC=C(C=C2)O,C1=CC=C(C=C1)COC2=CC=C(C=C2)O,Tyrosinase
Ibandronate sodium hydrate,CIDs23663991,,0,,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+],Farnesyl diphosphate synthase
Conivaptan hydrochloride,CIDs00216322,,0,,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6.Cl,"Vasopressin V1a receptor, Vasopressin V2 receptor"
Tolvaptan,CIDs00216237,tolvaptan,448.9413,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,Vasopressin V2 receptor
Ethosuximide,CIDs00003291,ethosuximide,141.16774,CCC1(CC(=O)NC1=O)C,CCC1(CC(=O)NC1=O)C,Voltage-gated T-type calcium channel
Marizomib / Salinosporamide A,CIDs11347535,salinosporamide A,313.7766,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,CC12C(C(=O)NC1(C(=O)O2)C(C3CCCC=C3)O)CCCl,20S proteasome
Chloro-IB-MECA,CIDs03035850,Cl-IB-MECA,544.73079,CNC(=O)C1C(C(C(O1)N2C=NC3=C2N=C(N=C3NCC4=CC(=CC=C4)I)Cl)O)O,CNC(=O)C1C(C(C(O1)N2C=NC3=C(N=C(N=C32)Cl)NCC4=CC(=CC=C4)I)O)O,Adenosine A3 receptor
Prochlorperazine dimaleate,CIDs00004917,prochlorperazine,373.94266,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,Dopamine D2 receptor
9-cis-Retinoic acid,CIDs00449171,alitretinoin,300.43512,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,Retinoid receptor
Amodiaquin dihydrochloride dihydrate,CIDs00064646,,0,,CCN(CC)CC1=C(C=CC(=C1)NC2=C3C=CC(=CC3=NC=C2)Cl)O.O.O.Cl.Cl,Ferriprotoporphyrin IX
ARRY-520,CIDs44224257,ARRY-520,420.476086,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,CN(C(=O)N1C(SC(=N1)C2=C(C=CC(=C2)F)F)(CCCN)C3=CC=CC=C3)OC,Kinesin-like protein 1
XL-647,CIDs10458325,EXEL-7647,491.385303,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,CN1CC2CC(CC2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC,"Receptor protein-tyrosine kinase erbB-2, Epidermal growth factor receptor erbB1, Ephrin type-B receptor 4"
Loratadine,CIDs00003957,loratadine,382.88322,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,Histamine H1 receptor
Clemastine fumarate,CIDs05281069,,0,,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C.C(=CC(=O)O)C(=O)O,Histamine H1 receptor
Mizolastine,CIDs00065906,mizolastine,432.493303,CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5,CN(C1CCN(CC1)C2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)F)C5=NC=CC(=O)N5,Histamine H1 receptor
Azelastine hydrochloride,CIDs00054360,,0,,CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl,Histamine H1 receptor
Lafutidine,CIDs05282136,lafutidine,431.54836,C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3,C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3,Histamine H2 receptor
Famotidine,CIDs05702160,famotidine,337.4454,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,Histamine H2 receptor
Testosterone,CIDs00006013,testosterone,288.42442,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,CC12CCC3C(C1CCC2O)CCC4=CC(=O)CCC34C,Androgen Receptor
Testosterone propionate,CIDs00005995,testosterone propionate,344.48768,CCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,CCC(=O)OC1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,Androgen Receptor
Eprosartan mesylate,CIDs05282474,,0,,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O.CS(=O)(=O)O,Type-1 angiotensin II receptor
Esomeprazole magnesium,CIDs00130564,,0,,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2],Potassium-transporting ATPase
RABEPRAZOLE SODIUM,CIDs14720269,,0,,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCCCOC.[Na+],Potassium-transporting ATPase
Oxcarbazepine,CIDs00034312,oxcarbazepine,252.26798,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,Sodium channel alpha subunit
Safinamide mesilate,CIDs03038502,,0,,CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O,Monoamine oxidase B
Isradipine,CIDs00003784,isradipine,371.38714,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,Voltage-gated L-type calcium channel
Sumatriptan succinate,CIDs00059772,,0,,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O,"Serotonin 1d (5-HT1d) receptor, Serotonin 1b (5-HT1b) receptor"
Naratriptan hydrochloride,CIDs00060875,,0,,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C.Cl,"Serotonin 1d (5-HT1d) receptor, Serotonin 1b (5-HT1b) receptor"
Rizatriptan benzoate,CIDs00077997,rizatriptan benzoate,391.4662,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O,"Serotonin 1d (5-HT1d) receptor, Serotonin 1b (5-HT1b) receptor"
Zolmitriptan,CIDs00060857,zolmitriptan,287.35684,CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,"Serotonin 1d (5-HT1d) receptor, Serotonin 1b (5-HT1b) receptor"
Citalopram hydrobromide,CIDs00077995,,0,,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.Br,Serotonin transporter
Venlafaxine hydrochloride,CIDs00062923,,0,,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O.Cl,"Serotonin transporter, Norepinephrine transporter"
Ondansetron,CIDs00004595,ondansetron,293.36296,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C,Serotonin 3a (5-HT3a) receptor
Tropisetron,CIDs00656665,,0,,CN1C2CCC1CC(C2)OC(=O)C3=CNC4=CC=CC=C43,Serotonin 3 (5-HT3) receptor
Amoxapine,CIDs00002170,amoxapine,313.78144,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,"Serotonin transporter, Dopamine receptor, Norepinephrine transporter"
Nepafenac,CIDs00151075,nepafenac,254.28386,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)N)N,C1=CC=C(C=C1)C(=O)C2=CC=CC(=C2N)CC(=O)N,Cyclooxygenase
Etodolac,CIDs00003308,etodolac,287.35354,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O,Cyclooxygenase-2
Acemetacin,CIDs00001981,acemetacin,415.82372,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,Cyclooxygenase
Zalcitabine,CIDs00024066,zalcitabine,211.21782,C1CC(OC1CO)N2C=CC(=NC2=O)N,C1CC(OC1CO)N2C=CC(=NC2=O)N,Human immunodeficiency virus type 1 reverse transcriptase
Stavudine,CIDs00018283,stavudine,224.21328,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,Human immunodeficiency virus type 1 reverse transcriptase
Emtricitabine,CIDs00060877,emtricitabine,247.246703,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,Human immunodeficiency virus type 1 reverse transcriptase
Clevudine,CIDs00073115,clevudine,260.219023,CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F,CC1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)F,Protein P
"2',3'-Dideoxyinosine",CIDs135398739,,0,,C1CC(OC1CO)N2C=NC3=C2N=CNC3=O,Human immunodeficiency virus type 1 reverse transcriptase
Nevirapine,CIDs00004463,nevirapine,266.29786,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,Human immunodeficiency virus type 1 reverse transcriptase
Zidovudine,CIDs00035370,zidovudine,267.24132,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],Human immunodeficiency virus type 1 reverse transcriptase
Pimecrolimus,CIDs06509979,pimecrolimus,810.45312,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)Cl)C)O)C)OC)OC)C)C,FK506-binding protein 1A
Clarithromycin,CIDs00084029,clarithromycin,747.95336,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,Bacterial 70S ribosome
Streptomycin sulfate,CIDs00019648,streptomycin,1457.38356,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,Bacterial 70S ribosome
Meropenem,CIDs00441130,,0,,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,Bacterial penicillin-binding protein
Tebipenem pivoxil,CIDs09892071,TBPM-PI,497.62804,CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)C(C)O,CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)C(C)O,Bacterial penicillin-binding protein
Chloramphenicol palmitate,CIDs00443382,chloramphenicol palmitate,561.53818,CCCCCCCCCCCCCCCC(=O)OCC(C(C1=CC=C(C=C1)[N+](=O)[O-])O)NC(=O)C(Cl)Cl,CCCCCCCCCCCCCCCC(=O)OCC(C(C1=CC=C(C=C1)[N+](=O)[O-])O)NC(=O)C(Cl)Cl,Bacterial 70S ribosome
Sulfapyridine,CIDs00005336,sulfapyridine,249.28894,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Bacterial dihydropteroate synthase
Sulfameter,CIDs00005326,Supramid,280.30298,COC1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,COC1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,Bacterial dihydropteroate synthase
Sulfaphenazole,CIDs00005335,sulfaphenazole,314.36226,C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N,C1=CC=C(C=C1)N2C(=CC=N2)NS(=O)(=O)C3=CC=C(C=C3)N,Bacterial dihydropteroate synthase
Sulfafurazole,CIDs00005344,sulfisoxazole,267.30422,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,Bacterial dihydropteroate synthase
Sulfamethoxazole,CIDs00005329,sulfamethoxazole,253.27764,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,Bacterial dihydropteroate synthase
Sulphadimethoxine,CIDs00005323,sulfadimethoxine,310.32896,COC1=NC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)OC,COC1=NC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)OC,Bacterial dihydropteroate synthase
Nitrofurazone,CIDs05447130,nitrofurazone,198.13624,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,DNA
Chloramphenicol,CIDs00005959,chloramphenicol,323.12938,C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],Bacterial 70S ribosome
Silver sulfadiazine,CIDs00441244,,0,,C1=CN=C(N=C1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Ag+],Bacterial dihydropteroate synthase
Metronidazole,CIDs00004173,metronidazole,171.15396,CC1=NC=C(N1CCO)[N+](=O)[O-],CC1=NC=C(N1CCO)[N+](=O)[O-],DNA
Aztreonam,CIDs05742832,aztreonam,435.43278,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,Bacterial penicillin-binding protein
Enoxacin,CIDs00003229,enoxacin,320.318883,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,"Topoisomerase IV, DNA gyrase"
Nalidixic acid,CIDs00004421,nalidixic acid,232.23528,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,Bacterial DNA gyrase
Cephradine,CIDs00038103,cephradine,349.40476,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CCC=CC3)N)SC1)C(=O)O,Bacterial penicillin-binding protein
Cefdinir,CIDs06915944,cefdinir,395.41352,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,Bacterial penicillin-binding protein
Cefoperazone sodium,CIDs23663974,,0,,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)[O-].[Na+],Bacterial penicillin-binding protein
Cefditoren pivoxil,CIDs06437877,cefditoren pivoxil,620.72082,CC1=C(SC=N1)C=CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C,CC1=C(SC=N1)C=CC2=C(N3C(C(C3=O)NC(=O)C(=NOC)C4=CSC(=N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C,Bacterial penicillin-binding protein
Cefprozil monohydrate,CIDs06436628,,0,,CC=CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)SC1)C(=O)O.O,Bacterial penicillin-binding protein
Indiplon,CIDs06450813,indiplon,376.43164,CC(=O)N(C)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C(=O)C4=CC=CS4,CC(=O)N(C)C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C(=O)C4=CC=CS4,GABA receptor alpha-1 subunit
Eszopiclone,CIDs00969472,eszopiclone,388.80828,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,CN1CCN(CC1)C(=O)OC2C3=NC=CN=C3C(=O)N2C4=NC=C(C=C4)Cl,GABA-A receptor; anion channel
Arbutin,CIDs00440936,arbutin,272.25124,C1=CC(=CC=C1O)OC2C(C(C(C(O2)CO)O)O)O,C1=CC(=CC=C1O)OC2C(C(C(C(O2)CO)O)O)O,Tyrosinase
Indinavir sulfate,CIDs05462355,,0,,CC(C)(C)NC(=O)C1CN(CCN1CC(CC(CC2=CC=CC=C2)C(=O)NC3C(CC4=CC=CC=C34)O)O)CC5=CN=CC=C5.OS(=O)(=O)O,Human immunodeficiency virus type 1 protease
Ritonavir,CIDs00392622,ritonavir,720.94422,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,"Cytochrome P450 3A, Human immunodeficiency virus type 1 protease"
Lopinavir,CIDs00092727,lopinavir,628.80082,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,Human immunodeficiency virus type 1 protease
Atazanavir sulfate,CIDs00158550,,0,,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O,Human immunodeficiency virus type 1 protease
Darunavir,CIDs00213039,darunavir,547.66358,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2COC3C2CCO3)O)S(=O)(=O)C4=CC=C(C=C4)N,Human immunodeficiency virus type 1 protease
Amprenavir,CIDs00065016,amprenavir,505.6269,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,Human immunodeficiency virus type 1 protease
Viracept,CIDs00064142,nelfinavir,663.88806,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,Human immunodeficiency virus type 1 protease
BMS-707035,CIDs54682040,HIV integrase inhibitor,410.419963,CN1C(=O)C(=C(N=C1N2CCCCS2(=O)=O)C(=O)NCC3=CC=C(C=C3)F)O,CN1C(=O)C(=C(N=C1N2CCCCS2(=O)=O)C(=O)NCC3=CC=C(C=C3)F)O,Integrase
Terbinafine hydrochloride,CIDs05282481,,0,,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21.Cl,Squalene monooxygenase
Liranaftate,CIDs00003936,liranaftate,328.4286,CN(C1=NC(=CC=C1)OC)C(=S)OC2=CC3=C(CCCC3)C=C2,CN(C1=NC(=CC=C1)OC)C(=S)OC2=CC3=C(CCCC3)C=C2,Squalene monooxygenase
Furosemide,CIDs00003440,furosemide,330.74414,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,Sodium-(potassium)-chloride cotransporter 2
Torasemide,CIDs00041781,torasemide,348.42,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,Sodium-(potassium)-chloride cotransporter 2
Betaxolol hydrochloride,CIDs00107952,,0,,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,Beta-1 adrenergic receptor
Carvedilol,CIDs00002585,carvedilol,406.47424,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,"Adrenergic receptor alpha-1, Adrenergic receptor beta"
Doxazosin mesylate,CIDs00062978,,0,,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O,Adrenergic receptor alpha-1
Alfuzosin hydrochloride,CIDs00071764,,0,,CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl,Adrenergic receptor alpha-1
Tamsulosin hydrochloride,CIDs05362376,,0,,CCOC1=CC=CC=C1OCCNC(C)CC2=CC(=C(C=C2)OC)S(=O)(=O)N.Cl,Adrenergic receptor alpha-1
Silodosin,CIDs05312125,silodosin,495.53449,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,Alpha-1a adrenergic receptor
Trazodone hydrochloride,CIDs00062935,,0,,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl.Cl,"Serotonin transporter, Serotonin 2a (5-HT2a) receptor, Serotonin 2c (5-HT2c) receptor"
Clonidine,CIDs00002803,clonidine,230.09386,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl,Adrenergic receptor alpha-2
17-Methyltestosterone,CIDs00006010,17alpha-methyltestosterone,302.451,CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C,CC12CCC(=O)C=C1CCC3C2CCC4(C3CCC4(C)O)C,Androgen Receptor
Trospium chloride,CIDs05284631,trospium,427.9636,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],"Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M2"
Oxybutynin chloride,CIDs00091505,,0,,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl,"Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M2"
Orphenadrine hydrochloride,CIDs00009568,,0,,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.Cl,"Norepinephrine transporter, Sodium channel alpha subunit, Glutamate [NMDA] receptor, Histamine H1 receptor"
Fesoterodine fumarate,CIDs09849808,,0,,CC(C)C(=O)OC1=C(C=C(C=C1)CO)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(=CC(=O)O)C(=O)O,"Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M2"
AP-761,CIDs45270144,Actimis,501.50085,CN(C)C1=C(C(=NC(=N1)CC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(F)(F)F)N(C)C)CC(=O)O,CN(C)C1=C(C(=NC(=N1)CC2=CC=C(C=C2)NC(=O)C3=CC=C(C=C3)C(F)(F)F)N(C)C)CC(=O)O,G protein-coupled receptor 44
Travoprost,CIDs05282226,travoprost,500.54771,CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O,CC(C)OC(=O)CCCC=CCC1C(CC(C1C=CC(COC2=CC=CC(=C2)C(F)(F)F)O)O)O,Prostanoid FP receptor
Methocarbamol,CIDs00004107,methocarbamol,241.2405,COC1=CC=CC=C1OCC(COC(=O)N)O,COC1=CC=CC=C1OCC(COC(=O)N)O,Carbonic anhydrase I
Ziprasidone hydrochloride,CIDs00060853,ziprasidone,467.41186,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.O.Cl,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.O.Cl,"Dopamine D2 receptor, Serotonin 2a (5-HT2a) receptor, Serotonin 2c (5-HT2c) receptor"
Telotristat etiprate,CIDs25253377,telotristat etiprate,754.15461,CCOC(=O)C(CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N.C1=CC=C(C=C1)C(=O)NCC(=O)O,CCOC(=O)C(CC1=CC=C(C=C1)C2=CC(=NC(=N2)N)OC(C3=C(C=C(C=C3)Cl)N4C=CC(=N4)C)C(F)(F)F)N.C1=CC=C(C=C1)C(=O)NCC(=O)O,Tryptophan 5-hydroxylase
Iloperidone,CIDs00071360,iloperidone,426.480583,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,"Dopamine D2 receptor, Serotonin 2a (5-HT2a) receptor"
Risperidone???,CIDs00005073,risperidone,410.484483,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,"Dopamine D2 receptor, Serotonin 2a (5-HT2a) receptor, Serotonin 2c (5-HT2c) receptor"
Haloperidol,CIDs00003559,haloperidol,375.864223,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,"Serotonin 2a (5-HT2a) receptor, D2-like dopamine receptor"
Levosulpiride,CIDs00688272,levosulpiride,341.42582,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,"Dopamine D2 receptor, Serotonin 4 (5-HT4) receptor"
Olanzapine,CIDs135398745,,0,,CC1=CC2=C(S1)NC3=CC=CC=C3N=C2N4CCN(CC4)C,"D2-like dopamine receptor, Serotonin 2a (5-HT2a) receptor, Serotonin 2c (5-HT2c) receptor"
Duloxetine hydrochloride,CIDs00060834,duloxetine,333.8755,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl,"Serotonin transporter, Norepinephrine transporter"
Galantamine hydrobromide,CIDs00121587,,0,,CN1CCC23C=CC(CC2OC4=C(C=CC(=C34)C1)OC)O.Br,Acetylcholinesterase
Zanamivir,CIDs00060855,zanamivir,332.3098,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,Neuraminidase
AVN-944,CIDs09918559,AVN944,477.51238,CCC(CC#N)OC(=O)NC(C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC,CCC(CC#N)OC(=O)NC(C)C1=CC(=CC=C1)NC(=O)NC2=CC(=C(C=C2)C3=CN=CO3)OC,Inosine-5'-monophosphate dehydrogenase (IMPDH)
Danusertib (PHA-739358),CIDs11442891,danusertib,474.5548,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC,CN1CCN(CC1)C2=CC=C(C=C2)C(=O)NC3=NNC4=C3CN(C4)C(=O)C(C5=CC=CC=C5)OC,Serine/threonine-protein kinase Aurora
Fluspirilene,CIDs00003396,fluspirilene,475.572746,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,C1CN(CCC12C(=O)NCN2C3=CC=CC=C3)CCCC(C4=CC=C(C=C4)F)C5=CC=C(C=C5)F,Dopamine D2 receptor
Zonisamide,CIDs00005734,zonisamide,212.22572,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,Sodium channel alpha subunit
Azelnidipine,CIDs00065948,azelnidipine,582.64626,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,Voltage-gated L-type calcium channel
Lacidipine,CIDs05311217,lacidipine,455.54332,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,Voltage-gated L-type calcium channel
Alfacalcidol,CIDs05282181,alfacalcidol,400.63706,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,Vitamin D receptor
Topiramate,CIDs05284627,topiramate,339.36204,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,"Carbonic anhydrase IV, Glutamate receptor ionotropic kainate, GABA-A receptor; anion channel, Carbonic anhydrase II, Glutamate receptor ionotropic AMPA, Sodium channel alpha subunit"
Halofantrine hydrochloride,CIDs00037392,halofantrine,536.88465,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O.Cl,CCCCN(CCCC)CCC(C1=C2C=CC(=CC2=C3C=C(C=C(C3=C1)Cl)Cl)C(F)(F)F)O.Cl,Ferriprotoporphyrin IX
NITD609,CIDs44469321,NITD609,390.238363,CC1CC2=C(C3(N1)C4=C(C=CC(=C4)Cl)NC3=O)NC5=CC(=C(C=C25)F)Cl,CC1CC2=C(C3(N1)C4=C(C=CC(=C4)Cl)NC3=O)NC5=CC(=C(C=C25)F)Cl,P-type ATPase
Fosmidomycin,CIDs00000572,fosmidomycin,183.099662,C(CN(C=O)O)CP(=O)(O)O,C(CN(C=O)O)CP(=O)(O)O,"1-deoxy-D-xylulose 5-phosphate reductoisomerase, apicoplastic"
Miconazole,CIDs00004189,miconazole,416.12856,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,Cytochrome P450 51
Etonogestrel,CIDs06917715,etonogestrel,324.45652,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,CCC12CC(=C)C3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,Progesterone receptor
TRIMETHOPRIM,CIDs00005578,trimethoprim,290.31772,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,Bacterial dihydrofolate reductase
Tavaborole / AN2690,CIDs11499245,tavaborole,151.930743,B1(C2=C(CO1)C=C(C=C2)F)O,B1(C2=C(CO1)C=C(C=C2)F)O,Leucine-tRNA ligase
RIFAMPIN,CIDs135398735,,0,,CC1C=CC=C(C(=O)NC2=C(C(=C3C(=C2O)C(=C(C4=C3C(=O)C(O4)(OC=CC(C(C(C(C(C(C1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)C=NN5CCN(CC5)C)C,Bacterial DNA-directed RNA polymerase
TRICLOSAN,CIDs00005564,triclosan,289.54178,C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl,C1=CC(=C(C=C1Cl)O)OC2=C(C=C(C=C2)Cl)Cl,Bacterial enoyl-[acyl-carrier-protein] reductase
Mibefradil dihydrochloride,CIDs00060662,mibefradil,568.550603,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F.Cl.Cl,CC(C)C1C2=C(CCC1(CCN(C)CCCC3=NC4=CC=CC=C4N3)OC(=O)COC)C=C(C=C2)F.Cl.Cl,Voltage-gated T-type calcium channel
Hexylcaine hydrochloride,CIDs00102426,,0,,CC(CNC1CCCCC1)OC(=O)C2=CC=CC=C2.Cl,Sodium channel alpha subunit
Methdilazine hydrochloride,CIDs00014676,methdilazine,332.89074,CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42.Cl,CN1CCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42.Cl,Histamine H1 receptor
DESIPRAMINE HYDROCHLORIDE,CIDs00065327,,0,,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C31.Cl,Norepinephrine transporter
Tocainide hydrochloride,CIDs00108173,,0,,CC1=C(C(=CC=C1)C)NC(=O)C(C)N.Cl,Sodium channel alpha subunit
Dydrogesterone,CIDs00009051,dydrogesterone,312.44582,CC(=O)C1CCC2C1(CCC3C2C=CC4=CC(=O)CCC34C)C,CC(=O)C1CCC2C1(CCC3C2C=CC4=CC(=O)CCC34C)C,Progesterone receptor
Buprenorphine hydrochloride,CIDs09848989,U- 952,504.10108,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl,CC(C)(C)C(C)(C1CC23CCC1(C4C25CCN(C3CC6=C5C(=C(C=C6)O)O4)CC7CC7)OC)O.Cl,"Mu opioid receptor, Kappa opioid receptor"
Naltrexone,CIDs05360515,naltrexone,341.40092,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,C1CC1CN2CCC34C5C(=O)CCC3(C2CC6=C4C(=C(C=C6)O)O5)O,Opioid receptors; mu/kappa/delta
Saquinavir mesylate,CIDs00060934,saquinavir,766.94646,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O,Human immunodeficiency virus type 1 protease
cyclosporin A,CIDs05284373,ciclosporin A,1202.61124,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,Cyclophilin A
Mitomycine,CIDs00005746,mitomycin C,334.32722,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,DNA
ibrutinib,CIDs24821094,ibrutinib,440.49706,C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N,C=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N,Tyrosine-protein kinase BTK
Thioguanine,CIDs02723601,6-thioguanine,167.1917,C1=NC2=C(N1)C(=S)N=C(N2)N,C1=NC2=C(N1)C(=S)N=C(N2)N,"Inosine-5'-monophosphate dehydrogenase (IMPDH), DNA"
Uracil mustard,CIDs00006194,uracil mustard,252.09784,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,C1=C(C(=O)NC(=O)N1)N(CCCl)CCCl,DNA
Dexrazoxane,CIDs00071384,dexrazoxane,268.26914,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,"DNA topoisomerase II, Iron"
Sunitinib (free base),CIDs05329102,sunitinib,398.473783,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,"Stem cell growth factor receptor, Vascular endothelial growth factor receptor 2, Platelet-derived growth factor receptor beta, Platelet-derived growth factor receptor alpha, Vascular endothelial growth factor receptor 1, Tyrosine-protein kinase receptor RET, Tyrosine-protein kinase receptor FLT3, Vascular endothelial growth factor receptor 3, Macrophage colony stimulating factor receptor"
Vorinostat,CIDs00005311,vorinostat,264.3202,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Histone deacetylase 6, Histone deacetylase 3, Histone deacetylase 1, Histone deacetylase 2"
Azacitidine,CIDs00009444,5-azacytidine,244.20468,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,"RNA, DNA (cytosine-5)-methyltransferase 3A, DNA (cytosine-5)-methyltransferase 1, DNA"
Gemcitabine hydrochloride,CIDs00060749,gemcitabine,299.659086,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F.Cl,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F.Cl,"Ribonucleoside-diphosphate reductase RR1, DNA polymerase (alpha/delta/epsilon)"
Imatinib mesylate,CIDs00123596,,0,,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,"Stem cell growth factor receptor, Bcr/Abl fusion protein, Tyrosine-protein kinase ABL, Platelet-derived growth factor receptor beta"
Tamoxifen citrate,CIDs02733525,tamoxifen,563.63808,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,Estrogen receptor alpha
Sorafenib tosylate,CIDs00406563,,0,,CC1=CC=C(C=C1)S(=O)(=O)O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,"Serine/threonine-protein kinase B-raf, Stem cell growth factor receptor, Platelet-derived growth factor receptor beta, Serine/threonine-protein kinase RAF, Vascular endothelial growth factor receptor, Tyrosine-protein kinase receptor RET, Tyrosine-protein kinase receptor FLT3"
bendamustine hydrochloride,CIDs00077082,,0,,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl,DNA
Aminolevulinic acid hydrochloride,CIDs00123608,,0,,C(CC(=O)O)C(=O)CN.Cl,DNA
Pipobroman,CIDs00004842,pipobroman,356.05424,C1CN(CCN1C(=O)CCBr)C(=O)CCBr,C1CN(CCN1C(=O)CCBr)C(=O)CCBr,DNA
Mitomycin,CIDs00005746,mitomycin C,334.32722,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,CC1=C(C(=O)C2=C(C1=O)N3CC4C(C3(C2COC(=O)N)OC)N4)N,DNA
Ifosfamide,CIDs00003690,ifosfamide,261.085962,C1CN(P(=O)(OC1)NCCCl)CCCl,C1CN(P(=O)(OC1)NCCCl)CCCl,DNA
Dactinomycin,CIDs00457193,Lyovac Cosmegen,1255.41704,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,CC1C(C(=O)NC(C(=O)N2CCCC2C(=O)N(CC(=O)N(C(C(=O)O1)C(C)C)C)C)C(C)C)NC(=O)C3=C4C(=C(C=C3)C)OC5=C(C(=O)C(=C(C5=N4)C(=O)NC6C(OC(=O)C(N(C(=O)CN(C(=O)C7CCCN7C(=O)C(NC6=O)C(C)C)C)C)C(C)C)C)N)C,DNA
Mechlorethamine hydrochloride,CIDs00005935,,0,,CN(CCCl)CCCl.Cl,DNA
PF562271,CIDs11713159,PF-562271,507.48881,CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C,CN(C1=C(C=CC=N1)CNC2=NC(=NC=C2C(F)(F)F)NC3=CC4=C(C=C3)NC(=O)C4)S(=O)(=O)C,Focal adhesion kinase 1
I-BET,CIDs46943432,I-BET762,423.89538,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,CCNC(=O)CC1C2=NN=C(N2C3=C(C=C(C=C3)OC)C(=N1)C4=CC=C(C=C4)Cl)C,Bromodomain and extra-terminal motif (BET)
ABT-888,CIDs11960529,veliparib,244.29234,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,"PARP 1, 2 and 3"
PD325901,CIDs09826528,PD 0325901,482.19304,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOCC(CO)O,"Dual specificity mitogen-activated protein kinase kinase 2, Dual specificity mitogen-activated protein kinase kinase 1"
AZD1775,CIDs24856436,MK-1775,500.59538,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,CC(C)(C1=NC(=CC=C1)N2C3=NC(=NC=C3C(=O)N2CC=C)NC4=CC=C(C=C4)N5CCN(CC5)C)O,Serine/threonine-protein kinase WEE1
MK-4827,CIDs24958200,niraparib,320.3883,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,"Poly [ADP-ribose] polymerase-1, Poly [ADP-ribose] polymerase 2"
MK-8669,CIDs11520894,ridaforolimus,990.206122,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OP(=O)(C)C)C)C)O)OC)C)C)C)OC,CC1CCC2CC(C(=CC=CC=CC(CC(C(=O)C(C(C(=CC(C(=O)CC(OC(=O)C3CCCCN3C(=O)C(=O)C1(O2)O)C(C)CC4CCC(C(C4)OC)OP(=O)(C)C)C)C)O)OC)C)C)C)OC,Serine/threonine-protein kinase mTOR
Dinaciclib,CIDs46926350,dinaciclib,396.48602,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,"Cyclin-dependent kinase 1, Cyclin-dependent kinase 2, Cyclin-dependent kinase 5, Cyclin-dependent kinase 9"
Sunitinib,CIDs05329102,sunitinib,398.473783,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,"Stem cell growth factor receptor, Vascular endothelial growth factor receptor 2, Platelet-derived growth factor receptor beta, Platelet-derived growth factor receptor alpha, Vascular endothelial growth factor receptor 1, Tyrosine-protein kinase receptor RET, Tyrosine-protein kinase receptor FLT3, Vascular endothelial growth factor receptor 3, Macrophage colony stimulating factor receptor"
Zolinza,CIDs00005311,vorinostat,264.3202,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,"Histone deacetylase 6, Histone deacetylase 3, Histone deacetylase 1, Histone deacetylase 2"
5-FU,CIDs00003385,5-fluorouracil,130.077223,C1=C(C(=O)NC(=O)N1)F,C1=C(C(=O)NC(=O)N1)F,"Thymidylate synthase, RNA, DNA"
6-Thioguanine,CIDs02723601,6-thioguanine,167.1917,C1=NC2=C(N1)C(=S)N=C(N2)N,C1=NC2=C(N1)C(=S)N=C(N2)N,"Inosine-5'-monophosphate dehydrogenase (IMPDH), DNA"
Pemetrexed Disodium ,CIDs135413520,,0,,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)NC(=N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+],"Dihydrofolate reductase, Thymidylate synthase, GAR transformylase"
Estramustine phosphate sodium,CIDs00444000,MUZ9585Y7B,564.346701,CC12CCC3C(C1CCC2OP(=O)([O-])[O-])CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl.[Na+].[Na+],CC12CCC3C(C1CCC2OP(=O)([O-])[O-])CCC4=C3C=CC(=C4)OC(=O)N(CCCl)CCCl.[Na+].[Na+],"Estrogen receptor beta, DNA"
Erlotinib hydrochloride,CIDs00176871,,0,,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl,Epidermal growth factor receptor erbB1
Pazopanib hydrochloride,CIDs11525740,,0,,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl,"Tyrosine-protein kinase LCK, Stem cell growth factor receptor, Fibroblast growth factor receptor 3, Vascular endothelial growth factor receptor, Tyrosine-protein kinase ITK/TSK, Fibroblast growth factor receptor 1, Platelet-derived growth factor receptor, Macrophage colony stimulating factor receptor"
PYRIDOSTIGMINE BROMIDE,CIDs00007550,none,0,none,C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-],Acetylcholinesterase
PENTOLINIUM TARTRATE,CIDs00005849,pentolinium,538.58578,C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C.C(C(C(=O)[O-])O)(C(=O)O)O.C(C(C(=O)[O-])O)(C(=O)O)O,C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C.C(C(C(=O)[O-])O)(C(=O)O)O.C(C(C(=O)[O-])O)(C(=O)O)O,Neuronal acetylcholine receptor; alpha3/beta4
ETHINYL ESTRADIOL,CIDs00005991,ethynylestradiol,296.40336,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,Estrogen receptor alpha
OLMESARTAN MEDOXOMIL,CIDs00130881,olmesartan medoxomil,558.5851,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,Type-1 angiotensin II receptor
RUFINAMIDE,CIDs00129228,rufinamide,238.193526,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,Sodium channel alpha subunit
ZALEPLON,CIDs00005719,zaleplon,305.3339,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,CCN(C1=CC=CC(=C1)C2=CC=NC3=C(C=NN23)C#N)C(=O)C,GABA A receptor alpha-1/beta-1/gamma-2
TESTOLACTONE,CIDs00013769,testolactone,300.39206,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,CC12CCC3C(C1CCC(=O)O2)CCC4=CC(=O)C=CC34C,Cytochrome P450 19A1
ACETOHEXAMIDE,CIDs00001989,acetohexamide,324.3953,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2,CC(=O)C1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2,"Sulfonylurea receptor 1, Kir6.2"
CLOPIDOGREL,CIDs00060606,clopidogrel,321.82174,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3,Purinergic receptor P2Y12
CILASTATIN,CIDs06435415,cilastatin,358.45304,CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C,CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C,Renal dipeptidase
OXYPHENONIUM BROMIDE,CIDs00005748,oxyphenonium,428.40356,CC[N+](C)(CC)CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.[Br-],CC[N+](C)(CC)CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.[Br-],"Muscarinic acetylcholine receptor M3, Muscarinic acetylcholine receptor M1"
PROBENECID,CIDs00004911,probenecid,285.35926,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,"Solute carrier family 22 member 6, Solute carrier family 22 member 8, Solute carrier family 22 member 11"
METYROSINE,CIDs00441350,alpha-methyl-p-tyrosine,195.21512,CC(CC1=CC=C(C=C1)O)(C(=O)O)N,CC(CC1=CC=C(C=C1)O)(C(=O)O)N,Tyrosine 3-hydroxylase
ALBENDAZOLE,CIDs00002082,albendazole,265.3314,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,Tubulin
VALPROIC ACID,CIDs00003121,valproate,144.21144,CCCC(CCC)C(=O)O,CCCC(CCC)C(=O)O,Succinate semialdehyde dehydrogenase
ILOPROST,CIDs05311181,iloprost,360.48708,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,CC#CCC(C)C(C=CC1C(CC2C1CC(=CCCCC(=O)O)C2)O)O,Prostanoid IP receptor
TRIFLUPROMAZINE,CIDs00005568,triflupromazine,352.41707,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F,Dopamine D2 receptor
ENTACAPONE,CIDs05281081,entacapone,305.286,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,Catechol O-methyltransferase
ATENOLOL,CIDs00002249,atenolol,266.33608,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,CC(C)NCC(COC1=CC=C(C=C1)CC(=O)N)O,Beta-1 adrenergic receptor
SPIRONOLACTONE,CIDs00005833,spironolactone,416.57348,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,Mineralocorticoid receptor
CISAPRIDE,CIDs00002769,cisapride,465.945463,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,Serotonin 4 (5-HT4) receptor
ARMODAFINIL,CIDs09690109,armodafinil,273.3501,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N,Dopamine transporter
4-AMINOSALICYLIC ACID,CIDs00004649,APAs,153.13538,C1=CC(=C(C=C1N)O)C(=O)O,C1=CC(=C(C=C1N)O)C(=O)O,Dihydrofolate reductase
TRIAMTERENE,CIDs00005546,triamterene,253.26264,C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N,C1=CC=C(C=C1)C2=NC3=C(N=C(N=C3N=C2N)N)N,"Amiloride-sensitive sodium channel, ENaC"
RISPERIDONE,CIDs00005073,risperidone,410.484483,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,"Serotonin 2a (5-HT2a) receptor, Dopamine D2 receptor, Serotonin 2c (5-HT2c) receptor"
ACETAZOLAMIDE,CIDs00001986,acetazolamide,222.24544,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,CC(=O)NC1=NN=C(S1)S(=O)(=O)N,"Carbonic anhydrase I, Carbonic anhydrase II, Carbonic anhydrase XII, Carbonic anhydrase IV"
DESOXYCORTICOSTERONE PIVALATE,CIDs11876263,desoxycorticosterone pivalate,414.57752,CC12CCC3C(C1CCC2C(=O)COC(=O)C(C)(C)C)CCC4=CC(=O)CCC34C,CC12CCC3C(C1CCC2C(=O)COC(=O)C(C)(C)C)CCC4=CC(=O)CCC34C,Mineralocorticoid receptor
CARGLUMIC ACID,CIDs00121396,N-carbamylglutamate,190.154,C(CC(=O)O)C(C(=O)O)NC(=O)N,C(CC(=O)O)C(C(=O)O)NC(=O)N,"Carbamoyl-phosphate synthase [ammonia], mitochondrial"
METHYCLOTHIAZIDE,CIDs00004121,methyclothiazide,360.23734,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl,CN1C(NC2=CC(=C(C=C2S1(=O)=O)S(=O)(=O)N)Cl)CCl,Thiazide-sensitive sodium-chloride cotransporter
PHENSUXIMIDE,CIDs00006839,phensuximide,189.21054,CN1C(=O)CC(C1=O)C2=CC=CC=C2,CN1C(=O)CC(C1=O)C2=CC=CC=C2,Voltage-gated T-type calcium channel
BOSENTAN,CIDs00104865,bosentan,551.61406,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,"Endothelin receptor, ET-A/ET-B"
VARENICLINE,CIDs05310966,1) varenicline,211.26242,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,C1C2CNCC1C3=CC4=NC=CN=C4C=C23,Neuronal acetylcholine receptor; alpha4/beta2
SUMATRIPTAN,CIDs00005358,sumatriptan,295.40044,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C,"Serotonin 1b (5-HT1b) receptor, Serotonin 1d (5-HT1d) receptor"
EPTIFIBATIDE,CIDs00448812,eptifibatide,831.96186,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,C1CC2C(=O)NC(CSSCCC(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N2C1)CC3=CNC4=CC=CC=C43)CC(=O)O)CCCCN=C(N)N)C(=O)N,Integrin alpha-IIb/beta-3
ISOSORBIDE DINITRATE,CIDs00006883,isosorbide dinitrate,236.13632,C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],C1C(C2C(O1)C(CO2)O[N+](=O)[O-])O[N+](=O)[O-],Soluble guanylate cyclase
MESALAZINE,CIDs00004075,mesalazine,153.13538,C1=CC(=C(C=C1N)C(=O)O)O,C1=CC(=C(C=C1N)C(=O)O)O,"Arachidonate 5-lipoxygenase, Peroxisome proliferator-activated receptor gamma, Cyclooxygenase"
SUCCINYLCHOLINE CHLORIDE,CIDs00022475,none,0,none,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-],Muscle-type nicotinic acetylcholine receptor
CARBACHOL,CIDs00005831,none,0,none,C[N+](C)(C)CCOC(=O)N.[Cl-],Muscarinic acetylcholine receptor M3
MEPHENYTOIN,CIDs00004060,mephenytoin,218.25176,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,CCC1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,Sodium channel alpha subunit
TINIDAZOLE,CIDs00005479,tinidazole,247.27152,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,DNA
LIOTHYRONINE,CIDs00005920,"3,5,3'-triiodothyronine",650.97349,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)O)N)I)I)O,Thyroid hormone receptor
FURAZOLIDONE,CIDs05323714,furazolidone,225.15828,C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],C1COC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],DNA
MIGLUSTAT,CIDs00051634,miglustat,219.27804,CCCCN1CC(C(C(C1CO)O)O)O,CCCCN1CC(C(C(C1CO)O)O)O,Ceramide glucosyltransferase
DICHLORPHENAMIDE,CIDs00003038,dichlorphenamide,305.15884,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,C1=C(C=C(C(=C1S(=O)(=O)N)Cl)Cl)S(=O)(=O)N,"Carbonic anhydrase I, Carbonic anhydrase II, Carbonic anhydrase XII, Carbonic anhydrase IV"
BACLOFEN,CIDs00002284,baclofen,213.66078,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,GABA-B receptor
THEOPHYLLINE,CIDs00002153,theophylline,180.16402,CN1C2=C(C(=O)N(C1=O)C)NC=N2,CN1C2=C(C(=O)N(C1=O)C)NC=N2,"Phosphodiesterase 4, Phosphodiesterase 3, Adenosine receptor"
BRETYLIUM TOSYLATE,CIDs00006100,none,0,none,CC[N+](C)(C)CC1=CC=CC=C1Br.CC1=CC=C(C=C1)S(=O)(=O)[O-],Norepinephrine transporter
CANRENONE,CIDs00013789,canrenone,340.45592,CC12CCC(=O)C=C1C=CC3C2CCC4(C3CCC45CCC(=O)O5)C,CC12CCC(=O)C=C1C=CC3C2CCC4(C3CCC45CCC(=O)O5)C,Mineralocorticoid receptor
ULIPRISTAL ACETATE,CIDs00130904,ulipristal acetate,475.61908,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C,Progesterone receptor
ACETOHYDROXAMIC ACID,CIDs00001990,acetohydroxamic acid,75.0666,CC(=O)NO,CC(=O)NO,Bacterial urease
DIAZOXIDE,CIDs00003019,diazoxide,230.67138,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,CC1=NS(=O)(=O)C2=C(N1)C=CC(=C2)Cl,"Potassium channel, inwardly rectifying, subfamily J, member 8, Potassium channel, inwardly rectifying, subfamily J, member 11"
CHLORZOXAZONE,CIDs00002733,stealth,169.56516,C1=CC2=C(C=C1Cl)NC(=O)O2,C1=CC2=C(C=C1Cl)NC(=O)O2,Intermediate conductance calcium-activated potassium channel protein 4
DIGITOXIN,CIDs00441207,digitoxin,764.93906,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)O,Sodium/potassium-transporting ATPase
MELPHALAN HYDROCHLORIDE,CIDs09927978,none,0,none,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl.Cl,DNA
